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ABSTRACT
Articular cartilage is a resilient and load bearing material that provides 
diarthrodial joints with excellent friction, lubrication and wear characteristics required 
for continuous motion. However, articular cartilage has a poor regenerative capacity 
and its degeneration is a common cause of morbidity in terms of loss of joint function 
and osteoarthritis, frequently resulting in the need for total knee replacement.
Articular cartilage has a distinct zonal architecture with biochemical and 
cellular variations existing from the surface zone to the deeper calcified layers. Thus, 
the development of the tissue must be stringently controlled, both spatially and 
temporally in order for the complex structure to be established. Importantly, the 
surface zone is believed to be responsible for the appositional growth of articular 
cartilage during development and this growth is believed to be driven by a population 
of slow cycling progenitor cells within the surface zone itself.
The focus of this thesis is the isolation and characterisation of articular 
cartilage progenitor cells together with an exploration of the cells capabilities in 
potential cartilage repair therapies. The cells were identified on the basis of 
differential adhesion assays and colony forming ability. Subsequent experiments were 
carried out to show the differential expression of various cell surface markers eg 
Notch 1 receptors and the role of the onco-foetal form of fibronectin, known as 
fibronectin-EDA on the modulation of cell behaviour. In terms of the potential of the 
cells for use in tissue engineering, a promising feature of the cells is the discovery that 
enriched populations of the cells can undergo extensive expansion in simple 
monolayer cultures and yet retain their ability to undergo chondrogenic 
differentiation. This property may enable the use of the cells in commercial cartilage 
repair and/or tissue engineering strategies.
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Chapter 1: Introduction
1.1 ARTICULAR CARTILAGE STRUCTURE. FUNCTION AND
DEVELOPMENT
1.1.1 Introduction
Articular cartilage is a resilient and load-bearing material that provides diarthrodial 
joints with excellent friction, lubrication and wear characteristics required for 
continuous gliding motion and also acts as a shock absorber to distribute applied loads 
over the subchondral bone (Mow et al., 1992; Mankin et al., 1994). Although articular 
cartilage varies in thickness, cell density, matrix composition, and mechanical 
properties within the same joint, among joints, among species and with age, in all 
synovial joints it consists of the same components, the same general structure and 
performs the same functions (Stockwell, 1971; Athanasiou et al, 1991). Despite 
articular cartilage being in the order of only a few millimetres in thickness, its unique 
structure and composition allow it to withstand considerable biomechanical forces 
over many decades of walking, running and jumping (Buckwalter and Mankin, 1997; 
Mowetal., 1992).
The uniqueness of articular cartilage arises from the tissue being primarily composed 
of extracellular matrix with relatively few cells, known as chondrocytes. There is no 
direct blood supply, relying on diffusion for nutrition. Articular cartilage lacks nerves 
and a lymphatic system (Mankin et al., 1994). Although at first glance the tissue may 
appear to be of a simple nature, detailed examination reveals it to possess a distinct, 
highly ordered structure (Jeffery et al., 1991; Poole et al., 2001) that facilitates a 
complex interaction between the extracellular matrix and the chondrocyte (Benjamin 
et al., 1994; Buckwalter and Mankin, 1997) which serves to actively maintain the 
tissue throughout the life of the organism.
Articular cartilage has a limited capacity for repair (Campbell, 1969), a consequence 
of the unique properties described above. The chondrocytes have a low mitotic ability 
and are restricted in their ability to migrate to the site of injury due to the cells being 
individually enclosed in extracellular matrix. In addition, the lack of a blood supply 
eliminates the prospect of a repair response initiated and orchestrated by the process 
of inflammation (Newman, 1998). The lack of an effective reparative response means
2
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that limited damage to articular cartilage due to trauma or from degenerative diseases 
will remain unhealed. Such lesions, over time, may progress to more severe and 
progressive disabilities of the joint, culminating in total erosion of the articular 
cartilage and loss of joint function. Total or partial joint replacement procedures are 
routinely used to restore pain free motion as a last resort in the treatment of end-stage 
degenerative joint disease (Buckwalter and Lohmander, 1994; Buckwalter and 
Mankin, 1997a; Gilbert, 1988; Newman, 1998; Hunziker, 2001a).
This section presents an overview of the current understanding of articular cartilage 
structure, function and development in order to provide a basis for understanding its 
degeneration, current repair techniques and the prospects for more efficacious future 
therapies.
1.1.2 The chondrocyte
Articular cartilage is composed of a single cell type known as the chondrocyte which 
occupy around only 10% of the total tissue volume (Archer and Francis-West, 2003). 
This figure varies highly, primarily depending upon factors such as age and species 
(Buckwalter and Mankin, 1997). Chondrocytes differ in size, shape and metabolic 
activity throughout the thickness of the tissue (Zanetti et al, 1985; Aydelotte and 
Kuettner, 1988; Aydelotte et al., 1988; Archer et al., 1990) and these differences in 
chondrocyte phenotype are responsible for subtle differences in matrix composition 
throughout the depth of the tissue (Poole et al., 2001) (this aspect will be covered in 
greater detail in section 1.1.3). The structure of articular cartilage is illustrated in 
figure 1.1. Despite these location specific differences, chondrocytes share a number of 
features which together distinguish them from other cell types. The chondrocytes are 
metabolically active and are responsible for the synthesis and maintenance of a unique 
and stable extracellular matrix with which the chondrocytes surround themselves 
preventing the formation of cell-cell contacts. The chondrocytes are primarily 
spherical in shape, synthesise type II collagen and aggrecan (a large aggregating 
proteoglycan) (Buckwalter and Mankin, 1997) and various other minor collagens, 
proteoglycans and non-collagenous proteins (Neame et al., 1999; Poole et al., 2001). 
These matrix components are assembled by the chondrocyte into the complex 
structure that gives articular cartilage its characteristic properties. This complex
3
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structure needs to be constantly maintained by the cell, involving replacement of 
degraded matrix components and alterations in the macromolecular composition and 
framework in response to loading of the joint during use (Buckwalter and Mankin, 
1997). Thus the cells must sense these changes in the extracellular matrix composition 
due to degradation and loading and respond accordingly (Buschmann et al., 1995; 
Quinn et al., 1998; Durrant et al., 1999; Salter et al., 2001; Smith et al., 2004).
In the adult organism articular cartilage is avascular, thus chondrocytes derive most of 
their nutrition from the synovial fluid. The nature of this system results in a low 
oxygen concentration in the tissue relative to other tissues as nutrients must first 
diffuse through the synovial fluid and then through the cartilage matrix which is also 
restrictive with respect to molecular size and charge. Therefore, the chondrocyte 
depends primarily on glycolytic metabolism (Buckwalter and Mankin, 1997).
Chondrocyte activity and density within articular cartilage differs significantly 
between the phase of skeletal growth during foetal development and in the early 
stages of life and the phase when skeletal growth has ceased in the adult (Mankin et 
al., 1994). Cartilage is formed from undifferentiated mesenchymal condensations in 
the foetus (Archer et al., 1994; Archer and Francis-West, 2003) and subsequent matrix 
synthesis leads to the separation of cells which assume a spherical morphology. At 
these early stages in the growth of articular cartilage the cell density and metabolic 
activity is high as the chondrocytes proliferate rapidly and synthesise large quantities 
of matrix, thus driving growth. With skeletal maturity, metabolic activity, matrix 
synthesis and cell division declines and hence cell density declines (Stockwell, 1967; 
Leutert, 1980; Buckwalter and Mankin 1997). In the mature skeleton, articular 
chondrocytes rarely undergo mitosis under normal physiological conditions, although 
still synthesise collagens, proteoglycans and other matrix components in an ongoing 
maintenance of the macromolecular framework. With ageing, the capacity of the cells 
to synthesise certain components of the matrix (Thonar et al., 1986; Bolton et al., 
1999) and respond to stimuli, such as growth factors, decreases (Gueme et al., 1995; 
Loeser et al., 2000), thus limiting the ability of the cell to maintain the tissue. These 
age-related changes may ultimately contribute to the development of degenerative 
joint disease (Roughley, 2001).
4
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Figure 1.1: Histological section of articular cartilage (canine) stained with 
haematoxylin and eosin (Bar = 100pm) (A) and schematic representation of 
human articular cartilage illustrating the different zones and diameter and 
orientation of collagen macrofibrils (inset) (B). Taken from Breinan et al., (2001) 
and Poole et al., (2001) respectively.
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1.1.3 Extracellular matrix
The extracellular matrix (ECM) of articular cartilage is composed of tissue fluid and a 
complex framework of structural macromolecules. As the chondrocytes comprise only 
a small proportion of the total volume, the chemical nature of this complex molecular 
framework dictates the mechanical properties of the tissue. The stiffness and 
resilience of the articular cartilage is provided by the interaction of the tissue fluid 
with the macromolecular framework.
1.13.1 Tissue fluid
Water is the most abundant component of articular cartilage, contributing 80% 
of the wet weight. The interaction of water with the matrix macromolecules 
strongly influences the mechanical properties of the tissue (Maroudas and 
Schneiderman, 1987). The fluid contains dissolved gases, small proteins, 
metabolites and a high concentration of cations to balance the abundance of 
poly-anionic proteoglycans. A portion of the water is able to move freely in 
and out of the tissue. The volume, concentration and behaviour of the water 
within the tissue depends primarily on its interaction with the structural 
macromolecules, in particular the large aggregating proteoglycans that help 
maintain the fluid within the matrix and the concentration of electrolytes in the 
fluid (Buckwalter and Mankin, 1997). The abundance of poly-anionic 
carboxylate and sulphate groups of the proteoglycans attracts cations such as 
Na+. This increase in the osmolarity of the tissue is known as the Donnan 
effect. The increase in Donnan osmotic pressure caused by the cations 
associated with the proteoglycans is resisted by the collagen network. Thus, 
there is a balance of swelling pressure (hydration) and constraining forces 
(collagen network) leading to the formation of a cohesive and strong solid gel.
1.1.3.2 Structural macromolecules
Collagens, proteoglycans and non-collagenous proteins comprise the structural 
macromolecules of the tissue. Collagens contribute about 60% of the dry 
weight; proteoglycans 25-35%; non-collagenous proteins and glycoproteins
6
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15-20%. Collagens are distributed evenly throughout the thickness of the 
cartilage (except for the collagen rich superficial zone) and the collagen 
fibrillar network provides the tensile strength. Proteoglycans bind to the 
collagenous meshwork or become mechanically entrapped within it. The 
framework is organised and stabilised by non-collagenous proteins 
(Buckwalter and Mankin, 1997).
1.1.3.3 Collagens
More than 20 different collagen types have been identified so far (Gelse et al.,
2003), with types II, VI, IX, X and XI being present in articular cartilage 
(Mankin et al., 1994). Collagens contain a characteristic triple-helical structure 
composed of three polypeptide a-chains. The a-chains of collagen types II 
and XI aggregate together to form cross-banded fibrils that can be seen with 
electron microscopy. The fibrils are organised into a tight meshwork, 
providing tensile stiffness and mechanically entraps large proteoglycans 
(figure 1.2). Collagen types VI, IX and X do not form fibrils and are termed 
non-fibrillar collagens.
The major cartilage collagen which represents 90-95% of the total, is type II 
(Mankin et al., 1994; Buckwalter and Mankin, 1997). Type IX collagen 
molecules bind to the surfaces of the type II fibrils and project into the matrix 
and may also bind covalently to other collagen type IX molecules. Type XI 
collagen molecules bind covalently to type II collagen molecules and may 
form part of the interior structure of the cross-banded fibrils. Although the 
precise function of type IX and XI is uncertain, they probably help in the 
formation and stabilisation of the fibrils and stabilise both the collagenous 
meshwork and the collagen-proteoglycan interaction (Bruckner et al., 1988; 
Mankin et al., 1994). Type VI collagen forms an important part of the matrix 
immediately surrounding the chondrocyte and may be involved with matrix 
stabilisation and chondrocyte attachment to the matrix (Marcelino and 
McDevitt, 1995; Keene et al., 1988). Type X collagen is located only in the 
calcified cartilage zone at the junction of the articular cartilage with the
7
Chapter 1: Introduction
subchondral bone, suggesting a role in mineralisation (Schmid and 
Linsenmayer, 1985).
1.1.3.4 Proteoglycans
Proteoglycans are complex macromolecules that consist of a protein core to 
which are linked extend glycosaminoglycan (GAG) chains. Approximately 
80-90% of all proteoglycans in articular cartilage are of the large aggregating 
type called aggrecan (Mankin et al., 1994; Hardingham and Fosang, 1995) the 
structure of which is illustrated in figure 1.3. These proteoglycans consist of a 
large extended protein core to which are attached up to 1 0 0  chondroitin 
sulphate (CS) and 50 keratan sulphate (KS) glycosaminoglycans chains. The 
protein core is large and complex with several distinct globular and extended 
domains. One extended domain contains the majority of KS GAG chains 
which is adjacent to a large extended domain rich in attached CS GAG chains. 
A G1 globular domain at the N-terminal end of the protein core functions to 
non-covalently bind the proteoglycan to hyaluronate, and this binding is 
stabilised by link protein. As the GAG hyaluronate chain may be long and 
unbranching, many proteoglycans chains (up to 300) may bind, forming a 
large proteoglycan aggregate (Hardingham and Fosang, 1995). The formation 
of the large aggregates helps anchor the proteoglycans within the matrix 
preventing their displacement during deformation of the tissue. Versican is 
another hyaluronate binding proteoglycan from the same family as aggrecan, 
that also includes neurocan and brevican (Margolis and Margolis, 1994). 
Versican is present in articular cartilage to a lesser extent than aggrecan and 
may function (together with aggrecan) to stabilise the ECM and cell-matrix 
interactions (Chen et al., 2003).
Besides the large aggregating proteoglycans in cartilage there are small, 
leucine-rich proteoglycans including decorin, biglycan, fibromodulin, perlecan 
and lumican (Roughly and Lee, 1994; Poole et al., 1996a and 2001). Type IX 
collagen is also considered a proteoglycan as it contains a CS chain (Mankin 
et al., 1994). Decorin has one dermatan sulphate chain, biglycan has two 
dermatan sulphate chains and fibromodulin has several KS chains. Perlecan
8
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contains heparan sulphate whereas lumican contains KS. These small non­
aggregating proteoglycans have shorter protein cores than do aggrecan 
molecules and do not fill a large volume of the tissue or contribute directly to 
the mechanical behaviour. Instead these proteoglycans may bind to other 
macromolecules and/or influence cell behaviour. Decorin and fibromodulin 
bind type II collagen and may be involved with fibrillogenesis, organising and 
stabilising the type II meshwork (Hedbom and Heinegard, 1993; Mankin et al., 
1994; Roughly and Lee, 1994; Poole et al., 2001). Biglycan is localised in the 
pericellular matrix and may interact with type VI collagen (Roughly and Lee, 
1994).
1.1.3.5 Non-collagenous and non-proteoglycan components
Other matrix components include anchorin CII (a collagen binding 
chondrocyte surface protein involved in anchoring the chondrocyte to the 
collagen fibrils of the matrix), COMP (cartilage oligomeric protein), matrillin- 
I, CILP (cartilage intermediate layer protein), fibronectin and tenascin. The 
functions of the components is not clearly understood but may be involved in 
organisation and maintenance of the macromolecular structure of the matrix 
and cell-matrix interactions (Mollenhauer et al., 1984; Hedbom et al., 1992; 
DiCesare et al., 1994; Chevalier et al., 1994 and 1996; Lorenzo et al., 1998; 
Neame et al., 1999; Poole et al., 2001).
9
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Figure 1.2: Molecular organisation of the solid matrix of articular 
cartilage as a fibre-reinforced composite solid matrix. The swelling 
pressure exerted by the proteoglycan keeps the collagen network inflated. 
Taken from Mankin et al., 1994.
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Figure 1.3: (A) Schematic diagram illustrating the structure of the 
aggrecan molecule and its binding to hyaluronate. The protein core has 
several globular domains (Gl, G2, and G3), with other regions containing 
the keratan sulphate and chondroitin sulphate glycosaminoglycan chains. 
The N-terminal Gl domain is able to bind specifically to hyaluronate. 
This binding is stabilised by link protein. (B) Schematic diagram 
illustrating arrangement of aggrecan monomers as an aggregate which 
would be immobilised within the collagen network. Taken from Mankin 
et al., 1994.
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1.1.4 Architecture of articular cartilage
1.1.4.1 Zonal arrangements
Articular cartilage has a distinct zonal architecture (figure 1.1), comprising a 
superficial (or tangential zone), a transitional zone, a radial or deep zone and a 
calcified cartilage zone (Buckwalter and Mankin, 1997). The relative size and 
appearance of the zones varies with age, among species and between joints. 
Importantly this distinct architecture is now believed to be pivotal to the 
function and mechanical properties of the tissue.
In each zone, the chondrocytes are responsible for organising the collagens, 
proteoglycans and non-collagenous components into a unique and highly 
ordered structure. Although collagen II and aggrecan are present throughout 
the depth of the tissue, there are subtle differences in collagen II abundance, 
fibril size, orientation (Poole et al., 2001) and proteoglycan aggregate size and 
composition throughout the thickness (Zanetti et al., 1985; Bayliss et al., 1999; 
Poole et al., 2001). This zonal variation in composition is illustrated in figure 
1.1. In addition there are also variations in the presence of specific matrix 
components, for example Del 1 (Pfister et al., 2001) and lubricin 
(Proteoglycan-4 or superficial zone protein) (Schumacher et al., 1999) are 
localised in the surface layers. CILP is localised to the intermediate layers 
(Lorenzo et al., 1998) and the deeper zones are characterised by the presence 
of type X collagen (Schmid and Linsenmayer, 1985).
This biochemical heterogeneity is paralleled by variations in chondrocyte 
cellularity, morphology and metabolic activity in each of the different zones 
(Zanetti et al, 1985; Aydelotte and Kuettner, 1988; Aydelotte et al., 1988; 
Archer et al., 1990). In the superficial zone, the cells are ellipsoid-shaped and 
arranged parallel to the articular surface. In the transitional zone the cells 
assume a spheroidal shape in the deeper zone the cells lie in columns which 
are arranged perpendicular to the joint surface (Buckwalter and Mankin, 
1994). Superficial zone cells in culture are known to secrete less proteoglycan 
than cells lying deeper in the tissue (Aydelotte and Kuettner, 1988) and this
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proteoglycan contains a lower level of KS GAG chains (Zanetti et al., 1985). 
These properties of cultured chondrocytes isolated from the specific zones 
correspond to the known biochemical composition throughout the thickness of 
the tissue. Hence the biochemical composition and consequently biophysical 
properties of the matrix at different depths is a reflection of the specific 
metabolic activities of the cells within the particular zone.
1.1.4.2 Regional variations
Within the zones there are variations or regions in the cartilage matrix 
components, illustrated in figure IB. These are known as the pericellular, 
territorial and inter-territorial regions (Mankin et al., 1994; Buckwalter and 
Mankin, 1997; Poole et al., 2001). In the pericellular and territorial regions the 
chondrocytes bind to matrix macromolecules and protect the cells from 
damage during loading of the tissue. These regions may also act as a system 
whereby signals are transmitted to the chondrocyte following loading and 
deformation of the cartilage, thus allowing the chondrocyte to sense 
mechanical stimuli and respond appropriately (Buschmann et al., 1995; Quinn 
et al., 1998; Durrant et al., 1999; Salter et al., 2001). The primary function of 
the inter-territorial region is to provide the mechanical properties of the tissue 
(Mankin et al., 1994).
Pericellular region: The pericellular matrix covers the cell surface, is rich in 
proteoglycans and contains little collagen. Also present is the cell membrane- 
associated molecule Anchorin CII (Mollenhauer et al., 1984) and the non- 
fibrillar type-VI collagen (Marcelino and McDevitt, 1995). Cytoplasmic 
extensions project from the chondrocyte through the pericellular matrix and 
into the territorial matrix.
Territorial region: The territorial matrix envelopes the pericellular matrix. The 
thin collagen fibrils of the territorial matrix closest to the cell appears to bind 
to the pericellular matrix whereas more distant to the cell the fibrils bisect at 
various angles to form a fibrillar basket around the cells. This basket structure
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is thought to provide protection for the chondrocyte from mechanical loading 
(Mankin et al., 1994; Buckwalter and Mankin, 1997).
Inter-territorial region: This region makes up most of the volume of the tissue 
of adult, mature articular cartilage and contains the largest diameter collagen 
fibrils. In the superficial zone the fibrils are thinner and arranged parallel with 
the joint surface. In the transitional zone the fibrils lie at oblique angles 
relative to the joint surface and in the radial zone the fibrils are arranged 
perpendicular to the surface (Mankin et al., 1994; Buckwalter and Mankin, 
1997).
1.1.5 Changes in structure with age
The development of articular cartilage in the embryo and foetus will be discussed in 
the section 1.1.6. Following birth there is a shift from the immature to the mature 
form of articular cartilage (Mankin et al., 1994). Articular cartilage from neonatal or 
immature animals is relatively thick and blue-white in colour. The thickness of the 
articular cartilage reduces as ossification from the secondary centre of ossification 
progresses. In addition, immature articular cartilage is considerably more cellular than 
mature adult articular cartilage (Leutert, 1980) and there are also differences in the 
thickness of the various articular cartilage zones between immature and mature 
cartilage.
Cell replication in immature articular cartilage occurs at two distinct regions: one 
region occurs subjacent to the articular surface and probably accounts for the growth 
of the tissue during development. The second region occurs above the subchondral 
plate (Mankin, 1962). As the cartilage matures, proliferation becomes confined to the 
region above the subchondral plate and proliferation at the articular surface ceases. 
All mitotic activity ceases in the adult, coinciding with the development of a well- 
defined tidemark.
In addition to changes in cellularity there are also changes in matrix composition with 
age. Water content is higher in immature tissue and slowly reduces to a static level 
that remains constant throughout adulthood. In addition, the collagen content of foetal
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articular cartilage is lower than that of mature cartilage, with collagen concentration 
rising after birth and maintained throughout life. The major changes that take place in 
the cartilage matrix occur with the proteoglycans. Proteoglycan content is highest at 
birth and diminishes slowly throughout life. In addition, the length of the protein core 
and GAG chains reduce with age, together with the level of proteoglycan aggregation. 
There is also a shift towards reduction in the level of chondroitin sulphate relative to 
keratan sulphate (Thonar et al., 1986; Mankin et al., 1994; Bolton et al., 1999). There 
are subtle differences in the composition of GAG chains of minor proteoglycans such 
as decorin, fibromodulin, biglycan and lumican with age. Some of the changes are due 
to variations in synthesis whereas others are due to variations in degradation 
(Roughly, 2001). Although the functional consequences of these changes remains 
unclear it is likely some of the alterations in composition may predispose the tissue to 
degenerative changes.
1.1.6 Development of articular cartilage
Embryonic skeletal development involves the recruitment, commitment, 
differentiation and maturation of mesenchymal cells into cartilage and bone along the 
intramembranous and endochondral ossification pathways. The process of 
endochondral ossification begins during the sixth week of human embryonic 
development when mesenchymal cells differentiate, condense, and transform into 
chondrocytes which form a cartilaginous model of the early skeleton (Archer, 1994; 
DeLise et al., 2000; Vortkamp, 2001; Tuan, 2004). In the central region of the 
cartilaginous anlage, the chondrocytes hypertrophy and the matrix begins to calcify. 
Subsequently a periosteal sleeve of bone forms around the periphery of the anlage in 
the central portion. By the eighth week, capillary buds invade this central portion of 
the hypertrophied and calcified cartilaginous anlage, which brings mesenchymal cells 
to the region which subsequently differentiate into osteoblasts and osteoclasts 
(Iannotti, 1990). The osteoblasts lay down an osteoid matrix on the spicules of 
calcified cartilage forming trabecular bone. At this stage, the primitive long bone 
element now consists of a central diaphyseal region of trabecular bone with 
cartilaginous regions at both epiphyseal ends. At both interfaces between the 
epiphyseal cartilaginous regions and the central bone portion the growth plates form. 
Longitudinal bone growth at the growth plates is driven by proliferation of pre­
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chondrocytes, with subsequent chondrogenic differentiation and hypertrophy, terminal 
differentiation and mineralisation. At around birth, the epiphyseal cartilaginous 
regions ossify through secondary centres of ossification which form in the epiphyseal 
ends (Iannotti, 1990).
The mechanism underlying chondrocytic differentiation during endochondral 
ossification at epiphyseal growth plates has been the focus of much research in recent 
years (Sandell and Adler, 1999; DeLise et al., 2000; Vorthamp, 2001). Cartilage 
growth at epiphyseal plates is regulated by a complex series of molecular signals such 
as bFGF, IGF-I, Indian Hedgehog, parathyroid hormone related peptide, GDF-5, bone 
morphogenetic proteins and wingless signalling systems (Francis-West et al., 1999; 
Sandell and Adler, 1999; Volk and Leboy, 1999; DeLise et al., 2000; Vorthamp, 
2001; Buxton et al., 2003; Tuan, 2004). The factors driving the growth of articular 
cartilage during development have received comparatively less attention, possibly a 
result of a presumption that articular cartilage represents the remnants of the 
embryonic epiphysis that fails to be replaced by bone during endochondral 
ossification (Archer et al., 2003). Although this may still be case, it is now becoming 
clear that the development of articular cartilage is a complex process involving 
numerous signalling mechanisms regulated in a temporal and spatial manner (Archer, 
1994; Archer et al., 1994; Hayes et al., 2001; Hayes et al., 2003; Archer et al., 2003; 
Dowthwaite et al., 2004). In addition, complex temporal and spatial changes in 
patterns of matrix components of articular cartilage during growth have also been 
described (Morrison et al., 1996; Archer et al., 1996). In view of the well documented 
limited repair capacity of articular defects (Campbell, 1969; Hunziker, 2001a), 
understanding the mechanisms underlying the development of articular cartilage and 
the cellular and molecular processes involved in tissue patterning and morphogenesis 
may greatly facilitate the development of regenerative approaches to cartilage repair.
Of particular interest is the manner by which, during development, articular cartilage 
shifts from an immature, highly cellular and predominantly isotropic tissue with 
collagen orientation running parallel to the articular surface, to a mature, anisotropic 
tissue with a distinct zonal architecture with decreased cellularity (Meachim, 1969; 
Leutert, 1980; Mankin et al., 1994) and with collagen fibres predominantly 
perpendicular to the articular surface in the basal regions which then arch over to
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become parallel at the surface (Jeffrey et al., 2001). Does this change in matrix 
structure occur through remodelling of the existing matrix or by replacement of the 
existing matrix (Hayes et al., 2001; Archer et al., 2003)?
How this shift occurs is likely to be explained by understanding the mechanism by 
which articular cartilage develops following joint cavitation. As described earlier, 
early in development, condensation of pre-chondrogenic mesenchyme, via N- 
cadherin, N-CAM and CD44 interactions, begins the process of the formation of the 
cartilaginous skeleton (Archer, 1994; DeLise et al., 2000; Vortkamp, 2001; Tuan,
2004). Initially in the location of the prospective joint there is cartilaginous continuity 
which then segments secondarily through the formation of a non-cartilagenous region 
known as the interzone (Craig et al., 1987; Archer et al., 1994; Archer et al., 2003). 
The interzone comprises a thin layer of elongated cells closely compacted between the 
developing articular surfaces. The interzone becomes an important signalling centre 
(Hartman and Tabin, 2000) as the elements begin to oppose, and joint cavitation 
occurs, driven by the selective high-level synthesis of hyaluronan (Dowthwaite et al., 
1998; Ward et al., 1999) by interzone cells and presumptive synovial cells. The 
interzone subsequently disperses during cavity enlargement as the articular surfaces 
further develop.
In immature rabbit articular cartilage, two zones of proliferation are evident, one 
above the subchondral plate, one just beneath the articular surface. When skeletal 
maturity is reached, no zones of proliferation can be observed (Mankin, 1962 and 
1964). This observation is suggestive that articular cartilage growth occurs by 
apposition from the articular surface rather than by interstitial mechanisms. 
Subsequent studies using BrdU labelling in the articular cartilage of Monodelphis 
domestica (a marsupial bom with the hind limbs at an early stage of development) has 
indeed demonstrated that subsequent to the formation of the secondary centre of 
•ossification, the surface zone is responsible for the appositional growth of articular 
cartilage during development (Hayes et al., 2001). In addition, other studies have 
shown that the surface region has a central role in joint cavitation (Ward et al., 1999) 
and that many growth factors such as IGF-I and -II, and TGFpi-3 and their receptors 
are also highly expressed in this region (Archer et al., 1994; Hayes et al., 2001).
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Although the above evidence illustrates that the surface region plays a key role in the 
development and growth of articular cartilage, such a growth mechanism would 
require the presence of a population of progenitor cells in the surface of the tissue. 
These cells would generate new progeny which would then go onto expand within the 
transitional zone and progress to terminal differentiation in the upper and lower radial 
zones (figure 1.4). The extensive hypertrophy that accompanies terminal 
differentiation during endochondral ossification need not occur in the case of articular 
cartilage as there is no requirement for longitudinal growth. The deeper zones would 
be remodelled and resorbed during endochondral ossification (Hayes et al., 2001).
It is possible, the identification and characterisation of the progenitor cells present 
within the surface regions would further knowledge of cartilage developmental 
mechanisms and may provide insights into potential novel tissue repair routes.
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Progenitor cell (articular surface)
Transit amplifying unit cells 
(transitional zone)
Differentiation
Terminal
differentiation
Figure 1.4: Diagram summarising proposed cell lineage of articular cartilage. 
Progenitor cells in the articular surface divide to give to daughter cells, one being 
another progenitor cell, the other being a transit-amplifying cell within the 
transitional zone. The transit amplifying unit cell can then undergo further cell 
divisions along the chondrocyte differentiation pathway. Note that the maturing 
chondrocytes do not migrate through the matrix. Rather, as the articular 
cartilage grows through apposition, the relative position of the original transit 
amplifying cells moves relative to the original progenitor cells, which remain at 
the articular surface. Adapted from Hayes et al., 2001.
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1.2 ARTICULAR CARTILAGE INJURY AND OSTEOARTHRITIS
1.2.1 Introduction
Normal pain free movement depends on the unique properties of articular cartilage 
(Buckwalter and Mankin, 1997). Damage or degeneration of articular cartilage causes 
joint pain and loss of mobility and is amongst the most frequent cause of impairment 
in middle-aged and older people (Creamer & Hochberg, 1997; Jackson et al., 2001; 
Buckwalter et al., 2004). The degeneration of articular cartilage results from complex 
cellular, metabolic and structural changes in the tissue (Sandell and Aigner, 2001) and 
occurs most frequently in the clinical syndrome of idiopathic or primary osteoarthritis 
(OA). Articular cartilage degeneration may also result from joint injury (Buckwalter, 
2002; Buckwalter and Brown, 2004) or from developmental, metabolic (Lieberman et 
al., 1992) or inflammatory disorders that destroy the articular surface causing 
secondary osteoarthritis (Buckwalter and Mankin, 1997a; Creamer and Hochberg, 
1997).
In order to develop therapies for articular cartilage damage and osteoarthritis we first 
need to understand the biology of the tissue, the process of degeneration and the 
response of the tissue to injury and disease. The overriding feature of articular 
cartilage that pre-disposes the tissue to degeneration is the intrinsic lack of a 
reparative capacity of the tissue following injury and disease (Campbell, 1969; 
Newman, 1998) and was first described in the scientific literature centuries ago 
(Hunter, 1743). Although a limited attempted repair response is evident following 
injury (Campbell, 1969) the repair is ineffectual. This limited repair response 
challenges earlier views that the tissue is an inert material that simply degrades with 
wear and joint use. It is now evident that the degenerative process that occurs during 
idiopathic or secondary OA following trauma or other pathological disturbance is a 
highly complex cycle of events including cell changes, cell signalling and matrix 
changes (Sandell and Aigner, 2001). In addition, besides the articular cartilage, OA 
involves the entire synovial joint including the synovium and underlying bone 
(Buckwalter and Mankin 1997a; Buckwalter et al., 2000).
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This section presents an overview of the current understanding of articular cartilage 
injury and its degeneration, including an introduction to the disease of osteoarthritis. 
Changes that occur at the cellular and biochemical level will be described in order to 
provide a basis for understanding current and future repair strategies.
1.2.2 Impact of diseases of articular cartilage: prevalence and costs
OA affects people of all ethnic groups in all geographic locations. It develops in both 
men and women, although it occurs most commonly in women and it is the most 
common cause of long-term disability in most populations of people over 65. It is 
estimated that more than 20 million Americans have OA; the World Health 
Organisation estimates that 10% of the world’s people over the age of 60 years suffer 
from OA, and that 80% of people with OA have limitation of movement and 25% 
cannot perform major daily activities (Jackson et al., 2001; Woolf and Pfleger, 2003; 
Buckwalter et al., 2004). Interestingly, in areas of China, OA of the hip is reported to 
be 80-90% less frequent than in white persons in the US (Nevitt, et al., 2002).
The prevalence of OA in all joints increases with age. More than a third of people 
over 45 years report symptoms that vary from a sensation of occasional joint stiffness 
and intermittent aching associated with activity, to permanent loss of motion and 
constant deep pain. In some populations, more than 75% of people over the age of 65 
have OA that involves more than one joint (Buckwalter et al., 2004).
After the age of 40, the incidence of OA increases rapidly with each passing decade in 
all joints and in most joints the incidence is greater in women than in men. Because of 
the strong correlation between age and the incidence of OA, the total number of 
people suffering from this disease is rising rapidly as the proportion of the population 
over age 40 increases.
It is reported that the total economic burden of arthritis is 1 to 2.5% of the gross 
national product of western nations and that OA accounts for a major share of this 
burden. OA is estimated to cost more than $60 million per year in the US. OA is 
currently one of the most prevalent chronic conditions in the US and is second to 
heart disease in causing work disability in men over 50 years. These estimates of costs
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and economic impact do not include pain and suffering, adverse psychosocial effects, 
lost opportunities for increased productivity, decreased ability to participate in regular 
exercise that could improve general health and the costs to family members who help 
provide care for patients with OA (Jackson et al., 2001; Buckwalter et al., 2004; 
Heijbel et al., 2005).
1.2.3 Risk factors
In addition to the disorders responsible for the multiple forms of secondary OA, 
genetic pre-disposition, obesity, female gender, greater bone density and joint laxity 
have been identified as risk factors. Although these factors may increase the risk of 
OA in selected populations, the most important risk factor in all populations is age. 
Repetitive joint use over decades, joint injury, post-traumatic joint incongruity, 
instability or malalignment and joint dysplasia all can create mechanical demands that 
damage articular surfaces (Buckwalter and Brown, 2004; Buckwalter et al., 2004; 
Felson, 2004).
1.23.1 Age
Age is the overriding risk factor for OA. The percent of people with evidence 
of OA in one or more joints increases from less than 5% of people between 15 
and 44 years, to 25-30% of the people between 45 to 64 years of age and to 
more than 60% (may be as high as 90% in some populations) of the people 
over 65 years of age (Buckwalter et al., 2004; Gorevic, 2004).
The composition of the articular cartilage matrix changes with increasing age 
and this is linked to alterations in the activity of the chondrocyte (see section 
1.1.5). Importantly, with increasing age, chondrocyte senescence increases and 
the capacity of the chondrocyte to synthesise matrix components and respond 
to stimuli decreases (Thonar et al., 1986; Mankin et al., 1994; Gueme et al., 
1995; Bolton et al., 1999; Loeser et al., 2000; Martin & Buckwalter, 2002; 
Aigner et al., 2004; Loeser, 2004; Martin et al., 2004) (see section 1.1.2). 
Thus, there is an age-related decrease in the ability of the tissue to repair itself.
2 2
Chapter 1: Introduction
Some of the changes in matrix composition are due to variations in synthesis 
whereas others are due to variations in degradation (Roughley, 2001). 
Chondrocyte senescence is considered to result in phenotypic changes within 
the cell altering the expression of mediators of cartilage destruction such as the 
matrix metalloproteinases (MMPs) and the tissue inhibitors of 
metalloproteinases (TIMPs) (Price et al., 2002). Although the functional 
consequences of these age-related changes remains unclear, it is likely some of 
the alterations in composition may predispose the tissue to degenerative 
changes (Roughley, 2001).
1.2.3.2 Joint injury
Joint injuries and intra-articular fractures frequently lead to progressive joint 
degeneration that causes the clinical syndrome of post-traumatic osteoarthritis 
(Buckwalter and Brown, 2004). The pathophysiology of post-traumatic OA 
has not been fully explained, and it is not simply the magnitude and type of 
injury that determines whether an injured articular surface will repair and 
remodel or undergo progressive degeneration. Joint dislocations, direct and 
indirect joint impact loading, cruciate and collateral ligament, joint capsule 
and meniscal tears all lead to increased risk of OA (Lohmander and Loos, 
1994; Buckwalter and Mankin, 1997a; Buckwalter et al., 2000; Englund et al., 
2003; Buckwalter and Brown, 2004; Felson, 2004). Studies have found men 
with a history of knee injury were at a 5-6-fold increased risk of developing 
osteoarthritis (Felson et al., 1995). This usually occurs in a younger age group 
and can lead to prolonged disability and unemployment. Articular cartilage 
injuries will be covered in greater detail in section 1.2.6.
1.2.3.3 Overuse
Lifelong normal daily activities and regular recreational running have not been 
shown to cause increase the risk of joint degeneration (Buckwalter et al., 
2004). However, repetitive loading of joints over a decade or more, for 
example by individuals in physically demanding occupations such as farmers, 
construction workers, metal workers, miners and pneumatic drill operators
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increases the risk of joint degeneration (Sandmark et al., 2000; Holmberg et 
al., 2004). The risks are highest in jobs that entail both knee bending and 
mechanical loading (Cooper et al., 1994). The strongest association with 
occupational activity has been shown with OA of the knee in men. It is 
thought that up to 30% of all knee OA is attributable to occupational activity 
that involves repeated knee bending, kneeling, squatting or climbing (Felson 
& Zhang, 1998). Sports that subject joints to repetitive high levels of impact 
and torsional loading have also been demonstrated to increase the risk of joint 
degeneration, particularly in association with injuries (Buckwalter and Martin, 
2004). The continuous stress that physical activity places on the joints can 
result in microtrauma and degeneration of the articular cartilage. The onset of 
OA appears to be dependent upon the frequency, intensity and duration of the 
physical activity (Saxon et al, 1999).
1.23.4 Genetics
Epidemiological studies have demonstrated a major genetic component to OA. 
These studies have also revealed differences in risk between males and 
females and for different skeletal sites. Twin pair and family risk studies have 
highlighted the surprisingly large genetic component of OA. Linkage analysis 
studies have highlighted that chromosomes 2, 4, 6, 7, 11, 16 and the X may 
each harbour an OA susceptibility gene. Chromosomes 2, 4 and 16 were 
identified in multiple genome scans and are, therefore, the most likely to 
encode susceptibility. Association analysis of candidates suggests that the 
syntenic genes for collagen II and the vitamin D receptor (12ql2—ql3.1 may 
also encode for OA susceptibility (Loughlin, 2001; Loughlin, 2002; Spector 
and MacGregor, 2004; Peach et al., 2005; Spencer et al., 2005).
1.23.5 Obesity
Obesity is a well accepted risk factor for osteoarthritis and this has been 
demonstrated in numerous studies (Coggon et al, 2001; Nevitt, 2002; Eaton, 
2004; Felson, 2004a; March & Bagga, 2004). Although it is believed the 
increased risk of OA associated with obesity results from both mechanical and
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metabolic factors (Eaton, 2004), other studies (Davis et al., 1990; Sturmer et 
al., 2000) have indicated the risk is associated with the mechanical aspects 
only, with little evidence for the metabolic or systemic effects of obesity. 
Obesity is also associated with the development of disability and the 
radiological progression of OA once established (March & Bagga, 2004).
1.2.3.6 Sex
Although it appears there is a risk factor associated with gender in OA, reports 
vary on the actual prevalence. Data from the U.S. has shown there is a greater 
incidence of hand and knee OA in females, particularly beyond the age of 50, 
with incidences of hip OA being similar (with the exception of women in their 
80’s, where there seems to be a sharp increase in incidence compared to men) 
(Oliveria et al., 1995).
Other studies (March and Bagga, 2004) have suggested that prior to the age of 
50, men have more radiological OA than women, presumed to be largely due 
to secondary OA of the knee following trauma. After the age of 50, the 
prevalence among women increases dramatically. In the hip, the prevalence is 
higher in men aged 55-64. After the age of 65, the prevalence becomes greater 
in women. In the hand, women have a 2.6 times greater risk of developing 
OA. The figures described here are a good estimate of the ratio of OA in men 
and women and it is clear that women are generally at a higher risk of 
developing OA than men.
1.2.4 The degeneration of articular cartilage and osteoarthritis
OA develops most commonly in the absence of a known cause (primary or idiopathic 
OA). Less frequently it may develop as a result of joint injury, joint infection or from 
one of a variety of developmental, metabolic, inflammatory or neurological disorders 
when it is known as secondary or post-traumatic OA (Buckwalter and Mankin, 
1997a).
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OA is characterised pathologically by focal areas of damage to the articular cartilage, 
centred on load bearing areas, associated with remodelling and sclerosis of 
subchondral bone and in many cases the formation of subchondral bone cysts and 
marginal osteophytes (Reimann et al., 1977; Sobokbar et al., 2000; Salaffi et al., 
2003; Durr at al., 2004) (figure 1.5). There will also be varying degrees of mild 
synovitis and thickening of the joint capsule. OA is characterised clinically by the 
presence of symptoms and signs that may include joint pain, restriction of motion, 
crepitus with motion, joint effusions and deformity (Buckwalter and Mankin, 1997a). 
Although OA occurs most frequently in the foot, knee, hip, hands and spine it may 
occur in any synovial joint (Buckwalter, 2004).
Although there is a strong association between age and OA and a widespread view 
that OA develops as a result of “normal wear and tear,” the relationship between joint- 
use, aging and joint degeneration is uncertain. What is clear however is that OA is not 
simply a result of aging and mechanical wear from joint use (Aigner et al., 2004). Nor 
is primary OA caused by inflammation, although inflammatory episodes are common. 
OA consists of a sequence of changes in the cells and matrix that results in the loss of 
structure and function of articular cartilage accompanied by cartilage repair and bone 
remodelling reactions (Sandell and Aigner, 2001). Because of the repair and 
remodelling reactions, the degeneration of the articular surface is not uniformly 
progressive and the rate of degeneration varies among individuals and among joints. 
Occasionally, degeneration occurs rapidly, but in most cases it progresses slowly over 
many years, although it may stabilise or even decrease spontaneously, with at least 
partial restoration of the articular surface and a decrease in symptoms (Buckwalter 
and Mankin, 1997a).
Although OA is primarily characterised by loss of articular cartilage and remodelling 
of subchondral bone and formation of osteophytes, it usually additionally involves all 
of the tissues that form the synovial joint, including synovial tissue, ligaments, joint 
capsule and muscle. The earliest histological changes seen in OA include fraying or 
fibrillation of the superficial zone of articular cartilage, extending into the transitional 
zone (Buckwalter and Mankin, 1997a) (figure 1.6). As the disease progresses, these 
surface irregularities become clefts, more of the articular surface becomes roughened 
and the fibrillation extends deeper into the subchondral bone. There is decreased
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staining for proteoglycan in the superficial and transitional zones, breaching of the 
tidemark by blood vessels from subchondral bone and remodelling of subchondral 
bone (Reimann et al., 1977; Hamerman and Stanley, 1996). Chondrocytes are present 
as small clones, which arise from an attempted repair response involving limited 
chondrocyte proliferation. It is unclear at present whether the subchondral bone 
remodelling occurs initially and leads to the degeneration of the articular cartilage or 
whether loss of articular cartilage increases stresses on the subchondral bone leading 
to remodelling (Radin and Rose, 1986). Interestingly, in the Dunkin-Hartley guinea 
pig model of spontaneous OA, subchondral bone changes occur prior to the onset of 
changes in the articular cartilage (Anderson-Mackenzie et al., 2005). As the disease 
progresses and the cartilage fissures deepen, fragments of cartilage tear and are 
released into the joint space, decreasing the thickness of the cartilage. Eventually, the 
progressive loss of articular cartilage leaves only dense and often necrotic ebumated 
bone.
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Figure 1.5: Slab radiograph of (A) normal and (B) osteoarthritic femoral head. 
Osteoarthritic joint shows marginal osteophytes, change in shape of bone, 
subchondral cysts and focal areas of extensive loss of articular cartilage. Taken 
from Dieppe and Lohmander, 2005.
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Figure 1.6: Comparison of normal (A) and osteoarthritic (B) articular cartilage. 
Coronal sections taken from the knee of a Dunkin-Hartley Guinea pig, stained 
with Safranin O. Loss of proteoglycan staining in the matrix is clearly evident 
together with superficial fibrillation and clefts (black arrow) and chondrocyte 
cloning (white arrow). Scale bar = 250pm.
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1.2.5 Cel! biology of osteoarthritis
It is generally believed that degradation of cartilage in OA is characterised by two 
phases: a biosynthetic phase, during which the chondrocytes attempt to repair the 
damaged extracellular matrix and a degradative phase in which matrix synthesis is 
inhibited and enzymes produced by the chondrocytes digests the extracellular matrix. 
In the degradative phase, erosion of the cartilage is accelerated (Howell, 1986; 
Hamerman, 1989). It is during OA that the biosynthetic activity is unable to keep pace 
with the degradative catabolic activity, and degeneration of the tissue results.
1.2.5.1 Cytokines in the pathophysiology of OA
The presence of inflammation during the development of OA is well 
documented and believed to be involved in the progression of the disease. IL- 
lp and TNF-a are the predominant pro-inflammatory cytokines synthesised 
during the OA process. In addition to IL-ip and TNF-a there are a number of 
other cytokines that may modulate OA progression by having pro- 
inflammatory and anti-inflammatory properties (van de Loo et al., 1995; 
Martel-Pelletier et al., 1999).
The pathogenesis of OA involves the disturbance of the balance of degradation 
and repair of articular cartilage. In addition to changes in the articular 
cartilage, there are also distinct changes that occur in the synovial membrane 
and subchondral bone. Cytokines and growth factors appear to be first 
produced by the synovial membrane, and diffuse into the cartilage through the 
synovial fluid. They activate the chondrocytes, which in turn are able to 
produce catabolic factors such as proteases and pro-inflammatory cytokines. 
In the OA synovial membrane, the synovial lining cells are key inflammatory 
effectors (Martel-Pelletier et al., 1999).
1.2.5.2 Pro-inflammatory cytokines
IL-ip and TNF-a are believed to play key roles in the development of the 
disease process. IL-ip stimulates cartilage degradation and TNF-a drives the
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inflammatory process (van de Loo et al., 1995). IL-ip and TNF-a up regulate 
chondrocyte and synovial cell synthesis of IL-8, IL-6 and LIF in addition to 
increasing protease and prostaglandin production.
Although IL-lp and TNF-a are believed to be the key inflammatory mediators 
in OA, other pro-inflammatory cytokines including IL-8, LIF, IL-11, IL-6 and 
IL-17 have been shown to be expressed in OA. IL-8 is a potent chemotactic 
cytokine for neutrophils and also stimulates them to synthesise reactive 
oxygen intermediates. In OA patients, IL-8 has been detected in the synovial 
fluid, the lining cell layers of the synovium and the chondrocytes and can 
enhance the release of inflammatory cytokines such as IL-1 p, IL-6 and TNF-a 
in human mononuclear cells, which may further modulate the inflammatory 
process (Gueme et al., 1989; Maier et al., 1993; Villigier et al., 1993; 
Dechanet et al., 1994; Deleuran et al., 1994; Martel-Pelletier et al., 1999).
Leukemia inhibitory factor (LIF) has been detected in the synovial fluid of OA 
patients (Dechanet et al., 1994) and has been shown to enhance IL-1 p and IL-8 
expression in chondrocytes and IL-lp and TNF-a in synovial fibroblasts 
(Villigier et al., 1993). In addition, LIF stimulates the expression of 
collagenase and stromolysin by human articular chondrocytes without 
affecting production of specific tissue inhibitor of metalloproteinases (TIMPs).
1.2.5.3 Anti-inflammatory cytokines, antagonists and growth factors
The anti-inflammatory cytokines IL-4, IL-10 and IL-13 have been found in 
increased levels in the synovial fluid of OA patients (Martel-Pelletier et al.,
1999). These cytokines are considered to decrease production of IL-1 p, TNF- 
a  and MMP, up regulate IL-IRa and TIMP-1 and inhibit PGE2 release in 
various cell types. In human OA synovial fibroblasts, IL-10 down regulated 
TNF receptor density. IL-13 also has anti-inflammatory effects in human OA 
synovial tissue. IL-IRa blocks many of the pathological effects of OA 
including PGE2 production in synovial cells, collagenase production by
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chondrocytes and cartilage matrix degradation. Although IL-IRa is elevated in 
OA it is thought that this level may not be enough to inhibit the action of IL-1.
1.2.5.4 Cellular response in OA cartilage
The cellular responses seen in OA cartilage can be summarised into 3 
categories: (1) proliferation and cell death, (2) changes in extracellular matrix 
synthetic activity and degradation, (3) alterations in chondrocyte phenotype.
Proliferation and cell death
Although normal chondrocytes have a limited mitotic potential (depending on 
species), chondrocytes in OA cartilage have a proliferative capacity, albeit low 
(Hulth et al., 1972). The reason for this is unclear and is probably the activity 
that causes characteristic chondrocyte clustering in osteoarthritic cartilage 
(figure 1.6). There have been various reports on the extent of cell death in OA 
cartilage. Although cell death and apoptosis is believed to occur in OA 
cartilage the true extent of the actual amount remains undetermined due to 
varying reports in the literature (Meachim et al., 1965; Vignon et al., 1976; 
Blanco et al., 1998; Kim et al., 2000; Sandell and Aigner, 2001). Figures range 
from 5-11% cell death in normal cartilage to 22 to 51% in OA cartilage.
Changes in extra-cellular matrix synthetic activity and degradation
During OA there is an enhanced synthesis of extracellular matrix components. 
However, loss of proteoglycan from the matrix is a key feature of OA cartilage 
and can be clearly seen in histological sections (figure 1.6). Although some 
researchers have assumed this simply to be due to increased overall 
degradation, the true picture may be more complex as differences in matrix 
loss and chondrocyte activation occur in the different zones of the cartilage 
(Sandell and Aigner, 2001).
In normal cartilage, the overall rate of synthesis of matrix components by the 
chondrocytes matches the level of degradation. However, in OA the balance is
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altered such that the rate of proteoglycan degradation is increased through 
increased action of aggrecanases (Little et al., 1999; Sabatini et al., 2005). In 
addition, there is gross tissue reduction in proteoglycan synthesis although 
there are focal increases in proteoglycan around individual chondrocytes or 
groups of chondrocytes. The inhibition of proteoglycan synthesis and 
increased MMP production is believed to result from altered growth 
factor/cytokine signalling from pro-inflammatory cytokines such as IL-1 and 
TNFa.
Whereas the loss of proteoglycan is believed to be reversible, the degradation 
of collagen is considered to result in irreversible disruption of the collagen 
network (Shingleton et al., 1996). The loss of the proteoglycan is believed to 
be a key factor in the degradation of articular cartilage, resulting in decreased 
mechanical properties, predisposing the collagen network to mechanical 
disruption resulting in tissue fibrillation and Assuring. MMP-13 (collagenase 
3) and aggrecanase are the principle enzymes responsible for collagen and 
proteoglycan degradation in OA. Other MMPs are known to be involved in the 
catalytic process, by either activating pro-MMP13, secondary cleavage of 
collagen helices or directly degrading fibrilar collagen (i.e. MMP-3 
(stromolysin) and MT1-MMP) (Murphy et al., 1987; Ohuchi et al., 1997; 
Cowell et al., 1998).
The elevated MMP activity observed in OA is not only attributed to the 
increased synthesis and activation of MMP but also to a decrease in the 
production of the inhibitors of MMPs, the TIMPs and a2Macroglobulin. Thus, 
there is believed to be a shift in the balance in the regulation of MMP activity 
favouring excessive matrix degradation.
Alterations in chondrocyte phenotype
During OA there is a shift in the phenotype of the chondrocytes which is 
dependant on zone. The chondrocytes in the middle zone begin to express 
collagen IIA, typically associated with chondroprogenitor cells, in addition to
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aggrecan and collagen type II (Sandell and Aigner, 2001). In the upper middle 
zone there is a shift towards expression of collagen III. In the deeper zones the 
cells begin to re-express collagen X, a specific marker for hypertrophy of 
growth-plate chondrocytes.
1.2.6 Articular cartilage injuries
Despite the well known relationship between joint damage and the subsequent 
development of OA (section 1.2.3.5), the natural history of articular surface injuries is 
poorly understood (Lohmander, 1998; Newman, 1998; Buckwalter, 2002; Shelboume 
et al., 2003). Difficulties in diagnosis and limited awareness of these injuries make it 
difficult to determine their incidence or their relationship to the development of OA. 
Difficulties in understanding the natural history of chondral lesions or surface defects 
also arise as such injuries often occur in association with injuries to other tissues of 
the synovial joint such as the menisci, ligaments, joint capsule and synovium 
(Lohmander and Roos, 1994). In these cases, it is difficult to distinguish the effects of 
the cartilage injury from the effects of the injuries to the other tissues. In addition, the 
cartilage injury may be overlooked in such cases. The natural history of the lesion will 
also be dependant on whether the fracture is purely chondral or osteochondral or may 
not even result in visible disruption to the articular surface. Such latter injuries 
probably occur with greater frequency than chondral or osteochondral fractures but 
are more difficult to detect (Buckwalter, 2002).
1.2.6.1 Types of articular surface mechanical injury
Mechanical injuries to articular surfaces can be classified into 3 types: (1) 
Damage to cells and matrix of articular cartilage and subchondral bone not 
associated with visible disruption of the joint surface. (2) Visible disruption of 
articular cartilage limited to the articular cartilage eg. chondral flap tears or 
chondral defects. (3) Visible mechanical disruption of articular cartilage and 
bone known as intra-articular fractures. Each type of tissue damage stimulates 
a different repair response (Buckwalter and Mankin, 1997a; Newman, 1998; 
Buckwalter and Brown, 2004). Each of these types of injury will be dealt with 
in turn.
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1.2.6.2 Cell and Matrix Damage
The intensity and type of joint loading that cause chondral and subchondral 
damage without visible articular surface disruption has not been well defined. 
Impacts above normal physiological levels of joint loading generated during 
activities such as walking or lifting can produce disruption to the cartilage 
matrix, damage or kill chondrocytes, decrease proteoglycan synthesis, 
disruption of the collagen fibril framework and alter the hydration status of the 
tissue (Buckwalter, 2002). All of this can occur without visible disruption to 
the cartilage surface. The ability of chondrocytes to sense changes in matrix 
composition and synthesise new molecules makes it possible for them to 
repair damage to the macro-molecular framework (Buckwalter and Mankin, 
1997). It is unclear as to at what point this type of injury becomes irreversible 
and leads to progressive loss of articular cartilage. Chondrocytes will be able 
to restore the matrix as long as the loss of proteoglycan does not exceed the 
capabilities of re-synthesis and provided the fibrillar framework remains intact 
and enough chondrocytes remain capable of responding in the local area.
Hence when the balance of factors results in an inability to repair the damaged 
tissue, then the chondrocyte will be exposed to excessive stresses due to the 
altered mechanical properties of the tissue caused by the matrix disruption and 
will increase risk of subsequent degeneration.
1.2.6.3 Cartilage disruption
Following injury to cartilage that does not extend into the subchondral bone, 
the chondrocytes proliferate and increase synthesis of matrix molecules near 
the site of the injury. However, the newly synthesised matrix and proliferating 
cells do not fill the tissue defect, and soon after the injury, the increased 
proliferative and synthetic activity ceases (Campbell, 1969; Mankin, 1982; 
Newman, 1998; Buckwalter and Brown, 2004). The cellular proliferation 
results in small clusters of chondrocytes (chondrones), and is seen only in 
injury and osteoarthritis. Although this results in a permanent articular surface
35
Chapter 1: Introduction
defect, it is a matter of debate as to whether these lesions progress to OA 
(Newman, 1998; Shelboume et al., 2003).
1.2.6.4 Intra-articular fractures
Injuries that extend into subchondral bone cause haemorrhage and fibrin clot 
formation and activate an inflammatory response. Thus, the sequence of 
events following intra-articular fractures differs from injuries that cause only 
cell and matrix injury or damage limited to the articular cartilage surface only. 
Studies show that soon after injury, blood escaping from the damaged bone 
blood vessels forms a haematoma that temporarily fills the defects site. Fibrin 
forms within the haematoma, creating a fibrin clot that fills the bone defect 
and partially fills the cartilage defect and becomes invaded by undifferentiated 
mesenchymal cells from the marrow (Shapiro et al., 1993). At around 2 weeks, 
a portion of the mesenchymal cells assume the form of rounded chondrocytes, 
synthesising a matrix containing collagen II and proteoglycans, producing a 
hyaline-like matrix in portions of the defect. Later in the process, there are 
significant amounts of type I collagen present (20-35%) in the repair tissue 
and the proteoglycan content decreases significantly (Furukawa et al., 1980). 
In the bony portion of the defect, the cells produce immature bone, fibrous 
tissue and hyaline like cartilage and becomes vascularised. This is in contrast 
to the chondral portion of the defect which is rarely entered by blood vessels.
This fibrocartilagenous repair tissue that fills the osteochondral defect is less 
stiff and more permeable than normal articular cartilage with a composition 
intermediate between hyaline cartilage and fibrocartilage. In addition, the 
orientation and organisation of the collagen fibrils does not resemble that seen 
in normal articular cartilage (Mitchell and Shepard, 1976; Buckwalter and 
Mankin, 1997, Buckwalter and Brown, 2004) and there will be poor 
integration of the collagen fibrils of the repair tissue with that of the residual 
cartilage at the defect edge (Shapiro et al., 1993). By 12 months the matrix and 
cells become more typical of fibrocartilage. Evidence suggests that the 
chondral repair tissue begins to degenerate within 1 year or less (Buckwalter 
and Mankin, 1997a; Buckwalter, 2002). The fibrous tissue usually fragments
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and often disintegrates, leaving areas of exposed bone. The inferior 
mechanical properties of chondral repair tissue are thought to be responsible 
for its frequent deterioration (Furukawa et al., 1980; Buckwalter and Mankin, 
1997a).
It can be seen from this section that damage to articular cartilage occurs frequently in 
the population and the responses to that damage by the tissue is not only complex but 
can also be debilitating. The focus of the next section is to overview the current 
treatment options available today in order to understand where the prospects for 
therapies to be developed in the future may lie.
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1.3 CARTILAGE REPAIR
1.3.1 Introduction
The aims of operative treatment for cartilage defects or osteoarthritis (OA) are to 
decrease or eliminate pain and to improve function through increased range of motion 
(Buckwalter and Lohmander, 1994). Given the multitude of possible origins of these 
lesions, treatment attempts have involved symptomatic measures which are useful 
only if the patient gains relief, joint functionality can be significantly restored and if 
the progression to severe joint degeneration can be prevented or slowed down 
(Hunziker, 2001a).
There exists a wide variety of treatment options available to the clinician or surgeon 
depending on the patient, the nature of the lesion and the extent of the degeneration. 
These options range from relatively simple arthroscopic interventions, such as lavage 
and debridement at one extreme, to total joint replacement for late stage OA. 
Although these treatments tend to involve either the resection (eg. debridement, 
shaving) or replacement (eg. allograft, total joint replacement) of damaged tissue, or 
the relief of load and stresses on the tissue (eg. high tibial osteotomy), the ultimate 
goal is the restoration or regeneration of the joint surface, including hyaline cartilage 
and subchondral bone, which remains elusive (Buckwalter and Lohmander, 1994; 
Hunziker, 2001a). Whereas the techniques involved in resection, relief and 
replacement of damaged tissue have been around for some time and are current 
practice, the techniques for the regeneration of hyaline cartilage are only just being 
developed and are some years away from fruition in a commercial product or accepted 
surgical technique. Current techniques aimed at repair such as microfracture and, 
possibly, autologous chondrocyte implantation (ACI) fall short of regenerating true 
hyaline articular cartilage. In addition, as future techniques tend to involve biologic 
approaches (eg. cell-based therapies), as more studies are done the complexities and 
hurdles that need to be overcome along the way are becoming ever more apparent 
(Hunziker, 1999). This section will focus on current techniques for the treatment of 
articular cartilage defects, prior to a description of tissue engineering based 
approaches in the next section.
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1.3.2 Lavage and arthroscopy
The irrigation or lavage of a joint with solutions of saline is believed to be beneficial 
in osteoarthritic patients with painful knee joints. Some investigators have reported 
the beneficial effects to persist for greater than 12 months (Livesley et al., 1991), 
whereas others have reported no beneficial effect (Gibson et al., 1992). Other 
investigators have suggested the beneficial effects of lavage may be related to a 
placebo effect of the surgical intervention. There is no direct scientific evidence for 
the reported effects of lavage and indeed no biological basis for the beneficial effects 
seen. It is possible the effects may be due to the removal of debris or the rinsing 
removing some of the catabolic cytokines and other mediators involved in the 
generation of pain (Gilbert, 1988; Moseley et al., 2002).
1 3 3  Chondral shaving and debridement
Arthroscopic chondral shaving removes diseased or disrupted cartilage tissue using 
specially designed surgical tools. Although now only performed infrequently it is 
mainly used for the treatment of patello-femoral pain or chondromalacia patellae 
(Ogilvie-Harris and Jackson, 1984). The objective of the shaving is to remove the 
fibrillated cartilage to provide a smoother surface with reduced friction.
Debridement of the joint involves the arthroscopic shaving of severely degenerated 
cartilage combined with lavage, removal of loose bodies, meniscectomy and limited 
excision of osteophytes (McLaren et al., 1991; Gibson et al., 1992). Debridement used 
in combination with lavage has been shown to alleviate pain and provide short-term 
benefit in the treatment of osteoarthritis (Chang et al., 1993; Shannon et al., 2001).
Reports have indicated that debridement decreases the symptoms of OA in most 
patients (Baumgaertner et al., 1990; Ogilvie-Harrie and Fitsialos, 1991). As with 
lavage, the procedures do not initiate a repair response in the cartilage and the effect 
may be due to placebo or a decrease in pain stimulus due to the removal of cartilage 
particulates and/or inflammatory mediators from the joint space (Moseley et al., 
2002).
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1.3.4 Penetration of subchondral bone (abrasion chondroplasty, Pridie drilling 
and microfracture)
These techniques involve surgical penetration of the subchondral bone in regions of 
full thickness cartilage loss, leading to bleeding from the marrow spaces into the 
defect and the formation of a fibrin clot (Hunziker, 2001a). Undifferentiated 
mesenchymal cells from the marrow present in the fibrin clot are responsible for 
forming a fibrocartilagenous repair tissue of limited durability (Kim et al., 1991; 
Shapiro et al., 1993; Menche et al., 1996).
Surgeons have developed various methods for the penetration of subchondral bone to 
stimulate cartilage repair such as drilling (Pridie drilling), abrasion (abrasion 
chondroplasty), use of sharp picks (microfracture) or resection (spongialisation) 
(Insall, 1974; Ficat et al., 1979; Moseley et al., 1996; Akizuki et al., 1997; Sledge, 
2001).
Abrasion arthroplasty involves superficially abrading the subchondral bone so that 
bleeding and fibrin clot are produced. Subchondral drilling (Pridie drilling) is similar 
to abrasion arthroplasty except that the subchondral bone is penetrated in a more 
precise fashion using small drills. Microfracture (figure 1.7) involves the debridement 
of the damaged tissue down to the subchondral bone which is then perforated 
repeatedly with the use of a small pick (Gilbert, 1998; Sledge, 2001). It is currently 
not clear as to which of these methods produces the better results with few clinical 
studies directly comparing the different techniques. Although these procedures can 
lead to positive outcomes, the improvements can be variable which results from the 
unpredictable nature and limited durability of the fibrocartilagenous repair tissue itself 
and the age of the patient (Johnson, 2001; Steadman et al, 2003). One study compared 
abrasion with drilling for the treatment of experimental defects in rabbits and showed 
drilling to give better long term results (Menche et al., 1996). One clinical study 
compared abrasion chondroplasty and osteotomy to osteotomy alone and reported that 
individuals who received the combined approach had improved hyaline repair tissue 
formation after 12 months compared to osteotomy alone (Akizuki et al.,1997). There 
was no difference in clinical outcome observed after 2 years.
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Figure 1.7: Arthroscopic microfracture.
Taken from http://www.kneeclinic.info/probIems_articular_cartilage.php
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1.3.5 Osteotomy
High tibial osteotomy is a palliative surgical treatment frequently adopted for the 
treatment of painful OA (Wright et al., 2005). It is also undertaken to correct large 
extra-articular deformities such as those affecting the valgus or varus which can occur 
in association with OA. Osteotomy is thus undertaken with a view to not inducing 
cartilage repair but to relieve pain, improve alignment as well as biomechanical load 
transfer in knee joints. In cases of painful OA, patients are usually relieved of pain for 
some considerable time.
1.3.6 Perichondrial and periosteal grafting
The use of perichondrial and periosteal tissue to promote repair of cartilage lesions 
was first recognised approximately 50 years ago and has subsequently been utilised as 
an auto-transplantation material for cartilage repair in both rabbits and humans 
(Cohen, 1955; Homminga et al., 1990; Coutts et al., 1992; Kreder et al., 1994).
The basis underlying these studies is that the cambial layer of the perichondrium or 
periosteum maintains chondrogenic activity throughout life (Cohen, 1955; Nakahara 
et al., 1991) and this is considered to be due to a population of adult stem cells within 
this layer that can be driven down a chondrocytic lineage given the correct stimuli (De 
Bari et al., 2001). During the transplantation process, the tissue is oriented such that 
the cambial layer is uppermost on the floor of the full thickness cartilage defect. This 
allows the adult stem cells to proliferate, differentiate and hence repair the defect.
Studies examining the efficacy of periosteal and perichondral grafting in both humans 
and animals have yielded mixed results (Hunziker, 2001a), consequently some studies 
have attempted to improve outcomes by incorporating growth factors such as TGF-p, 
using continuous passive motion or polylactic acid matrices. All have met with 
limited success.
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1.3.7 Osteochondral grafting
The transplantation of multiple autologous osteochondral plugs is often referred to as 
Mosaicplasty™ (Smith &Nephew) or OATS™ (Arthrex) and is a widely used 
technique for the treatment of large osteochondral defects (figure 1.8). The procedures 
can be carried out on an open-joint or by arthroscopy. The procedures involve the 
removal of small cylindrical osteochondral plugs from non-weight bearing portions of 
the joint surface at the periphery of the joint using specialised surgical tools. The 
plugs are then transplanted into the previously prepared and debrided defect area on 
the weight bearing portion of the knee (Hangody et al., 2001; Jakob et al., 2002). 
Although the osseous portion of the plug is considered to become stably integrated 
into the subchondral bone, it is not currently known as to the longevity of the cartilage 
layer (Hunziker, 2001a). Clinical outcomes are reported to be favourable, showing 
reduced pain and improved joint function (Hangody et al., 2001; Jakob et al., 2002).
Allogeneic osteochondral grafting has been in practice for many years and uses fresh 
or cryopreserved tissue derived from cadaveric donors (Meyers et al., 1983; Czitrom 
et al., 1986; Garrett, 1986) and has yielded good results in patients with large 
osteochondral defects, such as those resulting from osteochondritis dissecans, 
extensive trauma, tumour resection or osteonecrosis. The results have been positive 
despite concerns over possible immunological problems or loss of tissue viability 
following cryopreservation (Langer et al., 1978; Stevenson et al., 1989; Sirlin et al., 
2001). However, a disadvantage of the technique is the low availability of suitable 
donor tissue, either fresh or cryopreserved.
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Figure 1.8: (A) Schematic diagram of osteochondral transplantation using 
mosaicplasty. Cylindrical grafts have been removed from the donor site (blue 
arrows) and implanted at the recipient site (red arrow). Taken from 
http://wTvw.pathologv.unibe.ch/Forschung/osteoart/osteoart.htm). (B) Open 
mosaicplasty on the medial and lateral femoral condyles. Taken from Hangody 
et al., 2001.
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1.3.8 Autologous chondrocyte implantation (ACI)
ACI was first described in the literature by Grande et al., (1989) and its subsequent 
use in the clinical setting was reported some years later (Brittberg et al., 1994). The 
procedure involves two operations (figure 1.9). In the initial operation, small portions 
of the patient’s cartilage are harvested during arthroscopy from non-load bearing areas 
of the joint. The chondrocytes are then harvested from this tissue and expanded in 
culture for 3-4 weeks. In the second procedure, the defect is debrided of all fibrous or 
damaged tissue and a periosteal flap is sewn to the edge of the normal tissue forming 
a cover over the defect. The cultured chondrocytes are then placed underneath the 
periosteal flap which may be sealed with fibrin glue (Hunziker, 2001a).
A number of concerns have been raised over the technique. Firstly the technique is 
expensive, involving two procedures and a culturing phase. Secondly it is 
questionable as to whether the outcomes are superior to that of marrow stimulating 
techniques such as microfracture (Knutson et al., 2004; Clar et al., 2005) although 
other studies have shown superiority of ACI over mosaicplasty (Bentley et al., 2003). 
Thirdly, the expansion of chondrocytes in monolayer conditions rapidly leads to their 
dedifferentiation or loss of phenotype (Benya and Schaffer, 1982; Von der Mark et 
al., 1997; Binette et al., 1998). The reversal of this process can occur in 3-dimensional 
culture and using combinations of growth factors but the reversal is rarely complete 
and occurs to a progressively lesser extent the longer the chondrocyte is kept in 
monolayer culture (Benja and Schaffer, 1982; Bonaventure et al., 1994). Thus one 
would expect the cartilage forming capabilities of the transplanted cells to be low.
A study has demonstrated an inability to reproduce in a canine model the results that 
were obtained in rabbits earlier (Grande et al., 1989; Breinan et al., 1997) and showed 
that the transplanted cells did not contribute to the repair response. Other studies have 
shown that the majority of the periosteal flaps are frequently lost from the defect soon 
after implantation (Hunziker, 2001a) unless suitable measures are taken to immobilise 
the joint.
Despite these issues, ACI is widely used in clinical practice with reportedly good to 
excellent results (Brittberg et al., 1994; Peterson et al., 2000). However, a recent
45
Chapter 1: Introduction
report of a randomised clinical trial comparing ACI and the less expensive technique 
of microfracture suggests little difference in clinical outcomes and repair responses 
between the two techniques at two years post surgery (Knutson et al., 2004).
A recent development has been the replacement of the periosteal flap with a collagen 
membrane (Haddo et al., 2004). The use of the periosteal flap has been associated 
with complications such as hypertrophy of the graft and decalcification and 
delamination. The harvesting of the periosteum increases operating time and may lead 
to increased pain for the patient. Another development has been the introduction of 
three dimensional scaffolds or matrices in combination with the autologous 
chondrocyte transplantation. In these studies the chondrocytes are seeded onto a 
matrix such as a collagen membrane (MACI™) or hyaluronan (Hyalograft C™) 
(Pavesio et al., 2003; Ronga et al., 2004). The procedures have the advantage that the 
matrix can be secured using fibrin glue without a cover and so are suture-free -  
sutures have been associated with cell death in the healthy cartilage surrounding the 
defect (Breinan et al., 1997). Because no periosteal coverage is required to keep the 
graft in place, surgical time and morbidity are reduced, and handling of the graft is 
much simpler than currently available autologous chondrocyte implantation 
techniques. However, a recent study has shown that although MACI™ is technically 
attractive, clinical, arthroscopic and histological outcomes were similar for both ACI 
and MACI™ (Bartlett et al., 2005).
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Figure 1.9: Diagram illustrating the technique of autologous chondrocyte 
transplantation.
Taken from
http://www.alphaklinik.de/de/toft/diagnose therapie/arthrose/bioprothese-detail
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1.4 TISSUE ENGINEERING
1.4.1 Introduction
It is clear from the previous section that functional restoration of articular cartilage 
remains a challenge and none of the existing treatment regimens gives a consistently 
good outcome (Hunziker, 2001a). Orthopedic tissue engineering is a growing field 
which has the potential to develop novel approaches to the regeneration of cartilage 
defects.
Tissue engineering involves the investigation of how to repair and regenerate organs 
and tissues by the delivery of cells, maybe in combination with growth factors and 
biomimetic scaffolds (Sittinger et al., 2004). Key to the development of tissue 
engineering has been an increase in the knowledge of the role of growth factors in the 
control of proliferation and differentiation of many cells types, combined with the 
development of novel protocols for the rapid expansion of specifically selected cell 
populations. In addition, development of knowledge of the biology and culture of 
adult mesenchymal stem cells has signalled these cells may have an important role to 
play in regenerative biology.
Initial interest in tissue engineering began with the regeneration of skin and epidermis 
(Potten and Booth, 2002) and has since been applied to a whole range of tissue types 
including blood vessels, cardiac tissue, cornea, liver, kidney, bladder and pancreas 
(Atala and Lanza, 2002). Interest in the tissue engineering of cartilage has grown for a 
number of reasons. Firstly, the high incidences and high level of morbidity linked 
with cartilage degeneration and costs associated with it (Jackson et al., 2001; 
Buckwalter et al., 2004). Secondly, articular cartilage is aneural, avascular, and is 
considered to be composed of 1 functional cell type, the chondrocyte (Buckwalter and 
Mankin, 1997), thus negating the need for complex arrangements of multiple cell 
types (although this may be true that cartilage is composed of only 1 cell type, it is 
clear that chondrocytes are very different throughout the thickness of the cartilage 
(Zanetti et al, 1985; Aydelotte and Kuettner, 1988; Aydelotte et al., 1988; Archer et 
al., 1990)). As articular cartilage is avascular, its nutrition is derived from diffusion
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from the synovial fluid and thus chondrocytes may be ideally suited to the growth of 
tissue constructs in vitro in bioreactor conditions.
This section will overview current progress in the area of tissue engineering of 
articular cartilage and the potential use of mesenchymal stem cells in these 
applications. The important components of a tissue engineering system such as 
scaffold and cell type will each be reviewed followed by differing approaches to 
articular cartilage tissue engineering: (1) implantation of mature of semi-mature tissue 
or (2) in situ regeneration.
1.4.2 Scaffolds
Scaffolds or matrices in tissue engineering are intended to act as a 3-dimensional 
template to guide the regeneration of the tissue. Requirements that need to be borne in 
mind in the design of a tissue engineering scaffold are summarised in table 1.1. 
Scaffolds can be of natural or synthetic origin, each having their advantages and 
disadvantages.
1.4.2.1 Collagen
Scaffolds composed of collagen sponges or gels have been evaluated for tissue 
repair for many years (Speer et al., 1979). They have been evaluated in 
combination with cells such as chondrocytes (Kawamura et al., 1998) and 
bone marrow derived mesenchymal stem cells (Wakitani et al., 1994), 
sometimes with the inclusion of growth factors (Toolan et al., 1996).
1.4.2.2 Fibrin
Fibrin is a natural choice for a scaffold in articular cartilage tissue engineering 
due to its role in normal wound healing and its part in the repair of full 
thickness articular cartilage defects (Shapiro et al., 1993). Fibrin is pro- 
inflammatory with numerous roles involving cell adhesion, migration and 
binding of growth factors (Clark, 2001). In addition, the degradation products 
also have pro-inflammatory effects. Fibrin has been used in combination with
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Matrix properties Biological basis
Porosity Cell migration, ingress and egress of nutrients and cell
waste products
Carrier Lodgement and release of signalling substances
Adhesion Cell attachment
Biodegradability Physiological remodelling
Volume stability Smooth surface contour of repair tissue flush with that of
native articular cartilage
Biocompatibility Good contact with the native tissue compartment
Bonding Enhances interfacial integration between collagen fibrils
in repair and native tissue compartments
Internal cohesiveness Prevention of matrix outflow
Elasticity Resiliency during and following dynamic or static
deformation
Structural anisotropy Promotion of native anisotropic tissue organsiation
Table 1.1: Requirements of a scaffold for tissue engineering of articular 
cartilage. Adapted from Hunziker, 2001a.
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chondrocytes (Hendrickson et al., 1994) and with combinations of 
chondrocytes and growth factors (Fortier et al., 1999) or with growth factors 
alone (Nixon et al., 1999).
1.4.2.3 Agarose and Alginate
Agarose and alginate are polysaccharide hydrogels derived from seaweed 
(Frenkel and Di Cesare, 2004). Although both agarose and alginate have been 
used extensively in in vitro studies of chondrocyte differentiation (Benya and 
Shaffer, 1982; Bonaventure et al., 1994; Yaeger et al., 1997), studies in vivo 
have yielded poor results in cartilage repair studies. Alginate and agarose have 
slow resorption rates, and elicit a foreign body reaction (Rahforth et al., 1998; 
Diduch et al., 2000; Fragonas et al., 2000).
1.4.2.4 Chitosan
Chitosan is a co-polymer of glucosamine and N-acetylglucosamine and may 
be modified to form a hydrogel. Although in vitro it has been evaluated as to 
its ability to support chondrocyte growth and differentiation (Lahiji et al.,
2 0 0 0 ) it has not yet been used in in vivo cartilage repair studies.
1.4.2.5 Hyaluronan (HA)
Hyaluronan (Hyaluronic acid) is a major component of the cartilage matrix. 
Scaffolds composed of cross-linked HA have been used in conjunction with 
chondrocytes (Brun et al., 1999) and bone-marrow-derived mesenchymal stem 
cells (Radice et al., 2000) and favourable results have been obtained in vivo 
(Solchaga et al., 1999 and 2000). HA is also currently used clinically in 
autologous chondrocyte implantation techniques (Pavesio et al., 2003).
1.4.2.6 Polylactic acid/polyglycolic acid (PLA/PGA)
These polymers have been utilised in cartilage repair applications for over 10 
years (Vacanti et al., 1988; Freed et al., 1993; Vacanti et al., 1994; Cao et al.,
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1997) in the form of foams and fibrous mats. The scaffolds have been used 
chiefly to serve as a 3 dimensional scaffold for in vitro culture of chondrocytes 
to generate semi-mature or mature tissue prior to implantation.
1.4.3 Cell type
The choice of cell type for tissue engineering is key. Obviously the cell must be able 
to form a cartilage-like matrix. Ideally the cell type must support extensive expansion 
while retaining its ability to form a cartilaginous matrix in the appropriate conditions. 
In addition the cell type should be abundant in a readily accessible source.
1.43.1 Chondrocytes
Not surprisingly chondrocytes have been extensively studied in cartilage tissue 
engineering protocols. Both autologous (Grande et al., 1989) and allogeneic 
chondrocytes (Kawamura et al., 1998) have been investigated on fibrin 
(Hendrickson et al., 1994), agarose (Sittinger et al., 1994) or PGA scaffolds 
(Vacanti et al., 1988; Freed et al., 1993; Vacanti et al., 1994; Cao et al., 1997).
Although in general, positive results have been obtained, questions have been 
raised about the immunologic properties of allogeneic chondrocytes (Kawabe 
and Yoshinao, 1991) and the potential of chondrocytes to re-express the 
chondrocytic phenotype following expansion in monolayer culture (Benya and 
Shaffer, 1982; Bonaventure et al., 1994).
1.4.3.2 Perichondrial/periosteal cells
The chondrogenic potential of perichondrial and periosteal tissue has been 
known for some time (Cohen, 1955) and cells derived from these tissues have 
been investigated in tissue engineering applications (Chu et al., 1997; 
Dounchis et al., 2000). Despite the advantage that these cells may represent a 
precursor cell population with a high proliferative and differentiative capacity 
irrespective of donor age (De Bari et al., 2001) these cells have not proceeded 
past pre-clinical studies.
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1.4.3.3 Synovial cells
The chondrogenic capacity of synovial cells and tissue is well documented 
(Nishimura et al., 1999; De Bari et al., 2001a) and is believed to result from a 
common pool of chondrogenic precursor cells that has important functions 
during the development of the joint (Dowthwaite et al., 1998; Archer et al., 
2003). Although isolated synovial cells have not yet been used in tissue 
engineering studies for cartilage repair, studies have been attempted to use 
growth factors such as TGF-p to recruit synovial cells in situ into partial 
thickness defects (Hunziker and Rosenberg, 1996).
1.4.3.4 Stromal cells of the bone marrow
Mesenchymal stem cells (MSCs) were first identified in the bone marrow 
stroma by Owen and Friedenstein (1988) who isolated bone forming 
progenitor cells from the rat marrow. The cells have the capacity to 
differentiate into cells of connective tissue lineages, including bone, fat, 
cartilage and muscle. In addition, they play a role in providing the stromal 
support system for haematopoietic stem cells in the marrow. MSCs represent a 
very small fraction, 0 .0 0 1 -0 .0 1 % of the total population of nucleated cells 
(Pittenger et al., 1999). However, they can be isolated and expanded with high 
efficiency, and induced to differentiate to multiple lineages under defined 
culture conditions. The cells have generated a great deal of interest because of 
their potential use in tissue engineering and regenerative medicine (Deans and 
Moseley, 2000; Tuan et al., 2003; Barry and Murphy, 2004).
The strong chondrogenic potential of the cells derived from both rabbit 
(Johnstone et al., 1998) and human bone marrow (Mackay et al., 1998) led to 
suggestions as to the possibilities of the use of the cells in articular cartilage 
tissue engineering (Johnstone and Yoo, 2001). Indeed, the cells have been 
used in in vivo cartilage repair studies (Wakitani et al., 1994; Im et al., 2001) 
and in a human study for articular cartilage repair using ACI-like protocols 
(Wakitani et al., 2002).
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1.4.4 Tissue engineering approaches
One approach to the functional tissue engineering of cartilage involves the in vitro 
cultivation of cartilaginous constructs that would have a capacity to further develop 
structurally and biomechanically following implantation, and to integrate completely 
with the adjacent bone and cartilage. In these approaches, chondrogenic cells are 
seeded at high density onto biodegradable scaffolds and cultured in bioreactors 
(specialised environments designed to promote chondrogenesis) (Freed et al., 1999; 
Vunjak-Novakovic, 2003). This process is designed to generate immature but 
functional constructs which would subsequently remodel and mature following in vivo 
implantation.
However, these approaches have encountered problems with cell source, mechanical 
fixation and tissue integration and little success has been achieved to date in vivo. This 
has led many groups to attempt to induce chondrogenesis in situ using exogenous 
growth factors on suitable carrier matrices. For example studies have utilised IGF-I in 
fibrin matrices or TGF-p in a variety of matrices in partial and full thickness defects 
(Hunziker and Rosenberg, 1996; Nixon et al., 1999; Hunziker, 2001; Hunziker et al.,
2001). Some studies have combined these scaffolds with cells, for example 
chondrocytes in fibrin and IGF-I (Fortier et al., 1999), chondrocytes in agarose and 
FGF-2 (Weisser et al., 2001) and perichondrial cells in a polylactide matrix containing 
TGF-p (Dounchis et al., 1997).
It is unclear as to which of these approaches may prove to be successful in the future. 
Little success has been achieved to date over many decades of research (Hunziker, 
2001a). However, our increasing knowledge of cell signalling and developmental 
biology, combined with further advances in biomaterial development may lead to 
efficacious therapies in the future.
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1.5 AIMS OF THIS THESIS
As described in this introduction, articular cartilage is a complex tissue, reliant on a 
complex framework of extracellular matrix that dictates the mechanical properties of 
the tissue. The extracellular matrix is maintained by the chondrocyte, which 
constantly synthesises and remodels the matrix in response to changes in its 
composition and alterations in patterns of loading and other factors (Buckwalter and 
Mankin, 1997).
Current transplantation and tissue engineering strategies such as ACI (Brittberg et al., 
1994) have employed in vitro expanded chondrocytes from the full depth of the 
cartilage. However it is clear that chondrocytes differ in size, shape and metabolic 
activity throughout the thickness of the tissue (Zanetti et al, 1985; Aydelotte and 
Kuettner, 1988; Aydelotte et al., 1988; Archer et al., 1990) and these differences in 
chondrocyte phenotype are responsible for subtle differences in matrix composition 
throughout the depth of the tissue. Thus, in ACI-like procedures, these sub­
populations of chondrocytes will not be re-implanted in the zones they are present in 
the native tissue. In light of this, some studies have been carried out to assess the 
functional importance of the various sub-populations of cells in tissue engineering 
protocols (Waldman et al., 2003). Furthermore, section 1.1.6 introduced the 
developmental biology of the synovial joint and the importance of a putative 
population of chondroprogenitor cells in the surface region of the articular cartilage 
which drive the appositional growth of the tissue during development. In view of the 
possible role of these cells in driving development they could also potentially be 
applied to new tissue repair or tissue engineering therapies for the treatment of defects 
in articular cartilage and may also further our knowledge of cartilage developmental 
biology. In addition, in terms of cartilage repair, the re-establishment of the specific 
zones after injury or matrix degradation due to OA would be beneficial from a 
functional aspect since most repair strategies generate a fibrocartilagenous matrix and 
even when a hyaline matrix is achieved, there is little evidence of zonal variation 
(Kim et al., 1991; Shapiro et al., 1993; Menche et al., 1996). The matrix of this repair 
tissue does not have the same biochemical and hence biomechanical features of the 
normal articular cartilage and thus is prone to further injury or incomplete restoration 
of function.
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The isolation and characterisation of these articular cartilage progenitor cells from the 
superficial zone (SZCs) is the focus of this thesis, together with an exploration of the 
cells capabilities in potential repair therapies.
Chapter 2: General materials and methods:
General protocols used throughout the thesis.
Chapter 3: Characterisation:
This chapter describes the methods used to demonstrate the presence of the cells in 
the superficial zone of immature bovine articular cartilage and the methods to produce 
enriched cultures of the cells. It also describes the immunolabelling of the cells with 
antibodies to a number of cell surface markers.
Chapter 4: Fibronectin-EDA+:
Fibronectin-EDA+ is a form of fibronectin expressed during development, wound 
healing and tumourigenesis. This chapter describes the demonstration of the 
expression of fibronectin-EDA+ by articular cartilage progenitor cells in the 
superficial zone and the effect of fibronectin-EDA+ on articular cartilage progenitor 
cell behaviour.
Chapter 5: Articular cartilage progenitor cell expansion and chondrogenic 
ability:
The ability of a cell to undergo extensive in vitro expansion while still retaining its 
chondrogenic ability would be a desirable characteristic for tissue engineering 
purposes. This chapter describes the extensive subculture of enriched populations of 
bovine articular cartilage progenitor cells and an evaluation of their chondrogenic 
potential during the expansion process.
56
Chapter 1: Introduction
Chapter 6: Surgical cartilage cutting techniques and ex vivo cell transplantation 
defect creation:
The objective of this chapter is to determine whether the implantation of enriched 
populations of superficial zone articular cartilage progenitor cells into experimental 
defects in articular cartilage can reduce the cell death and matrix loss at the wound 
margin associated with surgical cutting techniques.
Chapter 7: Human studies:
Previous studies describing evidence for the existence of a population of articular 
cartilage progenitor cells within the superficial zone of articular cartilage have 
investigated developing or neonatal oppossum, murine or bovine tissue. The prospect 
of isolating articular cartilage progenitor cells from human cartilage would be of 
interest as the cells may replicate the extensive expansion and chondrogenesis 
properties exhibited by their bovine counterparts (Chapter 5). This chapter describes 
attempts to generate cultures enriched in human articular cartilage progenitor cells and 
examine the extent of retention of chondrogenic capacity during the expansion 
process.
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2.1 TISSUE DISSECTION
For studies on bovine tissue, metatarsophalangeal joints of 7 day-old calves were 
obtained from an abattoir. The joints were washed thoroughly using Virkon and 
transferred to a laminar flow hood. The skin was removed and the joint opened 
aseptically to expose the articular cartilage (figure 2 .1 ).
For cartilage cutting studies, strips of cartilage, approximately 30mm in length, 4mm 
wide and 3mm deep were removed and transferred to PBS (Oxoid) until used (figure 
2.1). For histological staining and immunostaining, tissue was further chopped into 
smaller pieces as required prior to embedding.
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Figure 2.1 Photograph of 7 day-old bovine metatarsophalangeal joints with 
cartilage strips removed (A) and a photograph of the removed cartilage strip (B).
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2.2 CELL CULTURE
2.2.1 Materials
All cell culture materials were obtained from Sigma unless otherwise stated. Heat 
inactivated foetal calf serum was obtained from Helena Biosciences.
2.2.2 Methods
All procedures were carried out in a class II laminar flow biological safety cabinet 
using standard aseptic technique. All reagents and disposable culture vessels were of a 
tissue culture grade.
2.2.2.1 Media components
Cell culture media was composed of the following components: Dulbecco’s 
Modified Eagles Medium (DMEM) with 4500mg/l glucose. DMEM was 
supplemented with the following components: Foetal calf serum (FCS) (10%), 
L-Glutamine (2mM), Penicillin (50IU/ml)/Streptomycin (50ug/ml) and Non- 
essential amino acids (1%). Tissue culture media was stored at 4°C.
2.2.2.2 Passaging and general cell culture maintenance
All cells were maintained at 37°C in a 5% CO2 atmosphere. When cells 
reached confluence the spent tissue culture media was removed and the 
monolayer was washed with PBS (Oxoid). Sufficient pre-warmed 
trypsin/EDTA (0.05% w/v/0.02% w/v) was added to the flasks to cover the 
monolayer. The cells were incubated in trypsin/EDTA at 37°C until they had 
started to round up and lift from the plastic. The cells were finally dislodged 
by gently tapping the flask and sufficient DMEM + 10% FCS was added to 
bring the final volume to lOmls. The cell suspension was centrifuged at 300g 
for 5 minutes at 4°C. Following centrifugation the supernatant was removed 
and the pellet resuspended in fresh DMEM + 10% FCS. Aliquots of the
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suspension were transferred to fresh flasks as appropriate to obtain the desired 
split ratio.
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2.3 HISTOLOGY AND IMMUNOSTAINING
2.3.1 Materials
All solvents, phosphate buffered formaldehyde and acetic acid were obtained from 
Fisher Scientific. Paraffin wax, DPX mountant and Weigert’s haematoxylin were 
supplied by Surgipath. Gill’s and Mayer’s haematoxylin were supplied by TAAB. All 
other materials and reagents were obtained from Sigma unless otherwise stated.
2.3.2 Paraffin wax embedding
For wax embedding all tissue samples were washed once with PBS and fixed 
overnight in phosphate buffered formaldehyde. Samples were chopped into small 
portions and transferred to embedding cassettes and infiltrated with wax using a 
Tissue-Tek VIP processor according to the protocol shown in table 2.1.
2.3.3 Sectioning
Paraffin wax blocks were sectioned at a thickness of 5 pm using a Reichert-Jung 
microtome. Sections were floated onto water and transferred onto ‘Superfrost’ glass 
slides (BDH). Sections were dried overnight on the slides at 40°C and then stored at 
room temperature.
2.3.4 Histological staining
Paraffin wax sections were dewaxed and stained using a Leica Autostainer XL. 
Staining protocol for Haematoxylin and Eosin is shown in table 2.2. Staining protocol 
for Safranin O/haematoxylin is shown in table 2.3. Staining protocol for Picrosirius- 
red is shown in table 2.4. Following staining, sections were mounted using DPX 
mountant and coverslipped.
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Reagent Concentration Time (hours:mins)
1 IMS 50% 1 : 0 0
2 IMS 70% 1 : 0 0
3 IMS 90% 1 : 0 0
4 IMS 1 0 0 % 1:30
5 IMS 1 0 0 % 1:30
6 IMS 1 0 0 % 1:30
7 Chloroform 1 0 0 % 0:30
8 Chloroform 1 0 0 % 0:30
9 Chloroform 1 0 0 % 0:30
1 0 Wax - 0:30
1 1 Wax - 0:30
1 2 Wax - 1 : 0 0
Table 2.1: Protocol for paraffin wax embedding using the Tissue-Tek VIP tissue 
processor.
IMS -  Industrial methylated spirits
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Reagent Time (min)
Xylene 5
Xylene 5
100% IMS 2
100% IMS 2
Distilled water 2
Gills haematoxylin 2-4
Gills haematoxylin 2-4
Tap water 2
Tap water 2
Scott’s tap water 2
Tap water 2
70% IMS v/v 1.5
90% IMS v/v 1.5
Alcoholic eosin 4
100% IMS 2.5
100% IMS 2
Xylene 2
Xylene 2
Xylene Mount
Table 2.2: Staining protocol for Haematoxylin and Eosin (H&E)
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Reagent Time (min)
Xylene 5
Xylene 5
100% IMS 2
100% IMS 2
95% IMS v/v 2 0  secs
70% IMS v/v 2 0  secs
Distilled water 1
Weigerts iron haematoxylin 6
Tap water 2
1 % acidified alcohol 1 sec
Tap water 3
0.02% Fast green FCF (aqueous w/v) 4
1 % acetic acid 3 secs
0.1% Safranin O 6
95% IMS v/v 1
100% IMS 2
100% IMS 2
Xylene 2
Xylene 2
Xylene Mount
Table 2.3: Staining protocol for Safranin O/Haematoxylin
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Reagent Time (min)
Xylene 5
Xylene 5
100% IMS 2
100% IMS 2
Distilled water 2
Celestine blue 14
Distilled water 0.5
Mayer’s haematoxylin 14
Tap water 2
Scott’s tap water 2
Tap water 1
Picro-sirius red 60
Acidified water 2
Acidified water 2
100% IMS 2
100% IMS 2
100% IMS 2
Xylene 2
Xylene 2
Xylene Mount
Table 2.4: Staining protocol for Picro-sirius red
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2.3.5 Reagents for histological staining
Scott’s tap water
2g Sodium hydrogen carbonate 
lOg Magnesium sulphate 
1000ml Tap water
Acidified water
5ml glacial acetic acid 
1000ml Water (tap or distilled)
1% acidified alcohol
5ml Hydrochloric acid (cone)
500ml IMS
Celestine blue
2.5g Celestine blue B 
25g Ferric ammonium sulphate 
500ml Distilled water 
70ml Glycerin
Picro-sirius red
500ml Saturated aqueous picric acid 
0.5g Sirius red F3BA
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2.3.6 Frozen embedding and sectioning
For frozen embedding, tissue samples were chopped into small portions 
(approximately 4mm x 4mm), immersed in OCT (Gurr) and then frozen using a liquid 
nitrogen cooled iso-pentane slush. 7 pm sections were cut from the specimens using a 
Leica Jung CM3000 cryostat and transferred onto poly-lysine coated slides (Sigma). 
Sections were fixed by immersion in acetone for 10 minutes at room temperature and 
air-dried. Slides were stored at -20°C until used.
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3.1 INTRODUCTION
The introduction (section 1.1) described the complex, zonal architecture of articular 
cartilage. The chapter described how although the main components of the articular 
cartilage extracellular matrix such as collagen II and the large aggregating 
proteoglycan aggrecan, are present throughout the thickness of the tissue, there are 
subtle differences in minor collagens and non-collagenous proteins from the surface 
zone to the deeper calcified layer (Zanetti et al., 1985; Bayliss et al., 1999; Poole et 
al., 2001). This biochemical heterogeneity results from different chondrocyte 
morphology and phenotypes at different depths in the tissue (Zanetti et al, 1985; 
Aydelotte and Kuettner, 1988; Aydelotte et al., 1988; Archer et al., 1990). For 
example, the surface zone is characterised by flattened, discoid cells that express 
lubricin (superficial zone protein, proteoglycan-4) and Del 1 (Schumacher et al., 
1999; Pfister et al., 2001). The mid zone is composed of rounder cells that express 
cartilage intermediate layer protein (CILP) (Lorenzo et al., 1998) and the deeper 
zones and calcified layers express collagen type X and alkaline phosphatase (Schmid 
and Linsenmyer, 1985).
In order for such complex tissue architecture to be established, the differentiation and 
proliferation of the chondrocytes during development of the tissue must be stringently 
controlled both temporally and spatially. It is now becoming clear that the surface 
zone is centrally involved in the regulation of the development of articular cartilage. 
The surface zone is an important signalling centre during development, where many 
growth factors are expressed (Archer et al., 1994; Hayes et al., 2001) and also plays a 
major role in the morphogenesis of the joint via differential matrix synthesis (Ward et 
al., 1999). Studies using BrdU labelling in Monodelphis domestica, a marsupial bom 
at an early stage of development, have illustrated that subsequent to the formation of 
the secondary centre of ossification, articular cartilage growth is appositional in nature 
(Hayes et al., 2001), a mechanism which requires the presence of population of 
stem/progenitor cells in the surface zone.
Stem cells have previously been identified in the epidermis on the basis of high cell 
surface expression of a 5pi integrins and rapid adhesion to extracellular matrix
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proteins (Jones and Watt, 1993). The cells that adhered most rapidly to substrates 
such as fibronectin possessed the ability to form large colonies from an initial low 
seeding density. Fibronectin is a component of the cartilage extracellular matrix, and 
articular cartilage chondrocytes are known to express the 015P1 integrin homodimers 
which are known to bind to fibronectin (Salter et al., 1995).
This chapter describes the identification of a population of articular chondrocytes 
within the superficial zone of developing articular cartilage with a high affinity for 
fibronectin and the ability to form large numbers of colonies from a low seeding 
density as described in Dowthwaite et al., (2004). These cells are believed to represent 
the stem/progenitor cell population hypothesised in Hayes et al., (2001). This chapter 
also describes a limited study of the expression of a number of cell surface proteins by 
superficial zone cells in vivo as well as an examination of the relative differences in 
cell size throughout the thickness of the tissue. These latter aspects have been 
investigated with a view to identifying possible routes to more rapid or more efficient 
means of isolation/enrichment of articular cartilage progenitor cells.
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3.2 MATERIALS AND METHODS
3.2.1 Differential adhesion and colony forming assays
3.2.1.1 Fibronectin coating of plates
Bovine plasma fibronectin (Sigma) was reconstituted to 2mg/ml with 2ml 
sterile deionised water and incubated at 37°C for 30 minutes to dissolve. This 
was diluted to lOpg/ml using Dulbecco's PBS with ImM MgC^ and lmM 
CaCb (Sigma). This solution was added to each well of 24 well plates and 
incubated overnight at 4°C for coating. The fibronectin solution was then 
aspirated and the plates were blocked with 1% BSA prior to addition of 
chondrocytes. Control plates were treated with Dulbecco's PBS with ImM 
MgCl2 and ImM CaCh containing 1% BSA (uncoated wells).
3.2.1.2 Cell isolation
Chondrocytes were isolated from the surface, middle and deep zone articular 
cartilage of 2-3 week old bovine metatarsophalangeal joints by fine dissection. 
The portions of cartilage were placed directly into Dulbecco's Modified Eagle 
Medium (DMEM) containing 5% foetal calf serum (FCS) and 0.1% pronase 
(Merck, 4xl06  units/g) and incubated at 37°C for 3 hours. Cartilage was then 
washed once with PBS and incubated in DMEM containing 5% FCS and 
0.04% collagenase (Worthington, 237U/mg) and incubated overnight at 37°C 
with gentle shaking.
Tissue digests were strained through a 70pm cell strainer (Falcon) to remove 
debris. The resultant filtrate was centrifuged at 300g for 5 minutes to pellet 
cells. Cell pellet was resuspended in 10ml of serum free DMEM, centrifuged 
at 300g for 5 minutes and the pellet resuspended in 10ml serum free DMEM. 
Cell number was then counted according using a Neubauer haemocytometer 
and resuspended to a final concentration of 4000 cells/ml.
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3.2.1.3 Differential adhesion and colony forming efficiency assays
After isolation, 750 chondrocytes in serum free DMEM were seeded into wells 
of coated and uncoated 24 well plates and incubated at 37°C for 20 minutes. 
After 20 minutes, the media was gently swirled and transferred to a second 
well and incubated for a further 20 minutes at 37°C. After 20 minutes the 
media was gently swirled and discarded. After removal of media at both time 
points, fresh DMEM containing 5% FCS was added to each well. Plates were 
incubated at 37°C in a 5% CO2 atmosphere.
Within 3 hours after initial plating, chondrocyte adhesion was assayed by 
counting the total number of cells adhering to the bottom of the dish using an 
inverted microscope equipped with phase contrast optics. Adhesion was 
expressed as a percentage of the initial seeding density.
After 7 days, media was removed from the wells and washed with PBS. Cells 
were then fixed for 1 0  minutes with ice-cold methanol and allowed to air dry. 
Wells were washed once with distilled water to remove the salt residue. 
Numbers of colonies (>32 cells) per well were either counted using darkfield 
illumination or the cells were stained using 0.1% crystal violet for 30 minutes 
and then washed extensively in distilled water prior to viewing using phase 
contrast microscopy. Colony forming efficiency (CFE) was calculated by 
dividing the number of colonies by the initial number of adherent cells.
Data was analysed using Student’s t-test to determine where significant 
differences exist. Differences were considered significant at the 0.05 
confidence limit.
3.2.2 Immunolabelling: Notch 1, BST-1, CD106 and CD166
Strips of cartilage were removed from 2-3 week old bovine 
metatarsophalangeal joints were frozen, embedded in OCT and sectioned as 
described in section 2 .1 .
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For immunolabelling, sections were washed twice for 10 minutes in PBS 
(Oxoid) prior to blocking with 2.5% normal rabbit serum (Dako) in PBS for 
20 minutes at room temperature. Blocking solution was wicked off using a 
tissue and sections were incubated with primary antibodies in PBS overnight 
at 4°C as described in table 3.1.
Sections were then washed three times for 10 minutes with PBS and incubated 
with secondary antibodies for 45 minutes at room temperature followed by 
washing again three times for 10 minutes. Sections labelled with biotinylated 
secondary antibodies were subsequently incubated in a 1 : 1 0 0  dilution of 
streptavidin-FITC (Dako) followed by washing three times for 10 minutes in 
PBS. Sections were then mounted with Vectashield (Vector) containing 
propidium iodide, coverslipped and viewed using a Leica confocal microscope 
and ArKr laser exciting at 488nm and 568nm.
Controls comprised of sections incubated with non-specific IgG raised in the 
same species as the corresponding primary antibody.
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Primary antibody Final
concentration
Secondary
antibody
Dilution
Notch 1 
(2 0 0 ja.g/ml)
Goat anti 
Notch 1 (Santa 
Cruz)
2 0 |ag/ml Rabbit anti 
goat IgG-FITC 
conjugated 
(Sigma)
1 in 1 0 0
BST1 
( 1  mg/ml)
Mouse anti­
human BST 1 
(MBL)
2 0 jig/ml Rabbit anti 
mouse IgG, 
FITC- 
conjugated 
(Sigma)
1 in 1 0 0
CD 105 
(0.25mg/ml)
Goat anti­
human TGF- 
pRIII (R&D)
12.5|ig/ml Rabbit anti 
goat IgG, 
biotin- 
conjugated 
(Sigma)
1 in 1 0 0
CD 166 
(0 .2 mg/ml)
Rabbit anti­
human 
ALCAM 
(R&D)
1 0 |ig/ml Rabbit anti 
goat IgG, 
biotin- 
conjugated 
(Sigma)
1 in 1 0 0
Table 3.1: Details of antibodies used in immunolabelling studies.
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3.2.3 Cell size analysis
Superficial, middle and deep zone chondrocytes were isolated from the articular 
cartilage of 2-3 week old bovine metatarsophalangeal joints as described in section 
3.2.1.2.
Aliquots of the isolated cell suspensions were pipetted onto a haemocytometer and 
coverslipped. Cells were viewed using an inverted Olympus CK40 microscope and 
photographed at xlOO magnification ensuring sufficient cells were present in the 
image (n>120). Image analysis using Image-Pro plus software calibrated with a 
graticule was carried out to determine the average diameter of cells present in the 
image. Statistical analysis was carried out using the Student’s t-test.
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3.3 RESULTS
3.3.1 Differential adhesion
Table 3.2 shows the initial cell adhesion over the two 20 minute time points for 
superficial, middle and deep zone chondrocytes cultured on fibronectin coated and un­
coated wells (BSA coated).
Significant differences in adhesion were evident between cells from all zones grown 
on fibronectin for 20 minutes and those grown on uncoated dishes for 20 minutes. 
Although there was no significant difference in adhesion between the first 20 minute 
time point and second 20 minute point for the superficial zone cells grown on 
fibronectin, there was a significant difference for the middle and deep zone cells 
between the time points when grown on fibronectin (p<0.05 and p<0.005 
respectively). Significant differences in adhesion were noted between superficial 
zones cells and middle zone cells (p<0.005), superficial zone cells and deep zone cells 
(p<0.05) and middle and deep zone cells (p<0.05) when cultured for 20 minutes on 
fibronectin.
3.3.2 Colony forming assays
Figure 3.2 shows the colony forming efficiency (CFE) of superficial, middle and deep 
zone chondrocytes cultured on fibronectin coated and uncoated wells for 7 days after 
the differential adhesion assay. CFE of the cohort of superficial zone cells that 
adhered to fibronectin within the first 20 minutes was significantly greater than the 
cohort of superficial zones cells than bound to fibronectin during the second 20 
minute incubation and all other middle and deep zone cell cohorts (p<0.01).
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Percentage cell adhesion
SFZ20 SFZ40 MZ20 MZ40 DZ20 DZ40
Fibronectin
coated
6.01±1.23 5.01±0.52 13.17±1.88 9.1811.37 7.2210.32 4.0210.21
Uncoated
(BSA
coated)
1.21±0.10 2.22±0.34 4.5911.18 3.0011.00 4.0011.98 3.0512.02
Table 3.2: Initial adhesion to fibronectin coated and uncoated we lls. SFZ =
superficial zone cells; MZ = middle zone cells; DZ = deep zone cells; 20 = first 20 
minute time point; 40 = second 20 minute time point, n = 4
Figure 3.1: Image illustrating colony formation by the population of superficial 
zone cells that binds to plasma fibronectin within 20 minutes. The adherent cells 
were cultured for 7 days in 5% FCS. Viewed using darkfield illumination on a 
stereomicroscope with x4 magnification.
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Figure 3.2: Colony forming efficiency of surface, middle and deep zone 
chondrocytes plated onto fibronectin coated and uncoated plates and cultured 
for 7 days in 5% FCS. FN = fibronectin coated; UN = uncoated; S= superficial 
cells; M = middle zone cells; D = deep zone cells; 20 = first 20 minute time point; 
40 = second 20 minute time point. *p<0.01 compared to all other cohorts.
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3.3.3 Immunolabelling: Notch 1, BST-1, CD106 and CD166
Figure 3.3A and B are confocal microscope images showing the immuno-localisation 
of Notchl in 2-3 week old bovine cartilage. Figure 3.3B is a higher magnification 
image of the superficial zone. Red fluorescence is a result of propidium iodide 
labelling of cell nuclei. Arrows illustrate the articular surface. Immediately apparent is 
that Notchl expression is almost entirely confined to the uppermost 2-3 cell layers of 
the cartilage. Figure 3.4 shows confocal microscope images of the immuno- 
localisation of BST-1, CD105 and CD166 in 2-3 week old bovine articular cartilage. 
BST-1 and CD 105 appear to be expressed differentially in the superficial zone. There 
was no noteable expression of CD 166. No expression of any of the proteins was 
detectable in the middle or deep zones of the cartilage. No green fluorescence was 
noted in any of the control sections.
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Figure 3.3: Confocal microscope images showing immunolocalisation of Notch 1 
in 2-3 week old bovine articular cartilage at low magnification (A) and higher 
magnification of the superficial zone (B). Scale bars = 100pm and 10pm in (A) 
and (B) respectively.
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Figure 3.4: Images showing immunolocalisation of BST-1 (A), CD105 (B) and 
CD166 (C). Arrows indicate articular cartilage surface. Scale bar = 50jim
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3.3.4 Cell size analysis
The diameter of chondrocytes from the surface, middle and deep zones of articular 
cartilage was determined using image analysis immediately following isolation. 
Figure 3.5 shows representative photographs of a superficial, middle, and deep zone 
chondrocytes respectively, viewed using phase contrast optics. Images analysis was 
used to determine the average diameter of large numbers of superficial (n=124), 
middle (n=275) and deep zone (n=182) chondrocytes and the results are shown in 
figure 3.6. There was a significant difference in average diameters between both 
superficial zone and middle zone (p>0.05) and superficial and deep zone cells 
(p>0.005).
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Figure 3.5: Phase contrast images of superficial (A), middle (B) and deep (C) 
zone articular chondrocytes immediately following isolation. Scale bar = 50pm
16 
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Figure 3.6: Average cell diameter of superficial, mid and deep zone chondrocytes 
(means +/- SEM). *p < 0.05, **p < 0.005 compared to superficial zone.
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3.4 DISCUSSION
This chapter and published data (Dowthwaite et al., 2004) has described the use of 
differential adhesion to serum fibronectin to identify a population of progenitor cells 
within the surface layers of developing bovine articular cartilage. The cells are 
capable of forming large numbers of colonies from an initially low seeding density, 
unlike cells isolated from the middle and deeper zones which also have a high affinity 
for fibronectin. The strong adhesiveness of the chondrocytes to fibronectin is 
explained by the high level of expression of the asPi integrin subunits, the fibronectin 
receptor (Dowthwaite et al., 2004). Interestingly, although surface zone cells express 
higher levels of the aspi subunits than middle and deep zone cells, this does not 
correspond with increased adhesiveness to the fibronectin substrate, rather middle 
zone cells exhibited a higher affinity for fibronectin but lack colony forming ability 
and may signify a transit amplifying cell population.
Previous studies have documented the expression of Notch family members during 
articular cartilage and growth plate development (Hayes et al., 2003). The expression 
of Notch 1 at the surface of the developing murine cartilage was mirrored in this 
chapter by Notch 1 expression at the surface of developing bovine articular cartilage. 
Genes of the Notch family encode a series of type I transmembrane receptors involved 
in controlling cell fate during development (Artavanis-Tsakonas et al., 1999; Bianchi 
et al., 2006). The signals transmitted by Notch receptors, combined with other cell 
factors, influence differentiation, proliferation and apoptotic events at all stages of 
development. For example, in skin, activation of Notch by the ligand Delta promotes 
terminal differentiation (Lowell et al., 2000), whereas in the growth plate, Delta- 
Notch 2 signalling inhibits the differentiation of pre-hypertrophic to hypertrophic 
chondrocytes (Crowe et al., 1999). Data described in Dowthwaite et al., (2004) 
suggests that Notch 1 plays a significant role in the signalling mechanisms controlling 
the clonality of surface zone chondrocytes, although its precise role in this regard is 
unclear, data suggests Notch 1 signalling maintains clonality, promoting proliferation 
and inhibiting differentiation.
In addition to Notch 1, data described here shows further proteins that are 
differentially expressed in the surface layers of developing bovine articular cartilage,
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bone marrow stromal cell antigen-1 (BST-1; CD157) and CD105 (endoglin). BST-1 is 
a highly glycosylated, glycosylphosphatidylinositol (GPI)-anchored membrane 
protein with a molecular weight of 43 kDa. which displays ADP ribosyl cyclase 
activity and facilitates pre-B cell growth. It is expressed in the bone marrow stroma 
and is thought to be involved in the regulation of haematopoiesis (Podesta et al., 
2005). Studies using gene chip analysis to compare gene expression between surface 
zone and middle zone chondrocytes highlighted the differential expression of BST-1 
by surface zone cells (B Thomson, personal communication). Immunolabelling 
studies described here have confirmed this finding at the protein level. The role of 
differential expression of BST-1 by the surface zone cells is unclear at present. 
CD 105, also known as endoglin is a homodimeric membrane glycoprotein and is 
thought to play a key role in cellular interactions with transforming growth factor-P 
(TGF- p). The precise role of endoglin in the surface layers is unknown. High levels 
of are known to be expressed in this region (Hayes et al., 2001) and thus, CD 105 may 
play a role in the regulation of TGF- P signalling in the surface regions during 
development.
Although Notch 1, BST-1 and CD 105 appear to be differentially expressed by the 
superficial zone chondrocytes, an examination of the data reveals that expression of 
these proteins is not restricted to progenitor cells. From the data it is clear that only 1- 
2% of the cells in the superficial zone are capable of forming colonies whereas the 
majority of the cells in the superficial zone appear to express these proteins. In the 
case of Notch 1, 75% of the superficial zone cells have been determined to express 
Notch 1 (Dowthwaite et al., 2004). Thus, these proteins could not be considered 
markers of the progenitor cells.
Chondrocytes are known to exhibit different phenotypes and morphologies 
throughout the depth of the tissue (Zanetti et al, 1985; Aydelotte and Kuettner, 1988; 
Aydelotte et al., 1988; Archer et al., 1990). In order to compare cell phenotype 
throughout the depth of the tissue, a protocol is needed for optimal separation of the 
different zones. Various methods of dissecting articular cartilage into separate zones 
of cartilage have been reported (Archer et al., 1990; Sun and Kandel, 1999), although 
it is unlikely these techniques yield pure preparations of the different types of 
chondrocytes, nor do they give cell populations that correspond exactly with the
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different zones of the tissue. The finding in this chapter that the middle and deep 
zones possess different sizes compared to the surface zone cells raises the possibility 
of the use of density gradient centrifugation to prepare more uniform and more pure 
fractions of chondrocytes (Min et al., 2002) that also correspond more accurately to 
the different zones of the tissue.
In conclusion, the surface zone of immature bovine articular cartilage contains a 
progenitor cell population that is responsible for the appositional growth of articular 
cartilage. The focus of the following chapters is to further characterise the cells and to 
investigate the potential of the cells in human cartilage repair therapies.
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4.1 INTRODUCTION
It is well accepted there is a close relationship between cellular phenotype and 
specialised extra-cellular (ECM) matrix formation. Cells synthesise an ECM 
according to their state of maturation and function and matrix components are able to 
modulate fundamental cellular properties, for example proliferation and 
differentiation (Adams and Watt, 1993). Tissue modulation processes in embryonal 
and immature tissues require a supporting and connecting extracellular matrix. In this 
respect, the ECM protein fibronectin has been extensively studied and found to be a 
nearly ubiquitous cell-cell and cell-matrix adhesion molecule.
Fibronectins (FNs) are multifunctional adhesive glycoproteins present as an insoluble 
form in the ECM and as a soluble form in various body fluids such as plasma. FNs are 
involved in many cellular processes, acting as substrates for cell migration and 
adhesion during embryogenesis, tumour progression, tissue repair and blood clotting 
(Hynes, 1990). FNs are disulphide-bonded dimers of two closely related subunits, 
each consisting of three types of homologous repeating units termed types I, II and III 
(Kosmehl et al., 1996). The domain structure of fibronectin is illustrated in figure 4.1. 
These repeats are organised into a series of functional domains that bind to integrins, 
collagens, heparin and heparan sulphate, fibrin, and FNs themselves.
FNs also interact with cells at three distinct regions: the central cell binding domain 
(CCBD), the COOH-terminal heparin-binding domain (Hep2), and the type Ill- 
connecting segment (IIICS) including the CS1 region. CCBD is the major cell- 
adhesive domain of FN and contains the Arg-Gly-Asp (RGD) motif and the Pro-His- 
Ser-Arg-Asn (PHSRN) sequence that are recognised by members of the integrin 
family of cell adhesion receptors, including a5(31, the primary FN receptor in many 
cell types (Manabe et al., 1997). Interaction of a5pl with CCBD has been shown to 
transduce signals that regulate cell proliferation, differentiation, and apoptosis 
(Giancotti and Ruoslahti, 1990; Meredith et al., 1993).
FNs purified from different sources have been determined to possess different subunit 
sizes. This heterogeneity of FN subunits arises mainly from alternative splicing of a
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primary transcript at three distinct places termed EDA, EDB and IIICS (Kombliht et 
al., 1985). The EDA and EDB segments are each encoded by single exons and 
comprise intact type III repeats, whereas the IIICS segment consists of five distinct 
variants due to exon subdivision. Up to 20 different FN subunits may result from 
alternative splicing at these regions.
Although there is substantial evidence that alternative splicing at these regions is 
regulated in a tissue-specific and onco-developmental manner, little is known about 
the specific functions of these various isoforms. Soluble plasma FN produced by adult 
hepatocytes contains neither EDA or EDB segments in both subunits and lacks the 
entire IIICS segment in one of the subunits (Yamada et al., 1985), whereas insoluble 
cellular FNs expressed during wound healing and in fetal and tumour tissues contain a 
greater percentage of EDA and EDB segments than those expressed in normal adult 
tissues (Camemolla et al., 1989; fffench-Constant et al., 1989; fffench-Constant and 
Hynes, 1989). Correspondingly, fibroblastic, tumourigenic and fetal cell lines express 
greater quantities of FNs with EDA and/or EDB segments. The presence of the EDA 
segment within the FN molecule has been shown to promote cell spreading and 
migration (Manabe et al., 1997) and regulate cell cycle progression and mitotic signal 
transduction through up-regulation of integrin-mediated mitotic signal transduction 
(Manabe et al., 1999). Thus EDA containing FN appears to be associated with cellular 
processes requiring high levels of cell proliferation and migration as occurs in 
tumourigenesis, embryogenesis and wound healing.
Specific temporal and spatial changes in the content of the extracellular matrix or in 
expression of cell adhesion molecules is likely to be involved in the regulation of 
cartilage differentiation and chondrocyte function (Dessau et al., 1980; Adams and 
Watt, 1993; Tuan, 2004). In addition, cartilage homeostasis is partly regulated by 
chondrocyte-extracellular matrix interactions and FN is known to play a role in 
chondrocyte adhesion and mechano-transduction signalling events (Millward-Sadler 
et al., 2000). Interestingly, although FN-EDA has been demonstrated to be absent 
from mature articular cartilage (Chevalier et al., 1996; MacLeod et al., 1996) its 
expression has been demonstrated in the surface layers of human fetal articular 
cartilage (Salter et al., 1995) and in chick embryonic limb pre-cartilage mesenchyme 
(Kuo et al., 2002; Peters et al., 2002; White et al., 2003), thus suggesting a specific
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role for the isoform during chondrocyte differentiation. Furthermore, antibodies 
specific for the EDA region inhibited chondrogenesis of limb micro-mass cultures in 
vitro and when injected into chick limb buds in vivo, caused moderate to severe 
skeletal malformations (Gehris et al., 1996 and 1997). Thus, the function of the EDA 
region appears to be the regulation of mesenchymal cell spreading (White et al., 2003) 
therefore permitting and/or promoting adequate cell-cell interaction to take place 
during the condensation form of chondrogenesis. The tissue localisation of FN-EDA 
during development appears to overlap with the predicted location of the articular 
cartilage progenitor cells (Salter et al., 1995). The enhanced adhesiveness of FN-EDA 
and its ability to promote cell spreading, migration and proliferation via increased 
binding to the a5pl integrin (Manabe et al., 1999) may be important to the 
maintenance of phenotype of the progenitor cells and/or necessary for supporting the 
high proliferative potential of the cells in this region.
The aims of this study were three-fold:
[1] Determine the expression of FN-EDA in immature bovine articular cartilage.
[2] Evaluate the expression of FN-EDA by fibroblast, tumour and fetal cell lines 
and purify FN-EDA from media conditioned by a selected cell line using immuno- 
affinity chromatography.
[3] Compare the difference between plasma fibronectin and purified FN-EDA on 
superficial zone and middle zone chondrocyte attachment and colony forming 
efficiency.
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Figure 4.1: Model of the domain structure of a fibronectin subunit. Taken from 
Kosmehl et al., 1996.
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4.2 MATERIALS AND METHODS
4.2.1 Immuno-localisation of Fibronectin-EDA in immature articular cartilage
4.2.1.1 Fibronectin-EDA immunolabelling
Strips of cartilage were removed from 7 day-old bovine metatarsophalangeal 
joints as described in section 2.1. The cartilage was embedded in OCT and 
sectioned as described in section 2.3.6.
For immunolabelling, sections were washed twice for 10 minutes in PBS 
(Oxoid) prior to blocking with 2.5% normal rabbit serum (Dako) in PBS for 
20 minutes at room temperature. Blocking solution was then wicked off using 
a tissue and sections were incubated with 50pg/ml IgG of a monoclonal mouse 
anti-fibronectin-EDA antibody (Oxford Biotechnologies) in PBS overnight 
and 4°C. Sections were washed three times for 10 minutes with PBS and 
incubated with a 1:100 dilution in PBS of a biotinylated rabbit anti-mouse 
secondary antibody (Dako) for 45 minutes at room temperature followed by 
washing three times for 10 minutes. Sections were then incubated with a 1:100 
dilution in PBS of a Streptavidin-FITC conjugate (Amersham Pharmacia) for 
1 hour at room temperature followed by washing for three times for 10 
minutes. Sections were finally mounted with Vectashield (Vector, 
Peterborough) containing propidium iodide for visualisation of cell nuclei, 
coverslipped and viewed using a Leica confocal microscope with an ArKr 
laser exciting at 488nm and 568nm.
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4.2.1.2 Fibronectin-EDA/Notchl double labelling
Protocol was repeated as described above with the addition of 20pg/ml of the 
polyclonal goat anti-human Notch 1 (C-terminal) antibody (Santa Cruz) 
together with the anti-fibronectin-EDA antibody. Detection was carried out 
using a rabbit anti-goat-FITC conjugated secondary antibody (Dako) for 
Notchl and a biotinylated rabbit anti-mouse secondary antibody followed by a 
streptavidin-Texas Red conjugate (Amersham Pharmacia) for fibronectin- 
EDA. The use of Texas Red provides a greater separation of emission spectra 
from FITC than TRITC and also excites to a greater degree on the 568nm 
spectral line of the ArKr laser than TRITC. Sections were mounted with 
Vectashield (Vector, Peterborough) without propidium iodide. Special care 
was taken to minimise crossover of fluorescence between the two photo­
multipliers due to emission spectra overlap by reduction of laser power at the 
specific excitation values.
4.2.13 Controls
Control sections were incubated with the same concentration of non-immune 
mouse IgGl and/or goat IgG.
4.2.2 Purification of Fibronectin-EDA from conditioned media
In these studies, fibroblastic, tumourigenic and fetal cell lines were used as these 
would be expected to produce greater quantities of FNs with the EDA segment (see 
section 4.1).
4.2.2.1 Fibronectin-EDA immunocytochemistry on cell lines
Human dermal fibroblasts (passage 4), MRC-5 cells (human fetal lung 
fibroblasts) (passage 22) and MG-63 cells (human osteosarcoma) (passage 
107) were passaged and maintained as described in section 2.2. Cells were
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counted using a haemocytometer and seeded into 4-well chamber slides at
100,000 cells/well and grown to confluence.
Monolayers were washed three times with PBS and fixed for 10 minutes with 
-20°C methanol. Monolayers were then washed three times for 10 minutes 
with PBS and blocked with 2.5% normal rabbit serum in PBS for 20 minutes. 
Monolayers were washed once with PBS and incubated with 50pg/ml IgG of a 
mouse monoclonal anti-FN-EDA antibody (Oxford Biotechnologies) in PBS 
for 90 minutes. Monolayers were again washed three times for 10 minutes 
with PBS, incubated with a 1:100 dilution of a biotinylated rabbit anti-mouse 
secondary antibody (Dako) for 1 hour, washed three times for 10 minutes with 
PBS and incubated with a 1:100 dilution of a streptavidin-FITC conjugate 
(Amersham Pharmacia) in PBS for 1 hour. Monolayers were then washed 
three times for 10 minutes with PBS, mounted with Vectashield (Vector, 
Peterborough) containing propidium iodide, coverslipped and viewed using a 
Leica confocal microscope with an ArKr laser exciting at 488nm and 568nm.
4.2.2.2 Fibronectin-EDA ELISA on conditioned media
ELISAs were used semi-quantitatively as a guide to the efficiency of 
production of fibronectin-EDA by the cell lines.
For coating of plates, media conditioned by various cell lines for various 
amounts of time was pipetted into the wells of 96 well plates at 200pl/well. 
Cell lines used are illustrated in table 4.1. MG-63 and MRC-5 cells were used 
to condition media over a 6 day period. In addition, MG-63 cells were allowed 
to condition media in the absence of serum. The use of media without serum 
would be preferable as serum contains large quantities of plasma fibronectin. 
Samples of this treatment were also taken over time to look at the extent of 
accumulation of FN-EDA in the media over the conditioning period. Human 
dermal fibroblasts and RCM-1 cells were allowed to condition media for a 
greater length of time as these cells took longer to reach confluence. 
Dermagraft conditioned media was also used (Supplied by Advanced Tissue
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CaCb and MgCE) was used for coating. Coating was allowed to take place 
overnight at 4°C.
PBS-T was prepared by adding 0.04g sodium azide and 0.1ml Tween-20 to 
200ml PBS. After coating, wells were washed five times with PBS-T and then 
blocked with 5% low fat milk powder in PBS-T for 2 hours at 37°C. Plates 
were washed five times with PBS-T and incubated with lOOpl of lOpg/ml 
anti-FN-EDA antibody (Oxford Biotechnologies) in PBS-T containing 1% low 
fat milk powder overnight at 4°C. Plates were then washed five times with 
PBS-T and incubated with lOOpl of an alkaline phosphatase conjugated rabbit 
anti-mouse secondary antibody (Sigma, Poole) diluted 1:3000 in PBS-T 
containing 1% low fat milk powder for 90 minutes at 37°C. Plates were then 
washed five times and the substrate added (lOmg p-nitrophenyl phosphate in 
lOmM diethanolamine, ImM MgCl2 , pH 9.8) and development of yellow 
colouration monitored and photographed.
In addition to the above, wells coated with plasma fibronectin were detected 
using a pan-fibronectin antibody (rabbit anti-human FN; Dako) diluted 1:100 
and detected using a horseradish peroxidase conjugated goat anti-rabbit 
secondary antibody at 1:100 dilution (Dako). The substrate for this consisted 
of 200pl of lOmg/ml tetramethyl benzidine in DMSO and 3 pi of hydrogen 
peroxide added to 20ml of 0.1 M sodium acetate buffer pH 6.0. Development 
of blue colouration monitored and photographed.
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Cell line Description Passage number Length of time 
conditioned (days)
MG-63 in serum-free 
media
Human
osteosarcoma
116 1
MG-63 in serum-free 
media
Human
osteosarcoma
116 2
MG-63 in serum-free 
media
Human
osteosarcoma
116 6
MG-63 Human
osteosarcoma
117 6
MRC-5 Human fetal 
lung fibroblast
43 6
Human dermal 
fibroblasts
Human
fibroblast
30 8
RCM-1 Human
adenocarcinoma
70 9
Table 4.1: Cell lines used to condition media for ELISA to evaluate FN-EDA 
content.
98
Chapter 4: Fibronectin-EDA+
4.2.2.3 Production of fibronectin-EDA immuno-affinity column
Anti-FN-EDA antibody (2mg) was dialysed twice against coupling buffer 
(0.1M NaHCC>3 , 0.5M NaCl, pH8.3) for 90 mins and overnight respectively at 
4°C using 10,000 MWCO dialysis tubing. CNBr activated Sepharose 4B 
(Amersham Pharmacia Biotech) (lg) was swollen in ImM HC1 and washed 
with >200ml ImM HC1 on a scinter funnel. The dialysed antibody was mixed 
with the gel and rotated at room temperature for 2 hours before the remaining 
active sites were blocked by incubation in 0.1 M Tris-HCl for 2 hours at room 
temperature. The gel was then washed with 3 cycles of high and low pH buffer 
to ensure removal of unbound material, transferred to PBS containing 0.02% 
sodium azide and packed into a column and equilibrated at lOml/h.
Aliquots of antibody (2 x 20pl) were removed prior to mixing with gel. In 
addition, aliquots of supernatant (2 x 20pl) were removed after incubation 
with gel. These aliquots were removed for protein estimation using the BCA 
assay (Pierce) according to the manufacturer’s instructions to evaluate degree 
of antibody coupling to the gel.
4.2.2.4 Affinity purification of fibronectin-EDA from conditioned media
Immuno-affinity chromatography methods used were similar to that described 
by Miyashita et al., (1998). Two confluent flasks of MG-63 cells were 
transferred to serum-free media and the media collected after two days, (p- 
amidino-phenyl)methanesulphonyl fluoride (PMSF; Sigma, Poole) was made 
up by dissolving 34.8mg in 95% ethanol. This was added at a ratio of 1:100 to 
the collected media to bring the final concentration to 2mM PMSF. Media was 
stored at -70°C until used.
All chromatographic steps were carried out at 4°C. Forty ml of the conditioned 
media was applied to column at lOml/h and re-circulated. Unbound material 
was washed from the column using PBS, fractions were collected every 10 
minutes and the absorbance at 280nm determined using a Perkin Elmer
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Lambda 2 spectrophotometer. When the absorbance reached a stable baseline, 
FN-EDA was eluted from the column with elution buffer (20mM CAPS, 
150mM NaCl, lOmM EDTA, pHl 1). Eluted fractions with peak absorbance at 
280nm were pooled and dialysed against 41 of lOmM CAPS, 150mM NaCl, 
ImM CaCb, pH 11 overnight at 4°C using 10,000 MWCO dialysis tubing. 
Aliquots were taken for protein estimation, SDS-PAGE and ELISA and the 
remainder stored at -70°C.
ELISA of the un-fractionated conditioned media, the unbound material from 
the column and eluted fractions were carried out as described above. Media 
and solutions from the column were added to the wells of the 96-well plates at 
200pl/well and coating was allowed to take place overnight at 4°C.
For SDS-PAGE, aliquots were freeze-dried and reconstituted to lOOpg/ml 
protein with deionised water. Ten pi aliquots of 1OOpg/ml of purified FN- 
EDA, plasma fibronectin (Sigma, Poole) and cellular fibronectin (Sigma, 
Poole) were prepared. Three pi of sample buffer (see below) was added to 
each of the samples. The total sample (lpg) of plasma fibronectin, cellular 
fibronectin and purified FN-EDA from the column was applied to a 4-12% 
bis-acrylamide gel (Nupage-Novex) and run at 200V for 2 hours in a running 
buffer of 25mM Tris, 190mM glycine, 0.1%SDS, pH8.3. The gel was stained 
with Simply Blue Safestain (Invitrogen, Paisley) for 1 hour at room 
temperature then washed twice for 45 minutes in distilled water. Rainbow 
recombinant protein markers (Amersham) with a molecular weight range of
10,000 to 250,000 were used for comparison according to the manufacturers 
instructions.
Sample buffer: lmg bromophenol blue; 800pl 2M Tris-HCl pH8.8; 50ml 60% 
sucrose; 3.5ml 20% w/w SDS; 500pl 2-Mercaptoethanol; 200pl UHQ water.
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4.2.2.5 Cell adhesion to purified FN-EDA
Pooled FN-EDA from the column (lOOp.1) was added to 6 wells of a 96 well 
plate and incubated overnight at 4°C. Control wells were coated with 1% 
BSA. The wells were then washed 3 times with PBS, blocked for 1 hour at 
37°C with 1 % BSA and washed a further 3 times with PBS. MG-63 cells 
were trypsinised as described in section 2.2.2.2, counted using a 
haemocytometer, resuspended in serum-free DMEM and 30,000 cells added to 
the wells of the 96-well plate and the cultures incubated for 30 minutes at 
37°C. The wells were then washed and live cell stain added (2.5pl calcein AM 
in 5ml PBS -  Molecular Probes), and viewed using a Leica DM-IRBE 
inverted confocal microscope using an ArKr laser exciting at 488nm.
4.2.3 Evaluation of articular cartilage progenitor cell behaviour on 
Fibronectin-EDA
4.2.3.1 Differential adhesion and colony forming efficiency assays using 
purified Fibronectin-EDA
Differential adhesion and colony forming assays were carried out as described 
in section 3.2.1. Plates were coated with purified FN-EDA, bovine plasma 
fibronectin (pFN) (Sigma) at lOpgml’1 using Dulbecco's PBS with ImM 
MgCE and ImM CaCE (Sigma).
Colonies were counted after 7 days. Media was removed from the wells and 
washed with PBS. Cells were then fixed for 10 minutes with ice-cold 
methanol and allowed to air dry. In some cases, fixed cells were stained with 
0.1% crystal violet for 30 minutes and washed with distilled water. Colonies 
were counted using phase contrast optics and colony forming efficiency (CFE) 
was calculated by dividing the number of colonies by the initial number of 
adherent cells. Data was analysed using a Student’s T Test and considered 
significant at the 0.05 confidence limit.
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4.3 RESULTS
4.3.1 Fibronectin-EDA immunohistochemistry
Figure 4.2A is a confocal microscope image showing the immuno-localisation of FN- 
EDA in the articular surface of 2-3 week old bovine cartilage. Figure 4.2B is an image 
taken from the middle zone and figure 4.2C shows the control image incubated with 
an equivalent concentration of non-immune mouse IgGl. Red fluorescence is a result 
of propidium iodide labelling of cell nuclei. Arrows illustrate the articular surface. 
Immediately apparent is that FN-EDA expression is cell-associated and is almost 
entirely confined to the superficial zone of the cartilage. Small amounts of 
fluorescence can be seen in the lower regions, however this was also seen on the 
control sections.
Figure 4.3 is a confocal microscope image of the articular surface showing Notch 1 
and FN-EDA co-localisation in the cells of the superficial zone of immature bovine 
articular cartilage. Arrows illustrate the articular surface. Control images showed no 
fluorescence.
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Figure 4.2: Immunolocalisation of Fibronectin-EDA in 2-3 week old bovine 
articular cartilage. Fibronectin was localised pericellularly around superficial 
zone chondrocytes (A) and absent from chondrocytes deeper into the tissue (B). 
Staining was absent in control sections incubated with a non-specific mouse IgGl 
(C). Scale bar = 50pm
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B
Figure 4.3: Co-localisation of Fibronectin-EDA (red fluorescence) and Notchl 
(green fluorescence) in the superficial zone of immature bovine articular 
cartilage (A). Staining was absent in control sections incubated with a non­
specific mouse and goat IgG (B). Scale bar = 50pm
104
Chapter 4: Fibronectin-EDA+
4-3.2 Fibronectin-EDA immunocytochemistry on cell lines
Figures 4.4 (A), (B) and (C) are confocal microscope images of anti-FN-EDA 
immunocytochemistry on the three cell lines. Figure 4.4 (D) is a confocal microscope 
image of MG-63 cells stained with an equivalent concentration of non-immune mouse 
lgGl as a control. FN-EDA in the cell monolayer is clearly visible in all three cell 
lines- Red fluorescence is a result of propidium iodide labelling of cell nuclei.
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(D) Control (non-specific IgG)
Figure 4.4: Confocal microscope images of three cell lines immunostained for 
FN-EDA. Scale bar = lOOpm.
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4.3.3 Fibronectin-EDA ELISA on conditioned media
Figure 4.5 illustrates the ELISA results from the conditioned media. The colouration 
that developed was not quantified using spectrophotometry. Instead, visual 
comparisons were made between the different treatment groups. There appeared to be 
little difference between any of the samples from the MG-63 cells (with or without 
serum), MRC-5 cells or the human dermal fibroblasts. From these results it was 
decided to use MG-63 cells in serum-free media as the source of FN-EDA. MG-63 
cells were chosen as the cells not only appear to secrete large amounts of FN-EDA 
into the media, but they also grow rapidly in culture. It was decided to use serum-free 
media for conditioning as serum contains a high level of plasma fibronectin that may 
interfere with the purification process and also non-specific proteases that may 
degrade the column. The absence of serum does not appear to affect the production of 
FN-EDA by the MG-63 cells. Figure 4.5 also shows that the anti-FN-EDA antibody 
does not cross-react with plasma fibronectin.
4.3.4 Production of fibronectin-EDA immuno-affinity column
Aliquots of antibody solution were taken before and after mixing with the Sepharose 
4B gel for protein estimation to estimate the degree of antibody coupling. Protein 
concentration in the antibody solution during the coupling step should decrease as the 
antibody binds to the Sepharose 4B gel. Table 4.2 shows the protein concentrations of 
the antibody solutions before and after coupling and suggests that all the antibody has 
bound to the gel. The reason for the negative protein value after coupling is unclear 
and may be due to the presence of material from the coupling gel interfering with the 
assay.
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Figure 4.5 Digital photographs of colour change during FN-EDA ELISA on 
various conditioned media and forms of fibronectin.
Protein concentration 
(pg/ml)
Before Coupling 188.6
After Coupling -29.4
Table 4.2: Protein concentrations of antibody solutions before and after coupling 
to the sepharose 4B gel.
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4.3.5 Affinity purification of fibronectin-EDA from conditioned media
Figure 4.6 shows the elution profile of proteins exiting the column. Fractions with 
peak absorbance after the addition of elution buffer were pooled and dialysed, then 
analysed by ELISA and SDS-PAGE to confirm the identity of the protein.
Figure 4.7 illustrates anti-FN-EDA and anti-total FN ELISA of various fractions from 
the column. This identifies the protein in the pooled fractions as being FN-EDA. The 
results also indicate that all the FN-EDA is not being fully removed from the 
conditioned media during the affinity purification as there is a level of FN-EDA 
present in the unbound material (ie. media which has passed through the column).
The pooled fractions were also subjected to SDS-PAGE in order to check the purity of 
the FN-EDA. Cellular fibronectin and plasma fibronectin was also added to the gel as 
a comparison. The results are shown in figure 4.8. The FN-EDA appears at 
approximately 270 kDa and runs as a tight band in comparison to cellular fibronectin 
and plasma fibronectin, thus suggesting its relative purity. FN-EDA and cellular 
fibronectin appear at a higher molecular weight than plasma fibronectin due to 
presence of extra polypeptide domains that are absent in plasma fibronectin.
4.3.6 Biological activity of FN-EDA
Figures 4.9 (A) and (B) show the attachment and spreading of MG-63 cells to non­
coated and purified FN-EDA coated cell culture plates in serum-free media. Whereas 
few cells adhered to the non-coated wells, MG-63 cells rapidly adhered to the FN- 
EDA coated wells, suggesting the purified FN-EDA has retained some of its 
biological properties.
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Affinity purification of FN-EDA+
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Figure 4.6: Elution profile during immuno-affinity purification of FN-EDA.
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Figure 4.7: Digital photograph of colour change during ELISA of fractions from 
affinity column.
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Figure 4.8: SDS-PAGE of cellular and plasma fibronectin in comparison to 
purified FN-EDA.
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B) Control -  non coated
Figure 4.9: Adhesion of MG-63 cells to purified fibronectin-EDA (A) in 
comparison to a non-coated surface (B). Scale bar = 100pm.
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4.3.7 Differential adhesion and colony forming efficiency of articular cartilage 
progenitor cells on FN-EDA in comparison to plasma fibronectin 
4.3.7.1 Differential adhesion
Table 4.3 shows the initial cell adhesion over the two 20 minute time points 
for superficial and middle zone chondrocytes cultured on FN-EDA and pFN 
coated wells.
The data illustrates that although middle zone chondrocytes have a higher 
affinity to the fibronectins than the superficial zone chondrocytes, there is no 
statistically significant difference between adhesion of the chondrocytes to 
pFN and FN-EDA at either time point.
4.3.7.2 Colony forming efficiency
Figure 4.10 shows the colony forming efficiency of superficial and middle 
zone chondrocytes cultured on FN-EDA and pFN coated wells for 6 days after 
the differential adhesion assay. The only detectable difference between the two 
substrates could be noticed in the superficial zone cells over the first 20 
minute adhesion; Superficial zone cells that adhere to FN-EDA over the first 
20 minutes appear to have a lower CFE than those that adhere to pFN 
(p<0.005). There no obvious differences in colony size.
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Percentage cell adhesion
SFZ20 MZ20 SFZ40 MZ40
FN-EDA
coated
9.83±1.7 15.13±2.7 3.8±1.3 8.45±2.8
pFN
coated
12.5±3.1 15.6±2.5 4.24±0.9 7.6±0.79
Table 4.3: Initial adhesion to FN-EDA and plasma fibronectin (pFN) coated 
wells. SFZ = superficial zone cells; MZ = middle zone cells. N = 4
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Figure 4.10: Colony forming efficiency of superficial and middle zone chondrocytes on plasma-FN (pFN) and FN-EDA following 20 
minute and 40 minute adhesion.
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4.4 DISCUSSION
There is substantial evidence that extracellular matrix regulates development and cell 
differentiation (Adams and Watt, 1993). Controlled production of matrix proteins and 
their isoforms in a spatial and temporal manner will have important roles in 
chondrocyte function and cartilage development. For example, regulated expression 
of various FN isoforms is a key mediator of chondrogenic differentiation. During 
chick embryonic limb chondrogenesis, FN structure changes from EDA+ in pre­
cartilage mesenchyme to EDA- in differentiated cartilage (Peters et al., 2002; White et 
al., 2003; Kuo et al., 2002). In addition, FN-EDA is reported to be expressed in 
human fetal cartilage (Salter et al., 1995), but not in the adult tissue (MacLeod et al., 
1996; Chevalier et al., 1996).
Heterogeneity of the FN molecule results from alternative splicing of a common 
primary mRNA transcript at three segments, EDA, EDB and IIICS (Kosmehl et al., 
1996). Although it is known the expression of the EDA and EDB segments is 
regulated spatially and temporally during development, wound healing and 
tumourigenesis, little is known about the function of the variable domains (Manabe et 
al., 1997). In vivo expression patterns of FN isoforms suggest a role for FN-EDA in 
cell growth and migration. The EDA segment is included in FN species expressed in 
embryonic tissues but is spliced out of the molecule as embryonic development 
progresses (Vartio et al., 1997; ffrench-Constant and Hynes, 1989). In adults, EDA 
containing FN reappears during wound healing and in tumour tissues (ffrench- 
Constant et al., 1989; Oyama et al, 1989), with levels of FN-EDA being higher in 
invasive tumours than in non-invasive ones (Oyama et al., 1989). Such an expression 
pattern in tissues populated with cells having high proliferative and migratory 
potentials suggests a role in promoting cell adhesion and migration in vivo.
In light of the evidence describing an association between primitive mesenchymal 
progenitor cells and FN-EDA expression (Gehris et al., 1996 and 1997; Peters et al., 
2002; White et al., 2003; Kuo et al., 2002) this study has sought to determine whether 
the isoform is also associated with the articular cartilage progenitor cells of the 
superficial zone, and to examine whether the isoform is important in maintaining or 
promoting the function/phenotype of the cells.
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Firstly, EDA containing FN was determined to be associated in a pericellular fashion 
with the superficial 2-3 cell layers of immature bovine articular cartilage and was seen 
to be co-expressed with Notch 1 in double labelling immunostaining experiments. As 
described in section 3.3.3 and discussed in section 3.4, Notch 1 is a cell fate 
determination receptor (Artavanis-Tsakonas et al., 1999) expressed non-exclusively 
on the surface of articular cartilage progenitor cells in the superficial zone of 
developing articular cartilage (Hayes et al., 2003; Dowthwaite et al., 2004). Thus, the 
differential expression of EDA containing FN by the progenitor cells suggests it may 
be an important component of the progenitor cell pericellular environment and may 
act to influence cell behaviour.
Secondly, experiments were carried out to determine whether isolated superficial zone 
cells displayed increased adhesiveness to purified EDA containing FN in comparison 
to plasma FN, and to examine the effect of growth of the progenitor cells on a 
substrate of EDA containing FN in comparison to plasma FN in terms of colony 
forming efficiency. Although no effect on adhesion could be determined, subsequent 
culture of the cells that had adhered to the substrates demonstrated a reduction in 
colony forming efficiency from 0.44 with plasma fibronectin to 0.33 (p<0.005) with 
FN-EDA in the cohort of superficial zone cells that binds in the 20 minute adhesion 
step ie. the cohort that contains the progenitor cell population.
Previous studies have described contradictory results in terms of cellular adhesiveness 
to FN-EDA. Guan et al., (1990) showed no difference between recombinant EDA+ 
and EDA- in terms of cell adhesion whereas Manabe et al., (1997) and (1999) showed 
increased adhesion of human HT1080 fibrosarcoma cells to EDA+FN. White et al., 
(2003) also found no difference in adhesion of chick limb-bud mesenchymal cells to 
various combinations of EDA and EDB containing recombinant FNs although 
spreading was decreased on EDA+/EDB+ FN. These discrepancies may, in part, be 
due to the nature of the EDA containing FN used in the studies. The recombinant 
EDA+ FN used in the studies of Guan et al., (1990) did not contain the IIICS segment 
whereas the IIICS segment was included in the isoforms evaluated in the studies of 
Manabe et al., (1997) and (1999) and this segment may be required for the EDA- 
dependant potentiation of the cell-adhesive activity of FNs. In the studies described
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here, the nature of the EDA+ containing FN is unclear. For example, the FN-EDA 
was purified from media conditioned by the human MG-63 osteosarcoma cell line 
solely on the basis of the presence of the EDA segment using immuno-affinity 
chromatography. The EDA containing FN may be heterogeneous in composition as it 
is unknown as to the extent of the presence of the EDB segment or other segments in 
the EDA containing FN. In addition, EDA containing FN occurs naturally in vivo as 
an insoluble aggregate of dimers of FN molecules (Yamada and Akiyama, 1984) 
whereas the EDA containing FN in the conditioned media in this study must have 
possessed a high degree of solubility and thus may differ structurally from the EDA 
containing FN shown to be laid down in the cell monolayers (figure 5.4) and that 
which is present in extracellular matrices. In addition, novel cartilage-specific variants 
of fibronectin have been demonstrated in human (Parker et al., 2002) and animal 
tissues (Macleod et al., 1996). Although the precise physiological roles for these 
variants is yet to be determined, the abundance of these isoforms in the tissue (50- 
80% of the total FN transcripts in cartilage) suggests they may play a key regulatory 
role in chondrocyte interactions with the ECM. It is unlikely EDA containing FN 
purified from MG-63 cell conditioned media will contain a high level of these variants 
and, thus, may not provide the correct signals to the chondrocytes and/or progenitors.
The reduction in CFE of the cohort of superficial zone cells that binds in the 20 
minute adhesion step (the cohort that contains the progenitor cell population) on FN- 
EDA was surprising, given the putative role of the isoform during development, and 
the significance of this is not clear. The reduced proliferation could either be due to 
alterations in integrin-mediated mitotic signal transduction induced by the presence of 
the EDA segment or the EDA segment could have resulted in the adhesion of a subtly 
different population of cells in the cohort that binds in the first 20 minutes. At this 
point it is unclear as to whether the FN-EDA remained bound to the tissue culture 
plastic throughout the experiment or whether it was competed from the surface after 
the adhesion step by the abundance of plasma fibronectin in the bovine serum of the 
culture media. In addition, the chondrocytes are likely to have secreted their own 
fibronectin rich ECM in culture (Dessau et al., 1978 and 1981) which would be the 
predominant substrate to which the progenitor cells would be attached. These data 
suggest altered integrin-mediated mitotic signal transduction may not be responsible
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for the reduced CFE as the influence of the FN-EDA on the behaviour of the 
progenitor cells may reduce with time.
In conclusion, this study has demonstrated the purification of EDA containing FN and 
an in vitro examination as to its effect on cell behaviour. Initial data suggests EDA 
containing FN may play a role in modulation of articular cartilage progenitor cell 
proliferation in vivo. Further studies using a more characterised FN-EDA substrate 
would be required to confirm the precise nature of the role of the EDA segment in 
articular cartilage progenitor cell behaviour.
119
Chapter 5: Articular cartilage progenitor cell expansion and chondrogenic ability
CHAPTER 5
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5.1 INTRODUCTION
The poor regenerative capacity of articular cartilage is well characterised (Hunziker, 
2001a) and has been attributed to a lack of proliferative activity of the chondrocytes 
surrounding the cartilage lesion (Campbell, 1969). Such lesions are frequently linked 
to joint pain, reduced function and often progress to secondary osteoarthritis 
(Buckwalter and Mankin, 1997a). Therapeutic intervention in the degenerative 
process includes debridement, various abrasion strategies, microfracture, mosaicplasty 
and arthroscopy (Gilbert, 1998), thus imposing a significant economic burden on 
healthcare providers (Jackson et al., 2001).
Recent studies have highlighted the promise of tissue engineering or cell 
transplantation for cartilage repair (Freed et al., 1993; Sittinger et al., 1994; Cao et al., 
1998). Such studies have employed cells frequently seeded onto synthetic (Freed et 
al., 1993; Cao et al., 1998) or natural scaffolds such as collagen (Kawamura et al., 
1998) or fibrin (Hendrickson et al., 1994). In addition to providing mechanical 
support, the scaffold acts as a provisional extracellular matrix and is supposed to 
support the cells in an optimal 3-D environment that supports cell proliferation and 
differentiation (Freed et al., 1999). The identification of a suitable cell source for 
cartilage tissue engineering has proved elusive. Whilst attention has mainly focussed 
on the use of autologous (Grande et al., 1989) or allogeneic (Kawamura et al., 1998; 
Grande et al., 1987) chondrocytes and mesenchymal stem cells derived from bone 
marrow (Wakitani et al., 1994; Kadiyala et al., 1997; Im et al., 2001; Johnstone and 
Yoo, 2001; Wakitani et al., 2002), other cell sources such as periosteum (De Bari et 
al., 2001), perichondrium (Chu et al., 1997) and synovial cells (Nishimura et al., 
1999; De Bari et al., 2001a;) have also been investigated.
Difficulties arise in the use of chondrocytes in tissue engineering processes due to the 
limited number of cell divisions a mature chondrocyte will undergo in vitro prior to 
the onset of senescence coupled with a loss of ability to form cartilage induced by the 
cell culture environment (Benya and Shaffer, 1982; Evans and Georgescu, 1983; 
Binette et al., 1998). The proliferative potential is dependent on species and inversely 
proportional to the age of the donor. The importance of this becomes apparent 
considering the limited number of chondrocytes that can be harvested from a patient
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and the large numbers of cells required for cell transplantation procedures and tissue 
engineering scaffold seeding protocols. The limited growth potential of chondrocytes 
in culture is further complicated by the rapid loss of phenotype, known as 
dedifferentiation, of chondrocytes in monolayer culture. Dedifferentiation is 
characterised by a loss of the normal spherical cell morphology with concomitant 
decrease in collagen II and aggrecan synthesis to a fibroblastic-like morphology with 
up-regulation of collagen I, III and versican (Benya and Shaffer, 1982; Von der Mark 
et al., 1997; Binette et al., 1998). This process is illustrated in figure 5.1. Possible 
solutions to enable the rapid expansion of chondrocytes whilst retaining their 
phenotype have been suggested and usually involve the use of growth factors such as 
basic-FGF or TGF-pi (Froger-Gaillard et al., 1989; van der Kraan et al., 1992; Pujol 
et al., 1994; de Haart et al., 1999; Martin et al., 1999; Jakob et al., 2001; Barbero et 
al., 2004). The reversal of dedifferentiation, known as redifferentiation, by transfer of 
the cells into a culture format that supports a spherical cell morphology such as 
agarose, alginate or pellet culture systems (Benya and Shaffer, 1982; Bonaventure et 
al., 1994; Yaeger et al., 1997; Jakob et al., 2001) has also been described. However, 
redifferentiation is rarely complete and occurs to a progressively lesser extent the 
longer the chondrocyte is kept in monolayer culture (Benya and Shaffer, 1982; 
Bonaventure et al., 1994). Although these methods at first glance appear promising, 
the inclusion of growth factors or the need to utilise 3-D culture environments to 
retain articular chondrocyte phenotype during expansion significantly increases the 
cost and complexity of the tissue engineering process.
The identification of a cell with extensive growth potential and which retains its 
chondrogenic ability after extensive growth in culture would be a major step forward 
in addressing these issues. Mesenchymal stem cells (MSCs) from the bone marrow 
stroma have a high capacity for self-renewal (Bruder et al., 1997) and therefore 
thought to be of great value for cartilage repair and other tissue engineering 
applications (Johnstone and Yoo, 2001). The chondrogenic potential of MSCs is well 
characterised (Johnstone et al., 1998; Mackay et al., 1998; Pittenger et al., 1999) and 
the effect of various growth factors on the proliferation and differentiation of MSCs 
have also been studied (van den Bos et al., 1997; Mastrogiacomo et al., 2001; Worster 
et al., 2001; Solchaga et al., 2005). However, MSCs have been shown to generate
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repair tissues with varying degrees of success in in vivo cartilage repair studies 
(Wakitani et al., 1994; Im et al., 2001).
Although we have demonstrated the ability of superficial zone articular cartilage 
progenitor cells to form colonies in vitro, it remained unclear as to whether this 
growth could be sustained to enable long-term cultures of phenotypically stable 
articular cartilage progenitor cells to be established. Furthermore, the extent to which 
the chondrogenic potential of these cells is retained during extensive growth and 
passaging in culture is unknown. The chondrogenic ability of progenitor cell 
populations can be studied by culture in pellet format in the presence of a serum-free 
media containing insulin and TGF-Pi, a system widely used by other workers to study 
chondrogenic differentiation and maturation (Kato et al., 1988; Ballock and Reddi, 
1994).
The objective of this study was to prepare enriched populations of bovine superficial 
zone articular cartilage progenitor cells (SZCs) and to evaluate their chondrogenic 
potential during expansion by transfer into pellet culture. Chondrogenesis was 
determined using safranin O staining and collagen I and II immunostaining.
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Figure 5.1: De-differentiation of adult human articular chondrocytes. Freshly 
isolated chondrocytes at day 1 of culture (A) and after 10 days in culture (B). 
Diagram illustrating the process is shown in (C). Bar = 100pm.
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5.2 MATERIALS AND METHODS 
5.2.1 Isolation and expansion of populations of cells enriched in articular 
cartilage progenitor cells 
5.2.1.1 Cell isolation
Bovine plasma fibronectin (Sigma) was used at lOpgml'1 in Dulbecco's PBS 
with ImM MgCb and ImM CaC^ (Sigma). This solution was then added to 
each well of 6 well plates and incubated overnight at 4°C for coating. The 
fibronectin solution was aspirated and the plates were blocked with 1% BSA 
prior to addition of cells.
Seven day-old bovine metatarsophalageal joints were dissected as described in 
section 2.1 and chondrocytes were isolated from the superficial zone of the 
articular cartilage by fine dissection. The portions of cartilage were placed 
directly into Dulbecco's Modified Eagle Medium (DMEM) (Sigma) containing 
5% foetal calf serum (FCS) and 0.1% pronase (BDH, 4x106 units/g) and 
incubated at 37°C for 3 hours. Cartilage was washed once with PBS and 
incubated in DMEM containing 5% FCS and 0.04% collagenase 
(Worthington, 237U/mg) and incubated overnight at 37°C with gentle shaking.
Tissue digests were strained through a 70pm cell strainer (Falcon) to remove 
debris. The resultant filtrate was centrifuged at 300g for 10 minutes to pellet 
cells and then resuspended in 10ml of serum free DMEM followed by 
centrifuging again at 300g for 5 minutes. The cell pellet was resuspended in 
10ml serum free DMEM, cell number counted and resuspended to a final 
concentration of 4000 cells ml"1.
5.2.1.2 Differential adhesion
Following isolation, 4000 superficial zone cells in 1ml serum free DMEM was 
seeded into each of the wells of fibronectin coated 6-well plates and incubated
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at 37°C for 20 minutes. After 20 minutes, the media was gently swirled and 
discarded. Fresh DMEM supplemented with 10% FCS, 2mM L-glutamine, 1% 
non-essential amino acids, lOOIU/ml penicillin and lOOpg/ml streptomycin 
was added to each well. The plates were incubated at 37°C in a 5% CO2  
atmosphere.
Within 3 hours after initial plating, chondrocyte adhesion was assayed by 
counting the total number of cells adhering to the bottom of the dish using an 
inverted microscope equipped with phase contrast optics. This was carried out 
on 6 wells to estimate the percentage of cells attached and used for calculation 
of the initial number of doublings that occur in the 6-well plate.
5.2.1.3 Cell expansion
When cells in the 6-well plate were seen to be approaching confluency, media 
was removed and the monolayer washed with PBS. Cells were removed by the 
addition of 1.5 ml typsin/EDTA (0.05% w/v/0.02% w/v) to each well for 10 
minutes. DMEM containing 10% FCS was then added and the media aspirated 
and pooled. The cell suspension was centrifuged at lOOOrpm for 5 minutes and 
the resultant pellet resuspended in lOmls DMEM/10% FCS and the cells were 
transferred to a 75cm culture flask (PI). When these cells were approaching 
confluency, the cells were removed from the flask by trypsinisation and
•y
transferred to a 175cm culture flask (P2). Cells were maintained and passaged 
during the expansion as described in section 2.2. Subsequent growth in
'y
175cm culture flasks was carried out by continual passage at a ratio of 1:3. 
Passaging occurred prior to the cells reaching full confluence to maintain the 
cells in the log phase of growth. Detailed accounts of cell numbers harvested 
and seeded at each stage were kept throughout the process to allow the number 
of population doublings at each stage to be calculated.
Number of cell doublings at each stage was calculated using the following
equation:
N° of doublings
N° cells harvested
N° cells seeded
l o g  2
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Aliquots of cells at PI, P3, P6, P9, PI2 and P23, were removed for pellet 
culture.
5.2.1.4 Controls
Normal chondrocytes were isolated from the full thickness of 2-3 week old 
bovine metatarsophalangeal joints by sequential digestion in pronase and 
collagenase as described above. These cells were maintained in culture and 
passaged at a ratio of 1:3. Pellet cultures were set up immediately following 
isolation and at P9. P9 was chosen as the cells would have been expected to 
have fully dedifferentiated by this point.
5.2.2 Chondrogenic differentiation: pellet culture
At PI, P3, P6, P9, P I2 and P23, cells were harvested, counted using a 
haemocytometer and aliquots of 250,000 cells were resuspended in chondrogenesis 
media (DMEM supplemented with 50IU/ml penicillin and 50pg/ml streptomycin, ITS 
premix (Becton Dickinson), ascorbate 2-phosphate (lOOpM; Sigma), dexamethasone 
(10'7M; Sigma) and TGFp-1 (lOng/ml; R & D Systems). One ml aliquots of this 
suspension were transferred into 15ml polypropylene Falcon tubes and the cells 
pelleted by centrifugation at lOOOrpm for 5 minutes. Pellets were incubated with the 
lids of the tubes loosened at 37°C in a 5% CO2 atmosphere for 14 days with media 
changes carried out every 2-3 days.
5.2.2.1 Histology and immunolabelling
After 14 days in culture, pellets were fixed overnight in phosphate buffered 
formaldehyde and embedded in paraffin wax as described in section 2.3. 
Sections of 5pm thickness were cut and stained with Safranin O/haematoxylin 
as described in sections 2.3.3 and 2.3.4 and immunostained for the presence of 
collagens I and II.
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§.2.2.2 Collagen II immunolabelling
Sections were dewaxed in xylene and transferred to 100% Industrial 
Methylated Spirits (IMS) (1 minute), followed by distilled water (1 minute) 
and finally into PBS. Antigen retrieval was carried out using Pepsin (Dako) in 
0.2N HC1 for 15 minutes at 37°C and washed in PBS. Sections were blocked 
with 2.5% normal rabbit serum for 20 minutes at room temperature followed 
by incubation with 2pg/ml mouse anti-collagen II antibody (Neomarkers clone 
2B1.5) overnight at 4°C. Some sections were also incubated with an 
equivalent concentration of non-immune mouse IgG as a control. Sections 
were washed again three times for 5 minutes with PBS and incubated with a 
1:100 dilution of biotinylated rabbit anti-mouse secondary antibody (Dako) in 
PBS for 1 hour at room temperature. Finally, sections were washed three times 
for 5 minutes with PBS and incubated with a 1:100 dilution of Streptavidin- 
FITC (Amersham) for 1 hour at room temperature. Following washing, slides 
were mounted with Vectashield (Vector) and coverslipped. Sections were 
viewed using fluorescence microscopy and photographed.
5.2.2.3 Collagen I immunolabelling
Method was repeated as described in section 6.2.2.2 with the following 
exceptions: Sections were blocked with 2.5% normal goat serum prior to 
incubation with lOug/ml of a polyclonal rabbit anti-bovine type I collagen 
primary antibody (Biogenesis) and detected using a biotinylated goat anti­
rabbit secondary antibody (Dako). Some sections were also incubated with an 
equivalent concentration of non-immune mouse IgG in place of the primary 
antibody as a control.
5.2.3 Osteogenic differentiation
A 175cm2 flask of P5 SZCs was passaged using trypsin/EDTA (0.05% w/v/0.02%
w/v), centrifuged for 10 minutes at lOOOrpm and resuspended in DMEM/10% FCS.
Cells were counted haemocytometer and resuspended to 50,000 cells/ml. One ml of
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this suspension was then transferred to each of 6 wells of 2 x 24 well plates. Cells 
were incubated overnight at 37°C in a 5% CO2 atmosphere. Media in the wells of one 
of the 24-well plates was then replaced with osteogenic media (see below). Media in 
the other plate was replaced with DMEM/10% FCS. Plates were incubated for 12 
days at 37°C in a 5% CO2 atmosphere with media changes every 2-3 days.
Osteogenic media: DMEM/10%FCS supplemented with 50IU/ml penicillin and 
50pg/ml streptomycin, 2mM L-glutamine, 1% non-essential amino acids, ascorbate 2- 
phosphate (50pM) (Sigma), dexamethasone (10*7M) (Sigma); and p-glycerophosphate 
(ImM) (Sigma).
Cell monolayers were examined visually for the presence of nodules and stained for 
the presence of alkaline phosphatase using Sigma Histochemical staining kit (86-R) 
according to the manufacturers instructions.
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5.3 RESULTS
5.3.1 Cell growth
Populations of cells enriched in bovine superficial zone articular cartilage progenitor 
(SZCs) cells underwent approximately 61 population doublings over 162 days in 
culture. At PO the cells had a doubling time of approximately 24 hours where after the 
cells maintained a moderately constant rate of growth, requiring subculture every 3-4 
days. This was maintained until P28 when the rate of growth declined with subculture 
being required every 7-8 days. After P35 cell growth had virtually stopped. Figure 5.2 
(A) and (B) illustrate the cumulative population doublings of SZCs plotted as a 
function of time and passage number respectively. The bars represent an average of 
two flasks from one experiment. Normal chondrocytes isolated from the full thickness 
of bovine articular cartilage were expanded in culture to P9, equating to 13 population 
doublings over 34 days. These cells were used as controls for the pellet culture 
experiments.
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Figure 5.2: Population doubling potential of bovine SZCs as a function of time 
(A) and passage number (B). Points and bars in black indicate stages at which 
pellet cultures were set up.
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5.3.2 Cellular Morphology
Cultures of SZCs at PO, P2 and P I6 consisted mainly of cells with a flattened 
morphology (figure 5.3). This morphology was generally maintained until at high 
passage (P25) a proportion of SZCs began to adopt broader, often bi-nucleate, 
irregular morphologies and these were in greater proportion at P36. Cultures of 
normal bovine chondrocytes consisted of predominantly spindle-shaped fibroblastic 
cells up to P9 (34 days).
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Figure 5.3: Morphology of bovine SZCs and chondrocytes cells throughout 
expansion. Cells are shown at PO (A), P2 (B), P I6 (C), P25 (D) and P36 (E). 
Normal chondrocytes isolated from the full thickness of bovine articular 
cartilage at P5 are shown in (F). * - denotes binucleate cells. Bar = 100pm.
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5.3.3 Chondrogenic differentiation: pellet culture
Enriched populations of bovine superficial zone articular cartilage progenitor (SZCs) 
expanded in culture and subsequently grown in pellets synthesised a cartilage-like 
matrix that stained strongly with Safranin O, indicating an abundance of sulphated 
proteoglycans (figure 5.4). The periphery of the pellets at all time points stained 
weakly with Safranin O. In addition, flattened cells were seen to be present on the 
surface of the pellet. PI, P3, P6, P9 and PI2 (PI2 = 25 population doublings) SZC 
cell pellets were rich in collagen II (figure 5.5) whereas pellets derived from P23 (P23 
= 42 population doublings) SZCs appeared to contain only low levels of collagen II. 
Control sections incubated with non-immune mouse IgG were negative for collagen II 
(data not shown). Pellet cultures of freshly isolated normal chondrocytes appeared to 
be smaller in size and histologically have less matrix and rounder cells than SZC 
pellets (figure 5.6). The matrix stained strongly for collagen II. In comparison, pellet 
culture of expanded normal chondrocytes at P9 (13 population doublings) synthesised 
a greater amount of matrix but this contained negligible collagen II. A low level of 
collagen I was consistently noted to be located around the periphery of all pellet 
cultures from both SZCs and full thickness chondrocytes. An example of this is 
illustrated in figure 5.7.
5.3.4 Osteogenic differentiation
When monolayers of SZCs were cultured in conditions known to promote osteogenic 
differentiation of mesenchymal stem cells (Pittenger et al., 1999), no osteogenic 
differentiation was noted. No nodules were seen to form and no red staining indicative 
of alkaline phosphatase was noted in the cells cultured in osteogenic media (figure 
5.8).
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Figure 5.4: Pellet culture of culture expanded SZCs. Safranin O staining 
(Bar = 200pm). Low magnification image inset (Bar = 500pm).
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Figure 5.5: Collagen II immunolabelling of pellet cultures of culture expanded 
SZCs. Note decrease in staining in pellets derived from bovine SZCs at P23 (Bar 
= 200pm).
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Figure 5.6: Pellet culture of control freshly isolated (A,C) and culture expanded 
full thickness chondrocytes at P9 (B,D). Safranin O staining (A,B) and collagen 
II staining (C,D). Bar = 200pm (Inset = 500pm).
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Figure 5.7: Collagen I immunolabelling of a pellet culture of expanded SZCs at 
P6 (A) and a control section incubated with an equivalent concentration of non- 
immune mouse IgG in place of the primary antibody (Bar = 200pm).
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Figure 5.8: Osteogenic differentiation assay. Expanded bovine SZCs (P5) culture 
in control (A) and osteogenic media (B). Note lack of alkaline phosphatase 
activity (red staining) of cells cultured in osteogenic media. Bar = 200pm.
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5.4 DISCUSSION
Previous studies have indicated that articular cartilage growth during development 
occurs by apposition from the articular surface (Hayes et al., 2001) rather than by 
interstitial mechanisms. This growth appears to be driven by a slowly dividing 
population of cells in the superficial zone of articular cartilage and a more rapidly 
dividing population of cells in the transitional zone. These observations suggest the 
presence of a specific articular cartilage precursor or chondroprogenitor cell 
population in the superficial zone and a population of transit amplifying cells in the 
transitional zone. Studies described in chapter 3 and published studies (Archer et al., 
2002; Dowthwaite et al., 2004) have confirmed that a population of articular cartilage 
progenitor cells do indeed exist in the superficial zone that exhibit differential 
adhesion to fibronectin, differential integrin expression, and the ability to form 
colonies from an initially low seeding density; properties that are common to known 
progenitor cell populations of other tissues (Jones and Watt, 1993). The study 
described here has produced cultures enriched in superficial zone articular cartilage 
progenitor cells (SZCs) and evaluated their ability to form cartilage as a function of 
expansion in culture.
This work has demonstrated the high expansion potential of SZCs. SZCs maintained a 
stable cellular morphology even after extensive expansion in monolayer culture. The 
polygonal morphology of SZCs contrasted with the more fibroblastic normal 
chondrocytes isolated from the full thickness of bovine articular cartilage. At high 
passage the growth rate of SZCs declined, and this was accompanied by a gradual 
increase in the proportion of SZCs adopting a broader, irregular, often binucleate 
morphology. Similar features have been described of chick sternal chondrocytes after 
a prolonged time in culture (Von der Mark et al., 1997), although SZCs in this study 
underwent this shift in morphology at a significantly later stage and is clearly age and 
species dependant.
Other studies have described the cloning of bovine SZC colonies and subsequent 
expansion and chondrogenic differentiation in comparison to full thickness 
chondrocytes with similar results to that described here ie reduction in collagen II in 
pellets derived from SZCs at around 40 population doublings. (Bishop et al., 2004).
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Interestingly these studies also showed the retention of Sox-9 expression by SZCs 
during expansion whereas Sox-9 expression was rapidly down-regulated in full 
thickness chondrocytes during expansion. Sox-9 is a transcription factor involved in 
the regulation of genes expressed during chondrogenesis. This clonal expansion 
results in a more homogeneous initial cell population which may have benefits in 
terms of characterisation of the cells and would be more advantageous in terms of 
transplantation.
Importantly, SZCs can be expanded using standard monolayer conditions and 
standard media components, whilst retaining their ability to differentiate into 
chondrocytes, synthesising a hyaline-like cartilage matrix following high levels of 
expansion. This expansion occurs without the need to incorporate growth factors in 
addition to the FCS during the expansion phase as has been suggested for bovine 
(Martin et al., 1999) and human (Jakob et al., 2001; Barbero et al., 2004) 
chondrocytes. SZCs retain the ability to synthesise a hyaline-like cartilage matrix rich 
in collagen II and sulphated proteoglycans, with low levels of collagen I even after 12 
passages (25 population doublings). Thus, SZCs can undergo chondrogenesis after a 
33xl06-fold expansion in monolayer culture. Low levels of immuno-detectable 
collagen II were also evident at P23, where the cells had undergone 42 population
19doublings, a 4x10 -fold increase in cell number. As expected in this study, normal 
chondrocytes isolated from the full thickness of immature bovine articular cartilage 
dedifferentiated relatively rapidly in monolayer culture and completely lost the ability 
to redifferentiate in pellet culture at P9, corresponding to 13 population doublings. 
Thus, in contrast to the SZCs, normal chondrocytes lost the ability to undergo 
chondrogenesis after only an 8000-fold increase in cell number. Further studies are 
required to determine whether the differentiation of SZCs produces a stable 
chondrocytic phenotype, without progression to terminal differentiation characterised 
by expression of alkaline phosphatase and Type X collagen (Kato et al., 1988), a 
property exhibited by bone marrow derived MSCs. Lack of progression towards 
terminal differentiation would be a desirable property of a cell for articular cartilage 
tissue engineering, as terminal differentiation may subsequently promote vascular 
invasion and calcification of the implanted cells.
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In this study, monolayers of SZCs exhibited an inability to differentiate down an 
osteogenic lineage in vitro. This data may illustrate the SZCs are committed to the 
chondrocytic lineage and lack multipotentiality. However, it contrasts with other 
studies showing plasticity of bovine articular cartilage progenitor cells in an 
embryonic chick trafficking system (Dowthwaite et al., 2004), where the cells 
engrafted into a variety of tissues including bone. This suggests component(s) of the 
embryonic environment that enable and drive osteogenic differentiation are absent 
from the in vitro culture conditions described here.
The reason for the increased phenotypic stability of SZCs in comparison to 
differentiated chondrocytes is unclear. Previous authors have speculated whether 
phenotypic stability in chondrocyte culture populations is related to their degree of 
maturity (Von der Mark et al., 1997), with younger or more undifferentiated cells (eg. 
from regions immediately beneath the perichondrium or in this case, the superficial 
zone of articular cartilage) requiring more doublings to dedifferentiate than older or 
more differentiated chondrocytes.
Similar data to that reported here has been obtained with other mesenchymal 
stem/progenitor cell populations. De Bari et al., (2001) and (2001a) have described 
the isolation of a population of cells from human periosteum and synovium that 
maintain a stable phenotype and retain a chondrogenic potential throughout the 
expansion phase. Although Bruder et al., (1997) have described the extensive 
subculture of bone marrow derived human MSCs and the retention of osteogenic 
potential even after extensive subculture, other groups have shown that the retention 
of chondrogenic potential of MSCs requires the addition of growth factors such as 
basic fibroblast growth factor (bFGF) in the culture media during the expansion phase 
(Mastrogiacomo et al., 2001; Solchaga et al., 2005).
The findings from this study could provide significant benefits in their application to 
cell based-strategies for cartilage repair. Current cartilage repair strategies have 
focused on Autologous Chondrocyte Implantation (ACI) (Brittberg et al., 1994) and 
tissue engineering (Freed et al., 1993; Hendrickson et al., 1994; Sittinger et al., 1994; 
Cao et al., 1997; Kawamura et al., 1998; Freed et al., 1999) approaches. ACI involves 
arthroscopically harvesting an area of the patient’s own cartilage from a non-weight
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bearing location for cell isolation. Chondrocytes are then isolated in a designated 
laboratory facility, expanded in culture and then, in a second procedure, the cells are 
returned to the defect site either by injection beneath a periosteal flap or via a 
biodegradable scaffold. There are a number of drawbacks to autologous cell 
approaches. The initial biopsy creates a second defect site with associated issues of 
donor site morbidity. Furthermore, there may be only a limited amount of healthy 
cartilage available for biopsy. As the ACI procedure requires two operations it is 
expensive and requires a specialised laboratory service for cell isolation and 
expansion. The extent of dedifferentiation of the chondrocytes during the expansion 
phase on the overall clinical outcome of the procedure is also unknown. The use of 
allogeneic progenitor cells such as SZCs has the potential to reduce this process to a 
one step procedure, preventing donor site morbidity and negating the need for a costly 
specialised laboratory service. While it appears that the SZC cell type would have 
sufficient expansion potential to meet the commercial need, it is currently not known 
if the cell type would be tolerated in the joint by the host immune system. Further 
studies are therefore required in order to determine the feasibility of such an approach.
An alternative approach to ACI for cartilage repair is that of tissue engineering routes 
where allogeneic cells are seeded onto a 3-D scaffold acting as a provisional 
extracellular matrix (Freed et al., 1999). These cell-seeded constructs may either be 
implanted immediately or cultured in bioreactor conditions in order to generate a 
functional tissue engineered neo-cartilage for subsequent implantation (Freed et al., 
1993). Whilst this process may have the advantage in that the matrix deposited around 
the cells may lower their immunogenicity, the fixation of such mature grafts into a 
joint site may prove problematic.
In conclusion, the development and application of both ACI and tissue engineering 
approaches in the clinical environment has been hampered due a restricted availability 
of suitable cartilage producing cells caused by limited chondrocyte growth potentials 
and culture-induced loss of phenotype (Benya and Shaffer, 1982; Evans and 
Georgescu, 1983; Von Der Mark et al., 1997; Binette et al., 1998). The enhanced 
potential of these SZCs to retain the ability to form cartilage after extensive expansion 
in culture may enable the generation of large cell banks for use in allogeneic tissue 
engineering applications.
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CHAPTER 6 
SURGICAL CARTILAGE CUTTING 
TECHNIQUES AND EX VIVO CELL 
TRANSPLANTATION
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6.1 INTRODUCTION
Lesions in articular cartilage generally do not repair or repair only partially under 
certain conditions. Such defects are often associated with disability, joint pain, 
locking and reduced range of motion. Left untreated these lesions may progress to 
osteoarthritis, requiring extensive surgical interventions such as osteochondral 
transplantation (mosaicplasty), high tibial osteotomy and joint replacement 
(Campbell, 1969; Gilbert, 1988; Buckwalter and Lohmander, 1994; Buckwalter and 
Mankin, 1997a; Newman, 1998; Hunziker, 1999; Hunziker, 2001a).
Surgical removal of articular cartilage is commonplace in the treatment of 
osteoarthritic diseases (McLaren et al., 1991). Osteochondral transplantation 
techniques such as mosaicplasty involves the incision of healthy articular cartilage, 
both to create the tissue plugs and prepare the lesion site for implantation of the plugs 
(Hunziker, 1999; Hangody et al., 2001;). In addition, early surgical interventions in 
the degenerative process such as lavage and arthroscopy, chondral shaving and 
debridement is carried out on the principle such options provide symptomatic relief 
from pain, restore joint functionality and delay the need for total joint replacement 
(Buckwalter and Lohmander, 1994; Newman, 1998; Gilbert, 1998; Hunziker, 2001a). 
Chondral shaving and debridement involves mechanical removal of loose cartilage 
fragments and smoothing of fibrillated areas using surgical cutting tools and 
instruments (Mitchell and Shepard, 1987; Kim et al., 1991; McLaren et al., 1991). 
Arthroscopic chondral shaving is also commonly used for the treatment of 
chondromalacia patellae (Ogilvie-Harris and Jackson, 1984). However, the beneficial 
effects of techniques such as chondral shaving and debridement remain controversial, 
with a lack of experimental or clinical evidence to justify the procedures (Buckwalter 
and Lohmander, 1994; Newman, 1998; Hunziker, 2001a). For example, chondral 
shaving has been shown to stimulate neither a degenerative nor reparative response in 
one study (Mitchell and Shepard, 1987) and induce degeneration in the remaining 
cartilage in other studies (Schmid and Schmid, 1987; Kim et al., 1991).
Experimental mechanical wounding of cartilage tissue using cutting tools has been 
demonstrated to initiate a deleterious response in the cartilage tissue immediately 
adjacent to the wound edge. This response is characterised by cartilage degeneration
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and cell loss (Shapiro et al., 1993; Hunziker and Quinn, 2002; Tew et al., 2000; 
Redman et al., 2004), probably due to both necrosis and apoptosis, and altered matrix 
metabolism characterised histologically by empty lacunae and loss of metachromasia 
from the extracellular matrix at the lesion edge (Bennett et al., 1932; Tew et al., 2000; 
Walker et al., 2000). In contrast, deeper into the tissue, adjacent to this ‘zone of cell 
death’ there is a zone of cell proliferation and up-regulation of matrix synthesis 
evidenced by increased 3H-thymidine and 35S incorporation in the territorial matrix of 
this region (Calandruccio and Gilmer, 1962; Mankin, 1962; Buckwalter, 2002; 
Redman et al., 2004). The use of sharper cutting instruments, such as scalpels, 
diminishes the extent of the ‘zone of necrosis’ thus causing cell proliferation and up- 
regulation of matrix synthesis to occur at the wound edge (Redman et al., 2004).
Current research into mechanisms of improving cartilage repair encompasses a variety 
of combinations of approaches such as incorporating growth factors into the defect 
(Hunziker, 2001), synthetic or natural scaffolds either alone (Solchaga et al., 2002) or 
seeded with chondrocytes or mesenchymal stem cells (Freed et al., 1993; Hendrickson 
et al., 1994; Wakitani et al., 1994; Cao et al., 1997; Kawamura et al., 1998). Cell- 
based approaches using mesenchymal stem cells (Im et al., 2001; Wakitani et al., 
2002), and in the technique of autologous chondrocyte transplantation (Brittberg et 
al., 1994) have also incorporated cells in the defect without a scaffold. Studies such as 
these have frequently been hampered by poor integration of the repair tissue with the 
native articular cartilage (Shapiro et al., 1993; Wakitani et al., 1994; Hunziker, 2001). 
This phenomenon may be partly due to the cell and matrix changes described above, 
as the lesion sites are most likely to undergo some form of preparation prior to the 
implantation procedure using surgical cutting tools and instruments. Thus, repair 
tissue may be attempting to integrate into ‘dead cartilage’ and may eventually 
separate in time. Therefore, the use of sharper, more precise cutting instruments may 
reduce this effect, allowing cell proliferation and matrix synthesis to occur 
immediately at the would edge and promote a more successful integration of the 
repair tissue with the host.
The superficial zone articular cartilage progenitor cells are believed to be responsible 
for the appositional growth of articular cartilage during development (Hayes et al., 
2001; Dowthwaite et al., 2004). As the cells appear to play a pivotal role in the
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growth of articular cartilage, we hypothesised they also may play an important role in 
repair. They may either be directly responsible for the laying down of the new repair 
tissue or may orchestrate a repair response by the secretion of growth factors or 
cytokines that may modulate the synthetic activity of the chondrocytes surrounding 
the defect site or may prevent entry of the cells into the apoptotic pathway. If this is 
the case then it may be that the cells could reduce the deleterious effects described 
above that occur at cartilage wound margins when implanted into the defect site.
Therefore the objectives of this study were two-fold:
[1] To develop a model to study the extent of cellular necrosis that occurs in 
cartilage following wounding and to use the model to evaluate the extent of 
cell death caused by several different surgical cutting techniques.
[2] To determine whether the implantation of populations of cells enriched in 
superficial zone articular cartilage progenitor cells (SZCs) into an 
experimental defect in articular cartilage can reduce the cell death and matrix 
loss at the wound margin in an ex vivo wound model.
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6.2 MATERIALS AND METHODS
6.2.1 Effects of surgical cutting techniques on cell viability at the cartilage 
wound margin.
6.2.1.1 Cartilage Cutting
Strips of cartilage were removed from 7 day-old bovine metatarsophalangeal 
joints as described in section 2.1 and kept in PBS (Oxoid) until used for 
cutting (1-2 hours).
Cartilage strips were then cut using the following techniques:
[A] Scalpel blade (fresh blade for each cut).
[B] Duckling elevator Acufex punch (014765 LI94).
[C] 4.0mm Full radius Dyonics powered cutter (7205306 L397678)
[D] 4.5mm Mosaicplasty tubular chisel (7207097 L395249)
[E] 6.5mm drilled trephine (7205515 L362684)
Cutting technique [A] served as a minimally traumatic negative control. 
Cutting technique [C] is an arthroscopic shaving tool illustrated in figure 6.1 A. 
For this technique, the strip of cartilage was clamped in a specially crafted 
aluminium cutting jig (figure 6.IB) using two crocodile clips. This was to 
allow accurate, reproducible cutting. The jig with attached cartilage strip was 
submerged in PBS for cutting. For cutting technique [D], the procedure was 
carried out prior to removal of the cartilage from the bone. Once the cartilage 
had been cut it was removed as previously described.
Following the cutting procedure the cartilage strips were cut into small pieces 
(approx. 5mm in length) and transferred to 6-well tissue culture plates 
containing 6ml DMEM +10% FCS. Plates were incubated overnight in a RS 
Biotech incubator at 37°C in humidified 5% CO2  atmosphere.
148
Chapter 6: Surgical cartilage cutting techniques and ex vivo cell transplantation
6.2.1.2 Visualisation of live and dead cells at cut cartilage surfaces
After the culture period, cartilage portions were processed by either of two 
methods:
[1] Live/dead staining o f cryostat sections
Cartilage portions were washed briefly with PBS and then immersed in PBS 
containing 2 pl/ml ethidium homodimer-1 (2mM, Molecular Probes) for 3 
hours to label the dead cells. Longer incubations, up to overnight, were also 
tried.
Cartilage portions were washed for 4 hours in 20ml PBS containing 
0.04mg/ml salmon sperm DNA (Sigma) and then frozen in OCT (Gurr) using 
a liquid nitrogen cooled iso-pentane slush. 7pm sections were cut from the 
centre of the portion using a Leica Jung CM3000 cryostat, placed on poly­
lysine coated slides (Sigma) and counterstained using 2pl/ml SytolO (2mM 
Molecular Probes). SytolO is a green fluorescent stain that will bind to the 
DNA of all cells present, live or dead. Sections were viewed using a Leica 
confocal microscope with an ArKr laser exciting at 488nm and 568nm.
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Figure 6.1: Illustration of Dyonics powered cutter (A) and cutting jig (B)
Portion of cartilage
Fxnerim ental cut Axis of second 
cut
Figure 6.2: Diagram illustrating axis of second cut perpendicular to the axis of 
the first experimental cut surface (red) for visualisation of wound margin using 
optical sectioning technique (Section 6.2.1.2).
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[2] Optical sectioning o f live/dead stained specimens
Portions were washed briefly with PBS and the cut across the centre of the 
portion, using a fresh scalpel blade each time, perpendicular to the axis of the 
first experimental cut surface (figure 6.2).
Samples were then immersed in 5ml PBS containing the 2.5pi of the green 
fluorescent probe Calcein AM (1 mg/ml) and lOpl of the red fluorescent probe 
Ethidium homodimer-1 (2mM) (both Molecular Probes) for 1.5 hours to label 
live and dead cells respectively. The portions were then viewed with the 
second cut surface face down in a petri-dish, containing a small quantity of 
PBS, using the inverted Leica confocal microscope with an ArKr laser 
exciting at 488nm and 568nm. Images from 6 different wound margins were 
captured with the wound margin parallel to the edge of the image for 
quantitation using image analysis.
6.2.1.3 Image analysis
Images from wound margins were captured for quantification using Image 
pro-plus software. The image was calibrated by the fact that when using the 
xlO objective the image is 1,000pm x 1,000pm or 2,000pm x 2,000pm when 
using the x5 objective. Image pro plus then calculated the average distance, in 
microns, between the two lines. This is illustrated in figure 6.3. Statistical 
significance was determined using one way ANOVA test followed by Tukey’s 
post hoc testing to determine where significant differences exist between 
treatment groups. Differences were considered significant at the 0.05 
confidence level.
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w it  512512
Figure 6.3: Illustration of image analysis technique to estimate the depth 
of the wound margin.
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6.2.2 Cell Transplantation
6.2.2.1 Cell isolation
Chondrocytes were isolated from the superficial and middle zone of articular 
cartilage of 7 day-old bovine metatarsophalangeal joints as described in 
section 3.2.1.2. After isolation, 2 x 106 cells in 1ml serum free DMEM were 
seeded into each of the wells of the fibronectin coated (10 pg/ml) 6 well plates 
(coated as described in section 3.2.1.1) and incubated at 37°C for 20 minutes. 
After this time, the media was gently swirled and discarded. Adherent cells 
were washed once with 5ml PBS and 1ml trypsin/EDTA 
(0.05%w/v/0.02%w/v) was added to each well and incubated at 37°C in a 5% 
CO2 atmosphere for 10 minutes. One ml of DMEM containing 10% FCS was 
then added and media from wells containing each cell type were pooled, 
centrifuged at 300g to pellet and resuspended in lOmls DMEM containing 
10% FCS. Cells were counted using a Neubeuer haemocytometer. For 
transplantation into defects made using a drill bit, cells were resuspended to 
give approximately 1.5 x 106 cells/3.5pi. For transplantation using the 
'Agarose gel system', cells were resuspended to approximately 1 x 106 cells 
/150pl.
6.2.2.2 Cartilage wounding using a drill bit and cell transplantation
Strips of articular cartilage were dissected from 7 day-old bovine 
metatarsophalangeal joints as described in section 2.1 and chopped into 
portions 5mm in length. Cartilage explants were placed into DMEM 
containing 10% FCS and incubated at 37°C in a 5% CO2  atmosphere overnight 
while the above cell isolation was taking place.
The next day, a defect a 2mm deep was made in the cartilage portions using a 
2mm drill bit. 3.5pl of cell suspension was carefully pipetted into the defect 
and cells were allowed to settle. The cartilage explant was very slowly covered
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with DMEM containing 10% FCS and incubated at 37°C in a 5% CO2 
atmosphere for 6 days. Replicates of 6 were used for each cell type.
6.2.2.3 Agarose gel-based system
Strips of cartilage were isolated as described above, chopped into 5mm x 5mm 
portions and placed in DMEM containing 10% FCS. The next day, a fresh 
wound margin was created on one side of the portion using either a scalpel or 
3.5mm Acufex punch.
Low melting temperature agarose (Sigma; A-9045) was made up to 4.6% in 
50ml deionised water and autoclaved. Agarose was remelted by briefly 
microwaving and kept molten in a 50°C water bath. From this solution, 6.5 ml 
was removed to leave 43.5 ml. To this remaining solution, 5ml lOx DMEM 
(sigma -  D-2554), 0.5ml 5000IU/ml penicillin and 5mg/ml streptomycin, 
0.5ml 200mM L-Glutamine and 0.5ml non essential amino-acids was added. 
The resulting solution was 4% agarose. It was also necessary to adjust the pH 
of the molten gel solution using several drops of 1M NaOH to return to the 
cherry red colouration. A small amount of this solution was then pipetted into 
5ml bijou tubes and a gel former was then placed into the agarose and allowed 
to solidify. This procedure forms a gel with a narrow slot that allows a portion 
of cartilage to be placed in it (figure 6.4). The cartilage portions were then 
transferred to the agarose slot with the wound margin facing upwards (figure
6.4 B) and DMEM containing 10% FCS was then used to cover the agarose 
and cartilage. Cells were introduced onto the wound margin by carefully 
inserting the pipette tip down into the agarose slot and pipetting 150pl of cell 
suspension just above the wound margin. A modified screw cap that had been 
drilled to accommodate a luer lock fitting and a 0.2pm filter was then placed 
onto the bijou tube to allow gas exchange and maintain sterility (figure 6.4 C). 
Explants were incubated at 37°C in a 5% CO2  atmosphere for 6 days. 
Replicates of 6 were used for each cell type.
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6.2.2.4 Histology and confocal microscopy
Cartilage explants were bisected perpendicular to the wound margin. One half 
was embedded in paraffin wax, sectioned and stained with Safranin 0 / 
haematoxylin as described in section 2.3. The other half was used to evaluate 
cell viability at the wound margin using confocal microscopy as described in 
section 6.2.1.2 method [2]. Image analysis of confocal images was carried out 
as described in section 6.2.1.3.
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Figure 6.4. Photographs illustrating agarose gel based system. (A) Gel former in 
bijou tube. (B) Cartilage explant (*) embedded in agarose with wound margin 
facing upwards (solid white arrow). (C) Modified bijou tubes for culture of 
explants (section 6.2.2.3).
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6.3 RESULTS
6.3.1 Effect of surgical cutting technique on cell viability at the cartilage wound 
margin.
The first processing technique (Live/dead staining of cryostat sections) was 
discontinued from use due to the ethidium homodimer-1 only penetrating approx 100- 
200pm into the tissue. This was demonstrated using pieces of cartilage freeze-thawed 
repeatedly prior to incubation in the ethidium homodimer-1. Penetration depth was 
not increased significantly even after overnight incubation in the ethidium 
homodimer-1. Although literature evidence suggests full penetration of ethidium 
homodimer-1 will occur after 24 hours at 4°C (Poole et al., 1996) a 24 hour 
incubation may result in additional cellular effects. In addition, this length of 
incubation plus the lengthy, work intensive sectioning results in a long turn around 
time for results.
By using the second processing technique (Optical sectioning of live/dead stained 
specimens) the problem of dye penetration could be avoided. Provided penetration of 
the ethidium homodimer-1 is more than a few cells deep and the laser power of the 
confocal microscope is kept high, the extent of cell death at the wound margin could 
be visualised.
Using this technique, images were captured of cell death at the wound margins caused 
by the five cutting techniques. Representative examples of the images captured for 
each cutting technique are shown in figure 6.5 and results of the quantification of the 
cell death using image analysis shown in table 6.1. Cartilage cutting using a scalpel 
produced minimal cell death whereas using an Acufex punch and the Dyonics 
powered cutter produced relatively low levels of cell death (54.7pm and 32.4pm 
respectively) although there was no significant difference from that achieved using the 
scalpel. Cartilage cutting using the 4.0mm Tubular Chisel and the drilled 6.5mm 
Trephine produced extensive cell death. However this effect may be due more to the 
instruments being blunt after extensive use than the cutting technique itself.
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Figure 6.5: Confocal microscope
images illustrating cell death at the 
wound margins of cartilage cut using 
various surgical cutting techniques. 
Images were obtained by Optical 
sectioning of live/dead stained 
specimens. The cut edge is towards the 
right hand side of the image. Scale bar 
= 200pm
Cutting
technique
A B C D E
Depth of 
cell death 
(pm ± s.d.)
9.2 ± 2.2 54.7 ±3.1 32.4 ± 7.3 215.0 ± 
54.1*
456.6 ± 
232.0**
Table 6.1: Table showing average wound margin thickness (depth of cell death) 
using various cutting techniques calculated using image analysis as described in 
section 6.2.I.3. Statistical significance was determined using one way ANOVA 
and Tukeys’ post hoc testing. *p<0.05; **p<0.01 compared to scalpel blade (A).
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6.3.2 Cell transplantation: effect on articular cartilage wounded using a drill 
bit.
It was evident from the histology and confocal microscopy (figures 6.7 and 6.8) that 
wounding the cartilage explants using a drill bit produced extremely variable defects, 
often involving quite extensive trauma to the cartilage. This variability and extensive 
trauma would make the quantification of the effect very difficult. In addition, 
although transplantation of cells into the defect in this manner resulted in a large 
number of cells being present in the defect, this also appeared variable. Apparent from 
the images is that the transplanted cells from the superficial or mid zone had little 
effect on the wound margin in terms of cell viability or matrix glycosaminoglycan 
(GAG) loss. The effect of the cells may have been masked by the variability inherent 
in the model. Therefore, a method of creating more constant defects was required, in 
addition to a means of introducing a more uniform number of cells onto the wound 
margin.
6.3.3 Cell transplantation using the agarose gel-based system
The use of this system allowed the creation of more consistent defects and the 
introduction of a more uniform number of cells onto the wound margin. Therefore, a 
more reliable evaluation of the effect of the cells on the wound margins could take 
place.
The use of a scalpel to wound the cartilage resulted in a very narrow wound margin of 
approximately 1-3 cells deep. This resulted in difficulties in determining whether the 
transplanted cells had any effect on the wound margin. It was, therefore, decided to 
use a 3.5mm Acufex punch to create the defect. The use of this tool resulted in a 
wound margin of approximately 9-11 cells deep. Results of transplanting the cells into 
the defects are illustrated in figures 6.9 and 6.10 and the results from the image 
analysis of the confocal images are shown in table 6.2. Apparent from the images and 
the data is that the transplantation of cells from the superficial or mid zone that have a 
high affinity for fibronectin had little effect on the wound margin in terms of cell 
viability. There was also no visible effect on matrix (GAG) loss, although this was not 
quantified.
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Transplanted cells
Wound 
r > margin
Figure 6.7: Confocal microscope images showing cell viability at wound margins 
created using a drill bit and left empty (A), transplanted with cells with a high 
affinity for fibronectin from superficial zone (B) and middle zone (C).
Scale bar = 200pm.
Figure 6.8: Images showing Safranin O staining of defects created using a drill 
bit and left empty (A), transplanted with cells with a high affinity for fibronectin 
from superficial zone (B) and middle zone (C). Scale bar = 400pm.
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Figure 6.9: Confocal microscope images from the agarose gel based system 
showing cell viability at wound margins created using a 3.5mm Acufex punch 
and left empty (A), transplanted with cells with a high affinity for fibronectin 
from superficial zone (B) and middle zone (C). Scale bar = 400pm.
Control (no cells) Superficial Zone Middle Zone
Thickness (pm ± SD) 180.3 ±  13.8 183.9 ±  12.1 185.3 ± 23.3
Table 6.2: Table showing average wound margin thickness (depth of cell death) 
using a 3.5mm Acufex punch and transplanted with cells calculated using image 
analysis as described in section 6.2.I.3.
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Figure 6.10: Images showing Safranin O staining of defects created using a 
3.5mm Acufex punch, cultured using the agarose gel based system and left empty 
(A), transplanted with cells with a high affinity for fibronectin from superficial 
zone (B) and middle zone (C). Scale bar = 400pm.
162
Chapter 6: Surgical cartilage cutting techniques and ex vivo cell transplantation
6.4 DISCUSSION
This study has demonstrated the capacity of various different cutting tools used for 
the surgical management of lesions in articular cartilage to induce cell death in the 
remaining native articular cartilage immediately adjacent to the lesion edge. 
Numerous other studies have observed similar responses to that described here 
following wounding of articular cartilage using surgical techniques (Bennett et al., 
1932; Schmid and Schmid, 1987; Kim et al., 1991), using experimental defects in in 
vivo (Shapiro et al., 1993; Hunziker and Quinn, 2002), and ex vivo models using 
trephines (Tew et al., 2000; Redman et al., 2004). Laser chondroplasty has also been 
shown to cause necrosis (Mainil-Varlet, 2001). Moreover, the use of sharp scalpels 
has been shown to induce minimal cell death and leave viable chondrocytes at the 
wound edge (Redman et al., 2004) and one study has even demonstrated total healing 
of articular cartilage defects created using a sharp scalpel to occur in a foetal lamb 
model (Namba et al., 1998). Redman et al., (2004) demonstrated minimal cell death 
induced in articular cartilage using scalpels in comparison to a trephine but did not 
compare the range of surgical cutting tools described here. These studies together with 
data generated here demonstrate that the extent of cell death induced is dependant on 
the type of cutting technique used with drill-powered trephines creating extensive cell 
death in comparison to the minimal or low levels of cell death caused by sharp 
scalpels, Acufex punches and the Dyonics powered cutter. Thus, the use of sharper, 
less traumatic and more precise cutting tools would reduce the mechanical stresses at 
the lesion edge and reduce cell death.
The confocal microscope technique used here utilises the properties of two fluorescent 
cell viability probes, calcein AM and ethidium homodimer-1 that detect live and dead 
cells respectively. Calcein AM is a cell membrane-permeant probe that is metabolised 
within living cells to a green fluorescent product that is excited by the 488nm line of 
the Krypton-Argon laser. Ethidium homodimer-1 can only cross the compromised 
membranes of dead cells where it binds nucleic acids and emits a red fluorescence 
when excited by the 568nm line of the Krypton-Argon laser. The use of these probes 
together allows the simultaneous visualisation of live and dead cells within the 
cartilage explants. However, previous studies have demonstrated that the cell death 
induced by wounding of cartilage with a trephine comprises a combination of necrosis
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and apoptosis (Tew et al., 2000; Walker et al., 2000). The initial necrotic response is 
proposed to be caused by the mechanical insult that occurs as a consequence of the 
wounding. This necrosis is followed by a ‘wave’ of apoptosis that occurs over the 
subsequent days following injury, extending deeper into the tissue and believed to be 
caused by mechanical disruption of the chondrocyte-extracellular matrix interaction 
(Tew et al., 2000; Buckwalter, 2002; Kuhn et al., 2004). Although the ethidium 
homodimer-1 does not discriminate between apoptotic and necrotic mechanisms of 
cell death the extent of the apoptotic response is likely to be proportional to the 
magnitude of the initial mechanical insult and extent of disruption of the chondrocyte- 
extracellular matrix interaction (Redman et al., 2004). In addition, the cell death in 
this study was measured 1 day after wounding whereas other studies have 
demonstrated the apoptotic cell death response to continue up to 10 days following 
wounding (Tew et al., 2000). Thus the degree of cell death shown here may be an 
underestimation of the total response that will occur over time.
The results described here were obtained from immature cartilage tissue and it is not 
known how this correlates with the responses that will occur in adult or more mature 
cartilage tissue. Previous studies have demonstrated immature and mature cartilage to 
respond to wounding in a similar manner (Tew et al., 2001) whereas another study has 
shown injurious compression to induce a greater apoptotic response in immature 
cartilage compared to more mature cartilage (Kurz et al., 2004).
Immediately evident from the above discussion is that understanding the events that 
occur in articular cartilage in response to wounding is of prime importance if future 
cartilage repair approaches are to prove successful. A feature frequently described of 
attempts to repair defects in articular cartilage is the poor integration between the 
repair tissue and the native articular cartilage (Shapiro et al., 1993; Wakitani et al., 
1994; Hunziker, 2001). The extent of cell death induced by the surgical cutting 
technique is likely to have a major bearing on whether or not the repair tissue that 
forms within the defect integrates successfully with the host tissue i.e. the use of 
sharper cutting techniques would reduce the size of the zone of cell death between 
repair tissue and host tissue and may promote a more successful integration (Tew et 
al., 2000; Redman et al., 2004). Wounding with a trephine has been shown to induce a 
zone of cell death and stimulate cell proliferation and up-regulation of matrix
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synthesis deeper in the tissue and adjacent to the ‘zone of cell death’ (Redman et al., 
2004). Interestingly, although wounding with a sharp scalpel induces minimal cell 
death and matrix disruption, presumably a result of minimising the stresses that occur 
in the tissue, there is still an up-regulation of matrix synthesis and cell proliferation 
immediately adjacent to the wound edge in response to the wounding (Redman et al., 
2004). Understanding the factors responsible for this shift in the attempted repair 
response to the lesion edge when mechanical stresses and hence cell death and matrix 
loss has been kept to a minimum is an example of how future approaches to cartilage 
repair may be improved. Alternatively, approaches to inhibit the apoptotic response 
may be of benefit. For example, such approaches could include the localised use of 
molecular inhibitors of apoptosis or the prevention of the loss of survival factors such 
as IGF-I from the extracellular matrix using hydrogels (Kuhn et al., 2004).
The potential ability of a chondrogenic cell type to prevent the detrimental apoptosis 
and loss of glycosaminoglycans that occurs in cartilage following wounding would be 
of great interest for tissue engineering based approaches to cartilage repair. However, 
data generated in this study showed there to be little effect of transplanting 
populations of cells enriched in superficial zone articular cartilage progenitor cells 
onto cartilage wound margins. No effect was observed on the wounding induced 
necrosis or loss of glycosaminoglycans from the wound edge. These results are in 
contrast to data generated in other studies (Bishop et al., 2002) that indicate that 
transplanting similar cells into defects in articular cartilage reduces the extent of cell 
death and matrix loss at the wound margin. The reasons for the contrasting results are 
unclear although may be due to the fact that the studies of Bishop et al., (2002) used 
cells transplanted in the form of pellets that were created several days prior to 
transplantation. Thus, the cells may have been in a different state of differentiation at 
the time of implantation in the defect to the cells used in the studies presented here. It 
would also be interesting to look at the effect on wound margins of purer populations 
of progenitor cells using clonal lines derived from individual colonies following 
differential adhesion. The populations used in these studies were only enriched and 
thus any beneficial effect of the progenitor cells may be being diluted by non­
progenitor cells in the populations.
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In conclusion, the surgical removal of articular cartilage has a detrimental effect on 
the remaining articular cartilage and this detrimental effect may, in part, lead to the 
poor integration of repair tissue in the defect. The extent of the detrimental response is 
dependant on the cutting technique used. Although the implantation of populations of 
cells enriched in articular cartilage progenitor cells failed to influence events at the 
wound margin, the model developed may be useful for evaluating the effects and 
integration of other cells or tissue engineered cartilage constructs on cartilage wound 
margins. The model may therefore provide a useful tool for the design of cell-based 
strategies for cartilage repair prior to in vivo evaluations.
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7.1 INTRODUCTION
Previous studies describing evidence for the existence of a population of articular 
cartilage progenitor cells within the superficial zone of articular cartilage and their 
role in development have investigated developing or neonatal opossum, murine or 
bovine tissue (Hayes et al., 2001; Hayes et al., 2003; Dowthwaite et al., 2004 
respectively). Little is known about the role of the cells in the development of human 
articular cartilage and the fate of the cells during maturation of the cartilage through 
to the adult organism. The prospect of isolating articular cartilage progenitor cells 
from human cartilage would be of interest as the cells may replicate the extensive 
expansion and chondrogenesis properties exhibited by their bovine counterparts 
(Chapter 5). The large expansion potential may allow the development and 
commercialisation of cartilage repair therapies through the establishment of allogeneic 
cell banks.
In order to study the properties of the human cells a tissue source is needed. As little 
is known about the existence of human articular cartilage progenitor cells or their fate 
during the ageing process, the optimal age of donor for their isolation is unknown. 
Bearing in mind their role in cartilage development they are likely to be more 
abundant in human neonatal or paediatric cartilage, however a demonstration of their 
existence in adult human tissue would be of benefit as it would be relatively easier to 
obtain suitable adult donor tissue compared with human neonatal or paediatric tissue. 
With this in mind, together with previous data suggesting their existence in 
developing neonatal animal articular cartilage (Hayes et al., 2001; Hayes et al., 2003; 
Dowthwaite et al., 2004) it was decided to attempt to prepare enriched populations of 
human articular cartilage progenitor cells from both adult and developing human 
tissue.
Little is known about the effect of aging on human chondrocyte proliferation and 
redifferentiation ability (Barbero et al., 2004). Previous studies have investigated age- 
related changes in proliferation of chondrocytes derived from human (Gueme et al., 
1995; Barbero et al., 2004) and animal donors (Adolphe et al., 1983; Evans and 
Georgescu, 1983). These studies have shown a species dependant proliferative 
potential with an inverse relationship between proliferative potential and age of the
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donor (Evans and Georgescu, 1983). The proliferative and chondrogenic ability of 
adult human chondrocytes during culture is low, preventing the widespread use of the 
cells in cartilage repair therapies or in the generation of allogeneic cell banks. The 
large numbers of cells required for these applications suggest the requirement for a 
stem cell or cartilage progenitor cell with extensive and rapid expansion capabilities. 
However, it is now becoming apparent that even mesenchymal stem cells derived 
from human bone-marrow lose their chondrogenic ability during expansion 
(Mastrogiacomo et al., 2001) thus prompting research into specific expansion 
conditions to prevent this. Studies have evaluated the effect of culture conditions or 
various serum lots (Lennon et al., 1996; Caterson et al., 2002; Sekiya et al., 2002) or 
the addition of growth factor supplements such as FGF-2 to the culture media on the 
cartilage forming potential of human marrow derived stem cells (Mastrogiacomo et 
al., 2001; Solchaga et al., 2005). These studies have shown it to be possible to 
enhance the retention of chondrogenic ability of human cartilage forming progenitor 
cells during expansion by careful optimisation of the culture conditions.
The objective of this study was to prepare enriched populations of human superficial 
zone articular cartilage progenitor cells (SZCs) and expand under different conditions 
and evaluate their chondrogenic potential at various passages by transfer into pellet 
culture. Chondrogenesis was determined using safranin O staining and collagen II 
immunolabelling. Neonatal, paediatric and adult human cartilage were examined. A 
secondary objective was to examine the structure of human articular cartilage 
throughout development using histological techniques.
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7.2 MATERIALS AND METHODS
7.2.1 Human Tissue
Human knee joints of neonatal, paediatric and adult donors were obtained using 
informed consent. Summary of the donors are shown in table 7.1. The knee joints 
were opened aseptically and the articular cartilage surfaces exposed. Tissue was 
removed for histology and cell culture.
7.2.2 Histology and immunolabelling
Articular cartilage was excised from condyle and in some cases the patellar groove 
surface of the joint. The cartilage was washed once in PBS, fixed and embedded in 
paraffin wax as described in section 2.3. Sections of 5pm thickness were cut and 
stained with haematoxylin and eosin as described in sections 2.3.3 and 2.3.4. Some 
sections were stained with safranin O/haematoxylin and picro-sirius red.
In some cases, cartilage was frozen as described in section 2.3.6 and embedded in 
OCT. Frozen sections were cut and immunolabelled for the presence of Notch 1-4 as 
follows.
Antibodies for Notch receptors 1, 3 and 4 were goat polyclonals against the human 
epitope. Antibody against Notch 2 was a rabbit polyclonal against the human epitope. 
Antibodies were provided by Santa Cruz. Immunolabelling for BST-1 and 
fibronectin-EDA was carried out as described in sections 3.2.2 and 4.2.1.1 
respectively.
For immunolabelling, sections were washed twice for 5 minutes in PBS (Oxoid) prior 
to blocking with 2.5% normal rabbit serum (2.5% goat serum for Notch 2 slides) 
(Dako) in PBS for 20 minutes at room temperature. Blocking solution was wicked off 
using a tissue and sections were then incubated with 20pg/ml of the antibodies in PBS 
for 45 minutes at room temperature. Sections were washed three times for 3 minutes 
with PBS and incubated with a 1:100 dilution in PBS of a biotinylated rabbit anti-goat
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secondary antibody (Notch2 sections biotinylated goat anti-rabbit secondary antibody) 
(Dako) for 45 minutes at room temperature followed by washing for three times for 3 
minutes. Sections were then incubated with a 1:100 dilution in PBS of a Streptavidin- 
FITC conjugate (Amersham Pharmacia) for 45 minutes at room temperature followed 
by washing three times for 3 minutes. Sections were mounted with Vectashield 
(Vector) containing propidium iodide, coverslipped and viewed using fluorescence 
microscopy.
Control sections were incubated with the equivalent concentration of non-immune 
IgG of the same species the primary antibody was raised in.
7.2.3 Cell isolation and expansion
7.2.3.1 Isolation and expansion of populations of cells enriched in 
articular cartilage progenitor cells
Protocol was repeated as described in section 5.2.1 with the following 
exceptions:
Human plasma fibronectin (Sigma, Poole) was used at lOpgml'1 in Dulbecco's 
PBS with ImM MgCk and ImM CaCb (Sigma, Poole) for coating of plates.
Following isolation, 7.8ml of the 4000 cells ml"1 suspension of superficial 
zone cells (SZCs) in serum free DMEM was seeded into each of 4 coated 
75cm2 flasks and incubated at 37°C for 20 minutes. After 20 minutes, the 
media was gently swirled and discarded. Expansion was carried out in media 
as shown in table 7.2. Fetal bovine serum (FBS) was obtained from Helena 
Biosciences. Human serum (HS) was obtained from Sigma (HI513). FGF-2 
was obtained from R&D Systems, Oxfordshire.
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1.232  Full Thickness Chondrocyte Controls
Chondrocytes were isolated from the full thickness of the articular cartilage 
(FTCs) of each of the donor joints. The tissue was harvested from the 
remaining half of the condyle and patellar groove that had not been used for 
superficial zone cell isolation. Cartilage was digested as described above. 
Following isolation, approximately 1 x 106 cells were seeded into each of 4 x 
75cm2 flasks and cultured in either DMEM/10% FBS and DMEM/10% HS 
(Donors 1 & 2), DMEM/10% FBS with and without 5ng/ml bFGF (Donor 3) 
or DMEM/10% FBS alone (Donors 4 & 5).
7.2.4 Chondrogenic differentiation: pellet culture
Pellets were cultured and analysed histologically as described in section 5.2.2.
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Donor Age/Sex Cause of Death Supplier
1 33 weeks gestation
Male
Neonatal
Trisomy 13 Cell Dynamics 
(Georgia)
2 35 days post-natal
Female
Neonatal
Pontus
cerebellum
hypoplasia
Cell Dynamics 
(Georgia)
3 2 years post-natal
Male
Paediatric
Microencephaly Cell Dynamics 
(Georgia)
4 38 years old
Female
Adult
Cirrhosis, liver 
failure
ScienceCare
Anatomical
(Arizona)
5 45 years old
Female
Adult
Respiratory 
failure, stomach 
sclerosis
ScienceCare
Anatomical
(Arizona)
Table 7.1: Summary of human donors used in these studies.
Donor Expansion Media
1 DMEM/10% FBS 
DMEM/10% HS
2 DMEM/10% FBS 
DMEM/10% HS
3 DMEM/10% FBS ± 5ng/ml FGF-2
4 DMEM/10% FBS
5 DMEM/10% FBS
Table 7.2: Expansion conditions for putative human superficial zone progenitor 
cells
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7.3 RESULTS
7.3.1 Histology
7.3.1.1 Donor 1
Histological staining of articular cartilage from donor 1 revealed a deep, 
highly cellular, vascularised and immature cartilage tissue (figure 7.1 A & B) 
that comprised most of the epiphysis of the femur and contained abundant 
sulphated glycosaminoglycans (figure 7.1C). The architecture and defined 
zones of articular cartilage present in the adult were absent. Large vascularised 
canals were present throughout the depth of the tissue, often extending to the 
surface. There also appeared to be a fibrous, denser staining region on the 
surface of the tissue that contained a greater abundance of collagen (figure 
7.2C) and little or no sulphated proteoglycans (figures 7.1C & 7.2B). This 
region contained highly oriented collagen fibres lying parallel with the surface 
of the tissue as shown when sections were stained with picro-sirius red and 
viewed using polarised light (figure 7.ID). Higher magnification examination 
of this surface area revealed it to be continuous with both the vascularised 
canals and vascularised synovial tissue at the periphery of the joint (figure 
7.2). The surface of this layer was composed of numerous flattened cells 
whereas deeper in this layer there were numerous chondrocyte clones 
indicating it to be a region of active cell proliferation (figure 7.2).
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Femoral condyle Patellar groove
Patellar groove Patellar groove
Figure 7.1: Haematoxylin and eosin (A & B) and safranin O (C) staining of 
donor 1 articular cartilage. A section stained with picrosiruis red and viewed 
using polarised light is shown in (D). Vascularised areas indicated by solid 
arrows. A & B bar = 1000pm. C & D bar = 400pm.
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Figure 7.2: Higher magnification image of area highlighted in Figure 7.1B 
stained with haematoxylin and eosin (A), safranin O (B) and picro-sirius red (C). 
Flattened cells are indicated by solid arrows. Chondrocyte clones are indicated 
by open arrows. Bar in all images = 200pm.
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7.3.1.2 Donor 2
Haematoxylin and eosin and safranin O staining of patellar groove cartilage 
derived from donor 2 again revealed a thick, highly cellular and immature 
tissue (figure 7.3). In contrast to donor 1, the tissue contained a much lower 
degree of vascularity and the fibrous surface layer evident in donor 1 was 
generally absent, only present toward the very periphery of the joint surface. 
There was a reduced level of glycosaminoglycans in the surface regions 
(figure 7.3B).
7.3.1.3 Donor 3
Haematoxylin and eosin and safranin O staining of patellar groove cartilage 
derived from donor 3 again revealed a highly cellular, immature tissue (figure 
7.4). However the cartilage appeared less cellular than donor 2 indicating a 
higher degree of maturity. The reduced glycosaminoglycan level in the surface 
layers was more extensive, extending deeper into the tissue. Vascularity 
occurred only in the very deepest regions of the cartilage and the fibrous 
surface layer was completely absent.
7.3.1.4 Donor 4 and Donor 5
Haematoxylin and eosin staining revealed features typical of mature cartilage. 
The cellularity was relatively lower than that noted in the immature cartilage 
from donors 1 to 3 and the cells were present in lacunae and arranged in 
columns in the deeper regions. The surface zone was sparsely populated with 
flattened cells (arrows) and contained a high proportion of empty lacunae. The 
surface zone of donor 4 appeared fibrous, although in contrast to donor 1 this 
region was relatively acellular, possibly a result of some form of early 
degradative changes.
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B
Figure 7.3: Haematoxylin and eosin (A) and safranin O (B) staining of donor 2 
articular cartilage from the patellar groove. Bar = 200pm.
-
Figure 7.4: Haematoxylin and eosin (A) and safranin O (B) staining of donor 3 
articular cartilage from the patellar groove. Bar = 200pm.
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________
Figure 7.5: Haematoxylin and eosin staining of adult articular cartilage from the 
femoral condyle of donor 4 (A) and donor 5 (B). Arrows indicate flattened 
surface cells. Bar = 200|im.
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7.3.2 Immunolabelling: Notch 1-4, fibronectin-EDA and BST-1
Figures 7.6 and 7.7 show the distribution of Notch 1-4 in normal neonatal 
(donor 1) and adult human (donor 4) articular cartilage. Red fluorescence is a 
result of propidium iodide counter staining of cell nuclei. Results are 
summarised in tables 7.3 and 7.4. The scores in tables 7.3 and 7.4 were 
obtained from an independent observer.
In the neonatal cartilage, Notch 1 was present towards the surface of the 
articular cartilage although it was not expressed in the uppermost cell layers. 
Notch 2 and 3 were present throughout the thickness of the tissue with slightly 
increased expression towards the surface. Notch 4 was undetectable.
In the adult cartilage, the superficial zone appeared to contain a population of 
Notch 3 positive cells (arrows). Notch 3 was not present in the middle zone. 
The middle zone contained predominantly Notch 2 positive cells. Notch 1 and 
Notch 4 were not detected in this study. Control sections were blank.
Figure 7.8 shows the expression of BST-1 and fibronectin-EDA in neonatal 
human articular cartilage. In a similar fashion to Notch 1, BST-1 was present 
towards the surface of the articular cartilage although it was not expressed in 
the uppermost cell layers. Fibronectin-EDA was abundant in the surface layers 
of the tissue. Expression of both proteins was absent in the deeper zones.
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Surface Deep Zone
Notch 1
Notch 2
Notch 3
Notch 4
Figure 7.6: Immunostaining of Notch 1-4 in neonatal human articular cartilage 
(donor 1). Notch 1 expression was noted in the surface regions (white arrow) 
although it was not expressed in the uppermost cell layers. Bar = 100pm
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Surface Middle/Deep Zone
Notch 1
Notch 2
Notch 3
Notch 4
Figure 7.7: Immunostaining of Notch 1-4 in adult human articular cartilage 
(donor 4). Arrows illustrate Notch 3 expression in uppermost cell layers. Bar = 
100pm
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Zone
Notch Superfical Middle Deep
1 +++ - -
2 + + (low) + (low)
3 + + (low) + (low)
4 - - -
Table 7.3: Summaiy of distribution of Notch 1-4 in neonatal human articular 
cartilage (donor 1) in figure 7.6
Zone
Notch Superfical Middle Deep
1 Very low/background levels throughout
2 + (low) ++ +
3 +++ + (low)# + (low)
4 Intermittent v. low level stain throughout. Occasional bright cell
- occasional groups of ++ stain extending into middle zone.
Table 7.4: Summary of distribution of Notch 1-4 in adult human articular 
cartilage (donor 4) in figure 7.7
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Figure 7.8: Immunostaining of BST-1 (A), fibronectin-EDA (B) at the surface of 
neonatal human articular cartilage (donor 1). Control of non-specific IgG is 
shown in (C). BST-1 expression was noted in the surface regions (white arrow) 
although it was not expressed in the uppermost cell layers. Fibronectin-EDA was 
clearly present in very surface layers of the tissue (grey arrow). Bar = 100pm
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7.3.3 Growth kinetics 
Donor 1
Both FTCs and SZCs derived from Donor 1 underwent between approximately 19 and 
24 population doublings (pds) over approximately 100 days in culture (figure 
7.9).There was little difference in growth rate between cells in human serum (HS) and 
foetal bovine serum (FBS), although expansion in HS promoted the growth of 
fibroblastic colonies (figure 7.13) which persisted throughout the expansion process.
Donor 2
Both FTCs and SZCs derived from Donor 2 underwent between approximately 14 and 
16 population doublings over approximately 75 days in culture (figure 7.10). The 
growth rate of both cell types declined after approximately 13 population doublings. 
Again, as with donor 1, expansion in HS promoted the growth of fibroblastic colonies 
which persisted throughout the expansion process.
Donor 3
FTCs derived from Donor 3 underwent approximately 10 population doublings when 
cultured with or without bFGF over 30 and 50 days in culture respectively (figure 
7.11). SZCs derived from donor 3 underwent 14 and 10 population doublings when 
cultured with and without bFGF respectively. The addition of 5ng/ml bFGF to the 
culture media resulted in a faster rate of growth of both SZCs and FTCs (figures 7.11 
and 7.14) and the cells adopted a more spindle-shaped morphology (figure 7.15).
Donor 4
The cells underwent approximately 15 population doublings over 55 days in culture 
(figure 7.12). The rate of growth rapidly declined after the first passage.
Donor 5
Initial SZC growth was extremely slow, requiring 4 weeks to reach confluence. 
Subsequent growth was negligible. Normal chondrocytes isolated from the full 
thickness of the articular cartilage also expanded extremely slowly. Cells were 
discarded after a further 4 weeks in culture and data is not plotted. No pellet cultures 
initiated.
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Figure 7.9: Donor 1 - Expansion of FTCs (A) and SZCs (B) in both human serum 
and foetal bovine serum
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Figure 7.10: Donor 2 - Expansion of FTCs (A) and SZCs (B) in both human 
serum and foetal bovine serum
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Figure 7.11: Donor 3 - Expansion of FTCs (A) and SZCs (B) in DMEM 10% FBS 
+/- bFGF
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Figure 7.12: Donor 4 - Expansion of SZCs in foetal bovine serum
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7.3.4 Cellular morphology
szc
szc
FTC
Figure 7.13: Images of human neonatal (donor 1) SZCs with a high affinity for 
fibronectin expanded in culture in FBS and HS showing altered growth 
characteristics in HS. HS tended to promote the growth of fibroblastic colonies 
(solid arrow) which remained throughout the expansion process as seen in (D) 
and (F). Bars = 100pm.
FBS HS
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(B) +bFG(A) -bFGF
Figure 7.14: Images of human neonatal (donor 3) SZCs (PI) with a high affinity 
for fibronectin expanded in culture in FBS with and without 5ng/ml bFGF. 
Images illustrate the faster growth in the presence of bFGF. Bar = 100pm.
(A) -bFGF bFGF
Figure 7.15: Images of human neonatal (donor 3) SZCs (P2) with a high affinity 
for fibronectin expanded in culture in FBS with and without 5ng/ml bFGF. 
Images illustrate the more spindle-shaped morphology in the presence of bFGF. 
Bar = 200pm.
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7.3.5 Pellet Culture
Donor 1 FTCs and SZCs expanded in culture and subsequently grown in pelleted 
micromasses synthesised a matrix that stained strongly with Safranin O and contained 
abundant collagen II (figure 7.16). However, this occurred only in pellet cultures 
derived from cells in the early stages of expansion -  up to 11 pds for SZCs and 1 pd 
for the FTCs. At higher levels of expansion the ability of the cells to produce a 
cartilagenous matrix rapidly declined. Safranin O staining was absent and the tissue 
was of a more fibrous nature. Collagen II staining was also absent at higher levels of 
expansion. Expansion in HS resulted in a slightly inferior quality cartilagenous matrix 
in that safranin O staining was reduced.
As with Donor 1, Donor 2 FTCs and SZCs at early stages of expansion synthesised a 
matrix that stained strongly with safranin O and contained abundant collagen II 
(figure 7.17). The quality of cartilage produced by Donor 2 FTCs and SZCs expanded 
in HS declined at approximately 5 pds and 10 pds respectively. Expansion in FBS 
resulted in a slightly poorer quality cartilagenous matrix than expansion in HS. Thus, 
cells derived from Donor 2 lost the ability to synthesise a cartilagenous matrix at an 
earlier stage than cells derived from Donor 1.
Pellet culture of expanded SZCs and FTCs derived from donor 3 gave rise to a vastly 
inferior cartilage matrix quality compared to donors 1 and 2 (figure 7.18). Only FTCs 
at PI gave rise to a matrix that stained with safranin O. Supplementation of the 
expansion media with 5ng/ml bFGF resulted in a slight increase in safranin O staining 
at P4 and PI for the FTCs and SZCs respectively.
Donor 4 SZCs expanded in culture to PI and subsequently grown in pelleted 
micromasses synthesised a cartilage-like matrix that stained moderately with safranin 
O (figure 7.19). Cells were rounded and present in lacunae. At P4, safranin O staining 
was completely absent and the tissues were of a more fibrous nature. FTCs derived 
from donor 4 expanded to PI and transferred to pellet culture synthesised a matrix 
that stained weakly with safranin O. Thus, as with donor 1, the SZCs retained the 
ability to form a cartilagenous matrix at a higher level of expansion that the FTCs.
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Figure 7.16: Donor 1 - Pellet culture of FBS culture expanded human SZCs and FTCs. Safranin O staining. Collagen II staining inset. 
Bar = 200pm.
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Figure 7.17: Donor 2 
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Figure 7.18: Donor 3 - Pellet culture of human SZCs and FTCs expanded in DMEM/10% FBS with and without 5ng/ml bFGF. Safranin 
O staining. Bar = 200pm.
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Figure 7.19: Donor 4 - Pellet culture of human SZCs and FTCs expanded in DMEM/10%FBS. Safranin O staining. Bar = 400pm.
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7.4 DISCUSSION
Interesting properties exhibited by enriched populations of bovine superficial zone 
articular cartilage progenitor cells (SZCs) warranted attempts at isolating the cells 
from human articular cartilage as the value of human cells possessing similar 
properties in potential cell-based cartilage repair therapies would be high.
Initial studies used histological techniques and immunolabelling to gain general 
information on the morphology of the tissue during development and to study the 
expression profile of the Notch family of receptors and other proteins by the 
developing chondrocytes. This profile would be compared to published information 
(Hayes et al., 2003; Dowthwaite et al., 2004) on developing animal tissue in order to 
gain clues as to the existence of the cells in the human case.
The neonatal and paediatric tissue showed morphological features typical to that of 
normal developing articular cartilage (McDermott, 1943; Gray and Gardner, 1950). 
Macroscopically, the cartilage comprised most of the epiphyses of the femur and tibia. 
The architecture and defined zones of articular cartilage present in the adult 
(Buckwalter and Mankin, 1997) were absent. The cartilage was also highly 
vascularised. Interestingly, the surface of the most immature donor tissue (donor 1; 33 
weeks gestation) showed histological features indicative of the appositional growth 
mechanisms described in Hayes et al., (2001) in that the surface of the tissue was 
composed of numerous flattened cells whereas immediately beneath these were 
numerous chondrocyte clones indicating it to be a region of active cell proliferation. 
As development advanced, the thickened fibrous layer on the surface of the tissue and 
vascularised canals evident in donor 1 receded together with the level of cellularity of 
the tissue, which further decreased into adulthood. It is important to note that the 
thickened fibrous layer on the surface of Donor 1 articular cartilage probably provided 
the bulk of the cells that were cultured. This layer was absent from the other donors so 
the expanded cell population of Donor 1 was taken from a different anatomical 
location. Some similarities existed in the expression of Notch receptor isoforms 
between data generated here and published data on bovine and murine tissue (Hayes 
et al., 2003; Dowthwaite et al., 2004). Notch 1 was expressed only in the surface 
regions of the developing human tissue. Notch 2 and 3 were expressed at low levels
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throughout the depth of the tissue. In this study we were unable to detect any level of 
Notch 4 expression which is in contrast to published data for mice (Hayes et al.,
2003). These data suggest Notch 1 may also play a role in determining cell fate during 
development of human articular cartilage as it is believed to in other species. In the 
adult human tissue, Notch 1 expression became absent from the surface regions and 
Notch 2 was confined to the middle regions. Notch 3 was expressed to a greater extent 
in the surface of the tissue, which is in contrast to published data (Hayes et al., 2003).
A factor that must be bome in mind when using human tissue is that it is unclear as to 
the effect of the pathologies that resulted in death of the donor had on the 
development and biology of the articular cartilage. For example, donor 1 suffered 
from a trisomy 13 (Patau Syndrome) which is associated with skeletal abnormalities 
such as polydactyly and syndactyly, although there were no obvious morphological 
abnormalities noted in the articular cartilage in this study. Donor 3 suffered from a 
microencephaly which may have resulted in disability and decreased mobility. This 
may have reduced the stresses and strains normally applied to the cartilage following 
birth. These mechanical factors play an integral role in the development of the tissue 
(Pitsillades, 2003) and their absence is bound to have affected the normal progression 
of the maturation of the tissue. In the case of the adult tissue, the cartilage will be 
undergoing the normal age related changes and even may be in the very initial stages 
of the development of osteoarthritis. It is also unknown as to the effect of the drugs 
the donors were receiving as part of their medical treatment prior to death, on the 
biology of the chondrocytes in culture.
The populations of cells enriched in superficial zone progenitor cells (SZCs) isolated 
from donor 1 displayed enhanced chondrogenic ability as a function of expansion in 
comparison to normal chondrocytes isolated from the full thickness of the cartilage of 
the same donor. This property was not replicated by the other donors apart from, 
curiously, the adult donor 4. Although this property is interesting, it is doubtful the 
expansion levels obtained in this study would be sufficient from a commercial 
perspective. The costs of establishing and maintaining an allogeneic cell bank for 
therapeutic use is extremely high. The establishment of a cell bank derived from more 
than 1 donor increases the costs dramatically due to expenses incurred through 
procurement of a suitable donor, screening and other regulatory and development
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aspects. Therefore one would ideally develop the cell bank from 1 donor as was the 
case with Dermagraft™, a human fibroblast-derived dermal substitute previously 
marketed by Smith and Nephew for the treatment of diabetic foot ulcers. If we 
consider the US focal defect market to be approximately 600,000 cases per year 
(Medtech Insight report, 2003) and estimate a product could achieve an initial 10% 
penetration into that market and if we also assume we would use approximately 1
V * * • 11xlO cells in a tissue engineered device then we would require around 6x10  cells to 
supply the market for one year. If we could achieve a total yield of 1 x 106 progenitor 
cells per donor then they would need to undergo over 18 population doublings to 
achieve the desired amount. Clearly there are a lot of assumptions made in this 
calculation but it serves to highlight the issues involved.
The inability to replicate entirely the bovine data is likely to be due to a lack of 
optimisation of the isolation, expansion and possibly differentiation conditions for the 
human cells. The optimisation process was hampered by difficulties in the 
procurement of tissue to the required specification. We required normal articular 
cartilage with no evidence of osteoarthritis or other pathologies. We were keen to 
obtain the whole knee to maintain the sterility of the cartilage during transit with a 
timeframe of less than 48 hours post mortem to cell isolation. The neonatal and 
paediatric tissue is particularly difficult to obtain to this specification. Obtaining tissue 
from amputations or surgical discard from operations is not feasible as these 
procedures are very rare in this age group. It was necessary to work with groups that 
see large numbers of potential donors, who are trained in obtaining consent, hospital 
liaison and working with the tissue banks and organ procurement organisations to 
check donor suitability, for serology, tissue harvest and shipment. The complexities of 
obtaining tissue to a challenging specification must be appreciated early in future 
research projects in order to ensure to supply of tissue does not become rate limiting.
As part of the limited optimisation process that was carried out, cells were expanded 
cells in both foetal bovine serum (FBS) and human serum (HS). The hypothesis being 
tested was that species-specific factors in the serum may be necessary for optimal 
expansion and differentiation. For example, bovine-specific factors present in the FBS 
may be necessary for the expansion and differentiation characteristics of the bovine 
SZC cell population. Although expansion in HS induced morphological changes in a
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subpopulation of the cells in the cultures this did not lead to an increased proliferative 
potential or differentiative capability, rather in one case (donor 1) HS marginally 
decreased the matrix quality of the cartilage-like tissue produced in the pellet cultures. 
The factors present in HS that promoted the altered cell morphology are unknown.
This study has served to highlight species-specific differences in cell behaviour in that 
it is difficult to extrapolate data obtained using animal cells to the human situation. 
For future studies, there are a number of factors that would need to be known in order 
to move forward. The optimal age of donor tissue for cell isolation is unknown. This 
is because the fate of the cells during development and subsequent maturation of the 
tissue is unknown, together with the level of variability between donors. Also, the 
technique used to produce enriched populations of the cells used in the study was 
identical to that used for bovine cells. More sophisticated techniques may be required 
for isolation of the human cell equivalents. For example, a more detailed 
characterisation of possible markers would aid identification of the cells in the tissue 
and tracking the fate of the cells during development and ageing. It would also aid 
optimisation of the isolation protocol in that it would allow calculations of yields and 
also may enable immuno-selection techniques such as fluorescence activated cell 
sorting (FACS) to enrich the populations if the markers are cell surface-based. A 
candidate for this may be the cell surface receptor Notch 1. However, FACS analysis 
and colony forming studies have shown that although 75% of the bovine cells from 
the superficial zone express Notch 1, only 1-2% of these cells form colonies 
(Dowthwaite et al., 2004) indicating Notch 1 expression in itself is not a marker of 
progenitor chondrocytes.
The expansion conditions would also need to be optimised. Researchers looking to 
study chondrogenic differentiation of bone marrow derived mesenchymal stem cells 
(MSCs) often rigorously select the serum to be used to supplement the medium 
(Lennon et al., 1996). The use of suboptimal serum lots is reported to result in rapid 
loss of multipotentiality and slow mitotic expansion. In addition, small differences in 
the cell culture protocols, such as seeding density of primary and subsequent cultures 
or formulation of the base medium is also reported to result in reduction in 
chondrogenic potential (Sekiya et al., 2002; Caterson et al., 2002; Solchaga et al., 
2005). Supplementation of the media with growth factors such as TGF-p and bFGF
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has been suggested to promote the retention of chondrogenic potential of bovine 
(Martin et al., 1999) and human (Jakob et al., 2001; Barbero et al., 2004) 
chondrocytes and human MSCs (Mastrogiacomo et al., 2001; Solchaga et al., 2005). 
However, data generated in this study showed supplement of the expansion media 
with bFGF led to only a very limited enhancement of chondrogenesis by SZCs.
In conclusion, this study describes the first attempts to demonstrate the existence of a 
population of cells within the superficial zone of human adult and neonatal articular 
that possess the ability to undergo expansion in monolayer culture and retain the 
ability to undergo chondrogenic differentiation to a greater extent than normal 
chondrocytes. Although data in this chapter has demonstrated this is possible, further 
optimisation of the isolation and expansion conditions will be necessary for the 
human cells.
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8. GENERAL DISCUSSION
Articular cartilage has a distinct zonal architecture with biochemical and cellular 
variations existing from the surface zone to the deeper calcified layers. Thus, the 
development of the tissue must be stringently controlled, both spatially and 
temporally in order for the complex structure to be established. A number of studies 
have highlighted the importance of the surface areas of articular cartilage in both the 
morphogenesis of the joint and in the regulation of subsequent growth and 
differentiation of the tissue (Archer et al., 1994; Ward et al., 1999; Hayes et al., 2001; 
Archer et al., 2003; Hayes et al., 2003). Importantly, the surface zone is believed to be 
responsible for the appositional growth of articular cartilage during development and 
this growth is believed to be driven by a population of slow cycling progenitor cells 
within the surface zone itself (Hayes et al., 2001; Dowthwaite et al., 2004).
This thesis has described a set of studies looking to isolate and partially characterise 
articular cartilage progenitor cells from the surface zone. In view of the possible role 
of these cells in driving development this thesis has also investigated potential 
applications of enriched populations of the cells in novel tissue repair or tissue 
engineering therapies for the treatment of defects in articular cartilage. Chapter 3 
described the techniques used to identify the cells within the superficial zone of 
immature bovine articular cartilage and a limited characterisation in terms of some 
cell surface markers expressed by the cells. The differential expression of Notch 1, the 
cell-fate determination receptor, is believed to play a key role in the developmental 
process by controlling the clonality of the surface zone cells (Dowthwaite et al.,
2004). Chapter 4 showed the cells are present within the surface zone in a distinct 
extra-cellular matrix enriched in the foetal splice-variant of fibronectin which contains 
the additional EDA segment. This chapter also illustrated that this specific form of 
fibronectin may act to modulate the behaviour of the cells and may play an important 
role in vivo in the control of proliferation and differentiation.
In terms of the potential of the cells for use in tissue engineering, a promising feature 
of the cells is the discovery that enriched populations of the cells can undergo 
extensive expansion in simple monolayer cultures and yet retain their ability to 
undergo chondrogenic differentiation (Chapter 5). If this could be replicated using
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human cells then this would side-step well documented issues with the use of adult 
chondrocytes in tissue engineering such as low growth potentials and loss of 
chondrogenic ability following expansion (Benya and Shaffer, 1982; Evans and 
Georgescu, 1983; Von Der Mark et al., 1997; Binette et al., 1998). The expansion and 
differentiation properties of the cells may allow the generation of large allogeneic cell 
banks for cell transplantation therapies from only small quantities of donor cartilage 
tissue. Sadly, our results using human cells did not replicate entirely those obtained 
from bovine cells (Chapter 7). However, this is most likely due to a lack of 
optimisation of isolation and expansion conditions for the human cell cultures, rather 
than an inherent lack of ability of the cells to perform like their bovine counterparts. 
The optimisation process was hampered due to difficulties in the procurement of 
normal human articular cartilage, in particular human neonatal articular cartilage. This 
limitation of tissue supply places great restrictions on the range of experiments that 
can be carried out, thus preventing an effective optimisation of the isolation and 
expansion conditions.
A survey of the literature and results obtained in clinical studies indicates we are still 
a long way off a viable and efficacious cell-based therapy for the regeneration of 
articular cartilage. The current treatment closest to that of a tissue engineering 
approach is ACI. Although ACI is a widely used technique with promising outcomes, 
doubts still remain as to its superiority over simpler and cheaper approaches such as 
microfracture (Breinan et al., 1997; Knutson et al., 2004). However, ACI is constantly 
evolving with the incorporation of scaffolds and the replacement of the periosteal flap 
(Pavesio et al., 2003; Haddo et al., 2004; Ronga et al., 2004) which may eventually 
lead to improvements in efficacy, ease of technique or reductions in costs. The 
problems faced by ACI will be faced by all future cartilage repair therapies. 
Techniques such as microffacture are cheap, safe, have a long history of use and as 
good a level of efficacy as every other technique. In order to displace techniques such 
as microfracture from the operating room new therapies must obviously offer 
significant advantages alongside increased efficacy. This does not necessarily mean 
that the cell-based therapy must work to the extent that it achieves a recreation of the 
architecture of the native articular cartilage and restore the joint to full pain free 
mobility. Although this would be a long term goal, it is too optimistic to believe we 
can achieve this in the near future. Extension of the efficacy of current treatment
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regimes using small step-wise changes would be of immediate benefit in delaying the 
need for total knee replacement further.
There are significant issues that need to be addressed in order to bring an effective cell 
based articular cartilage repair therapy to market. Cell source, promotion of lateral 
integration, control of differentiation and immunological aspects all require 
considerable attention.
The choice of cell type and source of that cell type is critical. Autologous cell sources 
have the benefits of the removal of the risks of disease transmission from donors and 
also reduce the risks of immunologic rejection. However, high costs associated with 
autologous cells, as seen during ACI, may drive the use of banked allogeneic cells in 
potential “off-the-shelf’ transplantation therapies. The use of allogeneic cells 
immediately raises concerns of immunologic rejection. Articular cartilage is an 
avascular tissue and thus may be shielded from detection by circulating immune cells. 
Allogeneic osteochondral grafts have been in widespread use for many years with 
positive outcomes although concerns have been raised about immunologic rejection 
(Meyers et al., 1983; Czitrom et al., 1986; Garrett, 1986; Stevenson et al., 1989; Sirlin 
et al., 2001). Whether the osseous or chondral parts of the graft are responsible for the 
immune response is uncertain, although recent reports suggest there is an immune 
response to the cartilage component (Phipatanakul et al., 2004). In light of concerns 
over immunologic responses, researchers have speculated on the potential of 
progenitor cells such as MSCs from the bone-marrow or synovium due to their 
interesting immune-modulting properties. Evidence suggests bone marrow derived 
MSCs have immune-suppressing capabilities, for example, in vitro, MSCs are capable 
of suppressing mixed lymphocyte reactions in response to autologous or allogeneic T 
cells. T cell proliferation stimulated by the addition of irradiated allogeneic peripheral 
blood lymphocytes or dendritic cells has been shown to be greatly suppressed when 
the cultures contained MSCs (Barry and Murphy, 2004). Also MSCs lack HLA Class 
II expression and have a low expression of co-stimulatory molecules thus rendering 
them non-immunogenic. Class II expression has also been shown to be absent from 
the surface of differentiated MSCs and the differentiated cells do not elicit an 
alloreactive lymphocyte proliferative response (Le Blanc et al., 2003). There are also 
several clinical reports of the use of allogeneic donor mis-matched MSCs with little
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evidence of host immune rejection or graft versus host disease (Aggarwal and 
Pittenger, 2005). It would be interesting to determine whether these same properties 
and indeed other properties of MSCs such as homing (Barry and Murphy, 2004) are 
also exhibited by human SZCs.
The fundamental principle behind the use of progenitor cells or MSCs is that 
undifferentiated cells, once delivered to the repair site, will differentiate under local 
signals into cells of the appropriate phenotype (Barry, 2003). These differentiated 
cells then contribute to the repair of the injured tissue. For example, studies have 
shown that scaffolds loaded with MSCs and implanted in osteochondral lesions give 
rise to both cartilage and bone cells. In addition, studies have shown that MSCs, when 
delivered by infusion to an immunocompromised mouse, can engraft to the normal 
myocardium and differentiate into a cardiomyocyte phenotype. Whereas such 
evidence indicates MSCs do indeed differentiate in situ, little is known about the 
specific local signals that drive it (Barry, 2003).
Although efforts are focussed on the use of cells on 3D scaffolds with the appropriate 
cues, there role of transplanted cells in repair is unknown. Solchaga et al., (2002) 
reported that a fibronectin coated hyaluronan-based sponge was able to organise and 
facilitate the reparative response following implantation within an osteochondral 
defect, even without pre-loading the scaffold with autologous bone marrow, 
suggesting an enhancement of the natural repair response by scaffold alone. 
Furthermore, it is unknown as to the fate of cells once implanted into the defect. The 
extent to which they persist or survive at the implantation site and the extent of their 
contribution to the repair tissue is uncertain. Although some studies have shown little 
contribution of the cells to repair in ACI (Breinan et al., 1997) other studies have 
shown that expanded chondrocytes persist at the repair tissue and contribute to the 
matrix formation in a goat model (Dell’ Accio et al., 2003). Other studies have shown 
that MSCs injected intra-articularly in a goat model of OA where the whole meniscus 
had been previously excised led to the prevention of articular cartilage degeneration 
due to the removal of the meniscus through the regeneration of a ‘neo-meniscus’ 
(Murphy et al., 2003). The injected MSCs did not appear to directly contribute to the 
regeneration of the neo-meniscus, rather they engrafted into various joint tissues and 
orchestrated the repair directly carried out by other cell types within the joint space.
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Although another study has shown cartilage tissue formed by MSCs derived from the 
synovium is unstable and rapidly resorbed when implanted subcutaneously in nude 
mice, more studies need to be carried out in relevant cartilage defects to confirm this 
(De Bari et al., 2004). The fate of the cells may also become an issue when cells are 
transplanted in OA joints. In these circumstances the environment is hostile, 
containing degradative enzymes and inflammatory cytokines, thus the cells and matrix 
they produce may require some protection in order to lay down an effective repair 
tissue.
Another aspect that requires attention is that of lateral integration. The poor 
integration of repair tissue with the native articular cartilage is widely recognised 
(Hunziker, 2001a). Poor integration must be addressed in order to achieve prolonged 
healing. Although various attempts have been made to resolve integration, for 
example using biological glues and other adhesives or brief enzymatic degradation, 
this still remains an issue. Without proper integration there will be constant shear 
stresses at the interface between the two tissues and incorrect distribution of 
mechanical forces over the joint surface.
In conclusion, tissue engineering is still in its infancy with many issues that need to be 
addressed. The widespread use of tissue engineering will depend upon the availability 
of validated methods for large scale culture, storage and distribution of a 
chondrogenic cell type.
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Introduction. Articular cartilage is a layered tissue, with differing cellular 
constituents, matrix components and matrix architecture in the superficial, 
mid and deep zones. Our research on cartilage wound biology has shown 
that a population o f chondroprogenitor cells exists within the superficial 
zone o f articular cartilage. These cells form colonies in vitro, express the 
cell signaling receptor Notch-1, produce the ECM component fibronectin- 
EDA, have a high affinity for fibronectin in cell adhesion assays and 
synthesize a cartilage-like ECM when grown in pellet cultures. Our 
research into tissue engineering has shown the need for a particulate cell 
binding material that can act as a microcarrier during the early stages o f cell 
culture and as a 'synthetic interterritorial matrix' during construct assembly. 
We have found that by adsorbing different cell adhesion factors onto a 
particulate biomaterial and regulating the cell-seeding conditions it is 
possible to produce cell seeded particulate biomaterials coated with either 
progenitors or more mature chondrocytes. Such differentially seeded 
particulate biomaterials could be assembled into a tissue engineered 
construct that begins to re-create the zonal cell distribution of healthy 
cartilage.
Methods. Synthesis and coating o f  the biomaterial. A polyanionic, 
particulate biomaterial was synthesized by sulphating Intrasite polymer 
(Smith and Nephew) with sulphur trioxide-pyridine complex. The material 
was freeze dried, washed in PBS, autoclaved and coated with either (i) 
heparin-binding cell-adhesion factors, (e.g. Fibronectin or Collagen VI; 
60mg/ml; 2.5 ml; 2h at 4°C), (ii) mixtures o f adhesion factors absorbed 
from foetal calf serum (FCS; 10%; 2.5 ml; 2h at 4°C) or (iii) PBS, 
(control). The chemical nature o f the modified polymer was confirmed by 
Raman, infrared spectroscopy, histological staining, (alcian blue CEC or 
safranin O) and elemental analysis, whilst the absorbtion o f the cell 
adhesion factors was confirmed by immunocytochemistiy.
Seeding the material with cells. Bone marrow stromal cells (BMSC) were 
obtained from fragmented trabecular neonatal bovine bone, grown to 
confluence and harvested by mild tiypsinisalion. Superficial zone 
chondrocytes (SZC) were obtained from superficial zone neonatal bovine 
cartilage by fine dissection and sequential digestion in 0.1% pronase and 
0.04% collagenase; chondrocytes were obtained from full thickness 
explants of neonatal bovine articular cartilage digested with 0.1% 
collagenase, (Worthington type II).
Sulphated Intrasite, (SI; 4.125 mg per layer o f construct) was coated with 
plasma fibronectin, (60ml/ml; 2.5 ml; 2h at 4°C) and seeded with 750k 
BMSC; or coated with serum-derived cell attachment factors, (10%; 2.5 ml; 
2h at 4°C), and seeded with 750k chondrocytes. Cultures were incubated 
for 3h to 28 days in 20 ml o f DMEM plus FCS; (10%), penicillin, 
streptomycin, non-essential amino acids, L-glutamine and ascorbate-2- 
phosphate (25mg/ml). Cell viability was assessed using MTT, (1 mg/ml; 
2.5 hours), whilst matrix production was assessed using 
immunocytochemistry, (collagen I, Biogenesis; collagen II, NeoMaricers; 
collagen VI, Abeam) and histological dyes, (picrosirius red and safranin O). 
Colony forming cell adhesion to cell-attachment factor coated SI. A  
minority of BMSC and SZC form colonies o f > 16 cells when cultured on 
tissue culture plastic in DMEM/10%FCS for 4 and 6 days respectively. 
These colony forming cells were regarded as putative progenitor cells. In 
these experiments, colony forming cells that do not attach to the coated SI 
particles attach to the culture plastic and may subsequently form colonies. 
Cells that do bind to the SI particles are removed during the washing step, 
thereby reducing the number of colonies formed on the culture plastic. 
Sulphated Intrasite was coated with plasma fibronectin, cellular fibronectin, 
collagen IV, polylysine, laminin (all 60mg/ml) or PBS in 2.5ml DMEM for 
2h at 4°C. The coated biomaterial was incubated with BMSC or SZC 
suspensions (125k cells/ml in serum free medium) for 3h at 37°C, the 
suspension diluted 1000 fold and aliquoted, (4 ml) to the wells of 12 well
plates. FCS (0.4 ml) was then added to the wells and the cultures incubated 
for a further 16 - 24 hours. The wells were then washed with PBS, and the 
cultures incubated for a further 4 - 6  days in DMEM/10% FCS (2 ml). 
Colonies, (discrete clusters o f > 16 cells), were visualized by phase contrast 
microscopy and counted blind. Results were expressed as a 'colony 
depletion score', defined as the number of colonies formed by cell 
suspensions exposed to adhesion factor pre-treated sulphated Intrasite 
divided by the number of colonies per well formed by cells exposed to PBS 
pretreated sulphated Intrasite.
Results. Sulphation and coating o f  the polymer. The sulphation of the 
polymer was confirmed by a distinct infrared spectroscopy peak at 1280 
cm-1 and by the binding of alcian blue to the modified material in the 
presence of 0.9 M MgC12 compared to <0.3 M for the unmodified material. 
Immunocytochemistry showed plasma fibronectin, cellular fibronectin, 
fibronectin-EDA and collagen VI all bound to SI. Likewise, a mixture of 
cell adhesion factors absorbed onto the surface o f the material, (including 
fibronectin and vitronectin) when it was incubated with serum.
Cell growth on coated SI. Neither mature chondrocytes nor BMSC adhered 
to unmodified Intrasite or to sulphated Intrasite that had been pre-treated 
with PBS alone. Both cell types bound to the surface o f the cell adhesion 
factor coated SI particles within 3 - 2 4  hours. The cells proliferated on 
adhesion factor coated SI, (ovine chondrocytes increased in numbers 14.4 
fold over 16 days when grown on FCS-coated SI), and agglomerated the 
particles to form macroscopic aggregates of cells, biomaterial and 
extracellular matrix components. Microscopic examination of chondrocytes 
growing on FCS coated sulphated Intrasite showed rounded, MTT+ve cells 
distributed on and between the polymer particles and lying within a 
picrosirius red positive matrix. Immunocytochemistry showed that mature 
chondrocytes secreted types II and VI collagens but not type I collagen 
during a 27 day incubation period. In contrast, BMSC produced a matrix 
that contained type I but not type II collagen.
Adhesion o f  colony forming cells to coated SI. Microscopic examination of 
the diluted suspensions o f cells and particles after the initial 3 hour 
incubation revealed a sparse distribution of particles, (some with adherent 
cells), together with unattached cells. Addition of FCS to these cultures for 
16-24 hours allowed the cells that had not attached to the biomaterial 
particles to adhere to the tissue culture plastic. The subsequent washing 
step removed the particles and any cells that had adhered to them, leaving 
only those cells that had adhered to the culture plastic. Results showed that 
there were 46.8±3.76 colonies per well when SZC were incubated with 
PBS pre-treated sulphated Intrasite compared to 21.0±1.39 colonies per 
well when the SZC were exposed to plasma fibronectin coated sulphated 
Intrasite, (i.e. a colony depletion score of 0.45; p< 0.001). Likewise BMSC 
incubated with adhesion factor coated sulphated Intrasite gave colony 
depletion scores o f plasma fibronectin, 0.49; collagen IV, 0.67; cellular 
fibronectin, 0.8; polylysine, 0.88 and laminin 1.26.
Discussion. These results show that colony forming cells, (i.e. putative 
progenitor cells), from the superficial zone o f articular cartilage or bone 
marrow stroma adhered to plasma fibronectin coated sulphated Intrasite 
particles. BMSC grown upon the fibronectin coated SI to formed 
aggregates o f cells, extracellular matrix and biomaterial. Chondrocytes 
attached to SI coated with serum-derived attachment factors, proliferated 
upon the material but retained their rounded morphology and secreted a 
matrix containing collagens II and VI but not collagen I, indicating that 
they had retained their differentiated phenotype. Assembly o f these two 
types o f cell-seeded particulates will allow the creation of a tissue 
engineered cartilage construct with a zonal architecture in which a layer of 
progenitor cells overlays a layer o f more mature chondrocytic cells.
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Introduction: There are two major problems which afflict current strategies in 
cartilage repair. One problem is tissue integration between host and reparative 
tissue. The second problem is the generation o f a repair tissue with the 
structural characteristics o f  articular cartilage. Using the marsupial 
Monodelphis domestica  as a model system, it has been shown that articular 
cartilage grows by apposition from the articular surface towards the 
subchondral bone and that this growth is driven by the proliferation o f  surface 
zone cells (1, 2), Additionally, a population o f  cells with an increased cell 
cycle time was identified within the surface zone; a property typical o f  many 
progenitor cell populations (2). The aim o f  our research is to identify and 
characterise a chondroprogenitor population from articular cartilage to enable 
the rapid culture o f  undifferentiated chondrocytes in vitro for future clinical 
use. Here we describe the isolation and partial characterisation o f  a cell 
population from the articular surface which exhibits differential adhesion to 
fibronectin, differential integrin expression and the ability to form large 
numbers o f colonies from an initialy small seeding density; properties that are 
common to known progenitor cell populations o f  other tissues. Additionally 
we report on the presence o f  the cell surface signalling molecule Notch 1 (N l)  
in a subpopulation o f  surface zone chondrocytes and that this Nl-expressing 
subpopulation has an enhanced ability to form large numbers o f  colonies from 
an initially low seeding density.
Materials and Methods: Tissue culture and  differential adhesion assay: 
Cartilage slices were isolated from the surface (SZ), middle (MZ) and deep 
(DZ) zones o f 7 day old bovine metacarpal-phalangeal joints by fine 
dissection. Slices were then incubated in pronase (0.1% in DMEM/5%FCS) 
for 3 hours at 37°C followed by collagenase (0.04% in DMEM/5%FCS) for 
16 hours at 37°C. Chondrocytes were counted and seeded onto fibronectin 
(10pg ml ')-coated or PBS/1% BSA-coated 35 mm dishes at 4,000 cells ml'1 
in serum free DMEM (DMEM-) for 20 minutes. After 20 minutes, media and 
non-adherent cells were removed and placed in similarly treated dishes for a 
further 40 minutes before this media and nonadherent cells were placed in a 
third dish. After removal o f  media at 20 and 40 minutes, fresh DMEM- was 
added to the remaining cells which were cultured for up to 10 days. In all 
experiments 6 fibronectin and 6 uncoated dishes were used for each zone o f 
cartilage. Fibronectin was used as a ligand in the experiments since it is 
known to be differentially expressed at the articular surface during 
mammalian development (3). Within three hours o f  plating, chondrocyte 
adhesion was assayed by counting the total number o f cells per dish using 
phase contrast microscopy and expressed as a percentage o f  the initial seeding 
density. Additionally, colonies o f  chondrocytes consisting o f  32 or more cells 
were counted at 0, 3, 6 and 10 days after differential adhesion (n = 6 
experiments). Colony forming efficiency (CFE) was calculated by dividing 
the number o f  colonies by the initial number o f  adherent cells. In some 
experiments (n = 3) the number o f  cells per colony were counted to determine 
the average number o f cells per colony. Results were analysed using the 
Students t test. Flow cytometry. Four hours after differential adhesion, 
chondrocytes were removed from dishes non-enzymatically and 2 x 10s cells 
were incubated for 3 hours with antibodies to a5  (AB1928) and p i 
(MAB1951) integrin subunits and anti-Nl (SC 6014) at room temperature. 
Cells were centrifuged at 3,000rpm, supernatants removed and cells washed 
three times in PBS with centrifugation between each wash. Cells were then 
incubated with relevant F1TC conjugated secondary antibodies for 1 hour at 
room temperature and washed three times in PBS as described above. Finally, 
labelled cells were resuspended in 500pi PBS and subjected to flow  
cytometry. Notch 1 Immunolabelling and  Immunomagnetic Isolation: Frozen 
sections o f 7 day bovine full depth articular cartilage were immunolabelled 
with anti-Nl antibody and localised with the appropriate secondary FITC
conjugated secondary antibody. Chondrocytes were isolated by sequent!; 
pronase/collagenase digestion from surface middle and deep zone articuk 
cartilage and incubated with M450 tosyl-activated Dynal beads conjugated t 
goat anti-human N l antibody for 4 hours at 4°C. N l selected cells wer 
counted and 4,000 cells ml'1 subjected to differential adhesion to fibronecti 
for 20 minutes. Initial adhesion and CFE were assessed as described above.
In all experiments, results were analysed using Students t test.
Results: Initial adhesion ranged between 3.5% and 14.5% o f the original cel 
number. Significant differences in adhesion were evident between surfac 
zone chondrocytes seeded on fibronectin for 20 minutes (9.05% +/- 0.44) am 
those seeded on PBS coated dishes for 20 minutes (3.83% +/- 0.27; p < 0.001 
and also with those seeded on fibronectin for 40 minutes (4.89% +/- 0.43; p ■ 
0.001). Middle zone chondrocytes were significantly more adherent at 21 
minutes (14.53% +/- 0.86) than at 40 minutes (10.58% +/- 0.51) when seede( 
onto fibronectin-coated dishes (p < 0.01). Additionally, middle zom 
chondrocytes were more adhesive to fibronectin at both time points comparer 
with PBS-coated dishes (p < 0.001). No differences in adhesion wen 
observed between deep zone chondrocytes regardless o f  substrate or timt 
point (p > 0.05 in all cases).
At days 0 and 3, no colonies containing 32 or more cells were present in an) 
sample. At 6 and 10 days, the CFE of surface zone chondrocytes initially 
cultured on fibronectin for 20 minutes was greater than that of the othei 
samples (p < 0.01 at 6 days, p < 0.001 at 10 days). In addition, the CFE ol 
surface zone cells initially cultured for 20 minutes on fibronectin was greater 
at 10 days compared with that at 6 days (p < 0.05). No change in CFE was 
evident between 6 and 10 days for any other sample (p > 0.05 in all cases). 
The average number o f cells per colony was greater in surface zone cells 
initially grown on fibronectin for 20 minutes at both 6 (p < 0.05) and 10 (p < 
0.01) days compared with all other samples. FACS analysis showed elevated 
levels o f both ot5 and p i integrin subunits in surface zone cells compared with 
middle and deep zone cells (p > 0.05).
N l immunolabelling revealed occasional N l positive cells within uppermost 
2-3 cell layers o f the articular cartilage. When surface zone cells were 
isolated and analysed for N l using FACS over 84% o f the surface zone 
population were N l positive and this result was reflected in the cell counts 
obtained after N l selection. Adhesion assays performed using N l selected 
chondrocytes revealed that the N l positive cells were more adherent than 
either negative cells or unselecetd cells (p > 0.05) and that the CFE of N l 
selected cells was increased 4 fold relative to negative cells and unselected 
cells (p > 0.001).
Discussion: The ability o f a population o f  cells to form large numbers o f 
chondrocyte colonies from a low seeding density, differences in a 5 p i integrin 
subunit expression and differentail N l expression when taken together with 
previous results demonstrating the prolonged cell cycle time at the articular 
surface (2), strongly suggest that a subpopulation o f progenitor chondrocytes 
resides in the articular surface. Additionally, the prolonged adhesiveness o f  
mid zone cells, their restricted ability to form large numbers o f colonies and 
their relatively short cell cycle (2) strongly indicates the presence o f transit 
amplifying cells within this zone. Furthermore, the use o f N l selection 
increases the CFE o f surface zone cells seeded on fibronectin fourfoldrelative 
to unselected cells suggesting that N l will be a useful marker in the further 
purification o f chondroprogenitor cells. The eventual isolation and 
purification o f  such a progenitor population will prove to be vital in advancing 
staetegies for cartilage repair.
This work was funded by The Arthritis and Rheumatism Campaign, UK.
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Introduction. The use o f  chondrocytes in cartilage repair strategies is 
hampered by the limited num ber o f  cell divisions a m ature chondrocyte 
will undergo in vitro  This lim ited growth potential in culture is further 
complicated by the rapid loss o f  phenotype, known as dedifferentiation, 
o f  chondrocytes in m onolayer culture characterised by a loss o f  spherical 
morphology and concom itant decrease in collagen II and aggrecan 
synthesis to a  fibroblastic-like m orphology w ith upregulation o f  collagen 
I and versican [1], A lthough the dedififerentiation o f  mature 
chondrocytes can be reversed by transferring cells into an environm ent 
supporting a spherical m orphology eg. pellet culture, alginate o r 3D 
scaffolds, their redifferentiation is rarely com plete. The identification o f 
a cell w ith extensive grow th potential and w hich retains its chondrogenic 
ability after extensive grow th in culture would be a m ajor step forward 
in addressing these issues. O ur research has identified a population o f 
chondroprogenitor cells in the superficial zone o f  articular cartilage with 
an extended cell cycle time, a high affinity for fibronectin in cell 
adhesion assays and an ability to form ©Ionies in vitro  from a low 
seeding density [2], Here we report on the isolation and extensive 
subculture o f  these cells together w ith an evaluation o f  their 
chondrogenic ability at various passages by transfer into pellet culture.
M ethods. Isolation o f  chondroprogenitor cells: C artilage portions were 
isolated from the surface zone articular cartilage o f  2-3 week old bovine 
metatarsophalangeal jo in ts  by fine dissection and sequential digestion in 
pronase (0.1%  w/v; 3 hours) and collagenase (0.04%  w/v; overn igh t) in 
DMEM containing 5%  FCS at 37°C. A fter isolation, 4000 superficial 
zone cells in serum  free DM EM  were seeded into w ells o f  fibronectin 
coated (10pg/m l) 6-well plates and incubated at 37°C  for 20 minutes. 
After 20 minutes, the m edia was rem oved and discarded. Fresh DM EM  
containing 10% FCS w as added to  each well. Expansion in Culture: 
When cells in the 6-well plate were approaching confluency (P0), cells 
were trypsinised and transferred to a 75cm2 culture flask ( P I ) and then 
into a 175cm2 culture flask (P2) when near-confluency was reached. 
Subsequent grow th in 175cm2 culture flasks w as earned  out by continual 
passage at a ratio o f  1:3. A t P0, P2, P5, P8, PI 1 and P22 a liquots o f  cells 
were removed for pellet culture. Detailed accounts o f  cell num bers 
harvested and seeded at each stage were kept throughout the process to 
allow the num ber o f  population doublings at each stage to be calculated. 
Controls for this experim ent consisted o f  norm al chondrocytes isolated 
from the full thickness o f  bovine articular cartilage placed into pellet 
culture immediately after isolation and also following expansion in 
culture to P8 (approx 13 population doublings over 34 days) to dlow  
dedifferentiation. Q uantitative real-tim e PCR (Taqm an) for collagen 1, II 
and aggrecan m RNA was carried out on these control m onolayer 
cultures o f normal bovine chondrocytes in order to confirm  
dedifferentiation had taken place. Pellet C ulture. A liquots o f  250,000 
cells were resuspended in chondrogenesis m edia (see below), gently 
centrifuged in 15ml polypropylene tubes and incubated at 37°C  in a 5%  
CO: atmosphere for 14 days with m edia changes carried out every 2-3 
days. Chondrogenesis m ed ia  DMEM  supplem ented with pen/strep; ITS 
premix; ascorbate 2-phosphate (lOOpM ), dexam ethasone (10 M); and 
T G F |i-l (lOng/m l). Histology a nd  immunolabelling: Pellets were fixed 
overnight in 10% neutral buffered formalin and em bedded in paraffin 
wax. Sections o f  5pm thickness were cut and stained with Safranin 
O/haematoxylin. For im m unolabelling, sections were labelled with 
antibodies to collagen I and II and visualised using appropriate 
secondary FITC conjugated antibodies.
Results. Cellular M orphology: Cultures o f  bovine chondroprogenitor 
cells at P0, P2 and PI 6 consisted mainly o f  cells o f  a polygonal, 
flattened morphology. This morphology was generally maintained, 
although at high passage (P25), a  proportion o f  chondroprogenitor cells 
began to adopt large, often binucleate, irregular morphologies. This is in 
contrast to cultures o f  normal bovine chondrocytes w hich consisted o f  
predominantly spindle-shaped fibroblastic cells up to P8 (34 days). 
Taqman confirm ed dedififerentiation o f  control full thickness bovine 
chondrocytes had taken place in that by 14 days in m onolayer culture
they were expressing negligible levels o f  collagen II and aggrecan 
mRNA and high levels o f  collagen I mRNA. Growth: 
C hondroprogenitor cells underwent approximately 58 population 
doublings over 134 days in culture. At P0 the cells had a doubling time 
o f  approxim ately 24 hours where after the cells m aintained a fairly 
constant rate o f  growth with cells requiring subculture every 3-4 days. 
This was maintained until P28 when the rate o f  growth declined with 
subculture being required every 7-8 days. Pellet Culture: 
C hondroprogenitor cells expanded in culture up to P22 and subsequently 
grow n in pellets synthesised a cartilage-like matrix that stained strongly 
with Safranin O, indicating the presence o f  sulphated proteoglycans 
(figure 1). The periphery o f  the pellets at all time points stained weakly 
with Safranin O but was positive for collagen I. P0, P2, P5, P8 and PI 1 
(PI 1 =  25 population doublings) chondroprogenitor pellets were rich in 
collagen II w hereas pellets derived from P22 (42 population doublings) 
chondroprogenitor cells appeared to contain low amounts o f  collagen II. 
Pellet cultures o f  freshly isolated normal chondrocytes appeared to be 
sm aller in volum e and histologically have less m atrix and rounder cells 
than in chondroprogenitor pellets (figure 2). The matrix stained strongly 
for collagen II. In com parison, pellet culture o f dedifferentiated normal 
chondrocytes at P8 (13 population doublings) synthesised a greater 
am ount o f  matrix but this stained less strongly for safranin O and 
contained negligible collagen II.
Figure 1: Pellet culture o f  culture expanded chondroprogenitor cells. 
Safranin O  staining. Collagen II im m unostaining inset. Bar =  200pm.
F0 1 P2 - £  M P5
P8
Figure 2: Pellet culture o f  freshly isolated and also culture expanded 
normal chondrocytes. Safranin O  staining. Collagen II immunostaining 
inset. B ar = 200pm .
I I
Freshly isolated P8
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Discussion. This study has demonstrated the high expansion potential o f 
articular cartilage progenitor cells in comparison to normal bovine 
chondrocytes. The cells retain the ability to synthesise a  cartilage-like 
hyaline m atrix rich in collagen II even after 11 passages which equated 
to 25 population doublings. Some collagen II was also evident at P22 
(42 population doublings). In this study, normal chondrocytes isolated 
from bovine articular cartilage rapidly dedifferentiated in m onolayer and 
had completely lost the ability to redifferentiate in pellet culture at P8 
(13 population doublings) although it remains to be seen whether this 
loss o f  redifferentiation potential had occurred at an earlier stage o f 
expansion. The enhanced potential o f  these articular cartilage progenitor 
cells to retain the ability to form cartilage after extensive expansion in 
culture is a  m ajor step forward for cartilage repair as it may enable the 
generation o f  large cell banks for use in allogeneic tissue engineering 
applications. Investigations are currently focusing on em ploying these 
cells in cartilage repair strategies.
References. [1] Von der Mark et a! (1977) Nature 267:531-532. [2] 
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INTRO DUCTIO N: Current strategies in cartilage 
repair are based on the transplantation o f cells from 
a variety o f  sources into the defect in question in 
order to generate a functional repair tissue. 
Difficulties arise in the use o f  chondrocytes due to a 
limited mitotic ability o f  mature chondrocytes in 
vitro and rapid loss o f  phenotype, known as 
dedifferentiation, in monolayer culture [1]. Previous 
research has identified a population o f  articular 
cartilage progenitor cells in the superficial zone o f  
articular cartilage with an extended cell cycle time, 
a high affinity for fibronectin in cell adhesion 
assays, ability to form colonies in vitro from a low  
seeding density [2]. Here we report on the isolation 
and extensive subculture o f these cells together with 
an evaluation o f their chondrogenic ability at 
various passages by transfer into pellet culture.
M ETHODS: Cell isolation: Superficial zone cells 
were isolated by sequential digestion in pronase and 
collagenase o f  superficial zone cartilage from the 
articular cartilage o f 2-3 week old bovine 
metatarsophalangeal joints. After isolation, 4000  
superficial zone cells in serum free DMEM were 
seeded into wells o f  fibronectin coated 6-well plates 
and incubated at 37°C for 20 minutes. After 20  
minutes, the media was removed and discarded. 
Fresh DMEM containing 10% FCS was added to 
each well. Expansion in Culture: Cells were 
subsequently transferred into 75cm2 and 175cm2 
culture flasks. Growth was maintained by continual 
passaging at a ratio o f  1:3. At various passages 
aliquots o f cells were removed for pellet culture and 
Real-time PCR (Taqman). Controls consisted o f  
normal chondrocytes isolated from the full thickness 
o f bovine articular cartilage. Pellet Culture'. 
Aliquots o f  250,000 cells were resuspended in a 
serum free chondrogenic media containing TGFp-1 
and centrifuged to form a pellet. Pellets were 
incubated for 14 days and then paraffin embedded 
and sections stained with Safranin O/haematoxylin 
and immunolabelled with antibodies to collagen I 
and II. Taqman was used to quantify expression o f  
collagen I, II, aggrecan and versican mRNA in the 
pellets.
RESULTS: Growth: Articular cartilage progenitor 
cells underwent approximately 61 population 
doublings over 162 days in culture. At P0 the cells 
had a doubling time o f  approximately 24 hours 
where after the cells maintained a moderately 
constant rate o f growth with cells requiring 
subculture every 3-4 days. This was maintained 
until P28 when the rate o f growth declined with 
subculture being required every 7-8 days. After P35 
cell growth had virtually stopped. Pellet Culture: 
Articular cartilage progenitor cells expanded up to 
P22 and grown in pelleted micromasses synthesised 
a hyaline-like cartilage matrix that stained strongly 
with Safranin O. PI, P3, P6, P9 and P12 (25 pop 
doublings) pellets were rich in collagen II protein 
and mRNA whereas pellets derived from P22 (42 
population doublings) cells contained low levels of 
collagen II. Pellet cultures o f freshly isolated 
normal chondrocytes also stained strongly with 
Safranin O and contained abundant collagen II. 
Dedifferentiated normal chondrocytes at P8 
contained negligible collagen II.
DISCUSSIO N & CONCLUSIONS: Although 
this study has illustrated the high expansion 
potential o f articular cartilage progenitor cells, 
more importantly, the cells retain the ability to 
synthesise a cartilage-like hyaline matrix rich in 
collagen II even after 12 passages (25 pop 
doublings). In contrast, normal bovine articular 
chondrocytes rapidly dedifferentiated in monolayer 
and completely lost the ability to redifferentiate in 
pellet culture at P8 (13 pop. doublings). This 
important property to retain the ability to form 
cartilage after extensive expansion in culture may 
enable the generation o f  large cell banks for use in 
allogeneic tissue engineering applications. 
Investigations are currently focusing on developing 
human articular cartilage progenitor cells isolation 
and expansion protocols and employing these cells 
in cartilage repair strategies.
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Summary
It is becoming increasingly apparent that articular 
cartilage growth is achieved by apposition from the 
articular surface. For such a mechanism to occur, a 
population of stem/progenitor cells must reside within the 
articular cartilage to provide transit amplifying progeny 
for growth. Here, we report on the isolation of an articular 
cartilage progenitor cell from the surface zone of articular 
cartilage using differential adhesion to fibronectin. This 
population of cells exhibits high affinity for fibronectin, 
possesses a high colony-forming efficiency and expresses 
the cell fate selector gene Notch 1. Inhibition of Notch 
signalling abolishes colony forming ability whilst activated
Notch rescues this inhibition. The progenitor population 
also exhibits phenotypic plasticity in its differentiation 
pathway in an embryonic chick tracking system, such that 
chondroprogenitors can engraft into a variety of connective 
tissue types including bone, tendon and perimysium. 
The identification of a chondrocyte subpopulation with 
progenitor-like characteristics will allow for advances 
in our understanding of both cartilage growth and 
maintenance as well as provide novel solutions to articular 
cartilage repair.
Key words: Cartilage, Progenitor cell, Notch
Introduction
Articular cartilage is an avascular, aneural tissue with a high 
matrix to cell volume ratio. The matrix comprises mainly type 
II collagen fibres and the high molecular weight aggregating 
proteoglycan aggrecan. The tissue is not, however, 
homogeneous with biochemical and morphological variations 
existing from the surface zone to the deeper calcified layer. The 
surface zone of the tissue is characterised by flattened, discoid 
cells that secrete surface zone proteoglycan (proteoglycan 4) 
(Schumacher et al., 1994). The mid zone of the tissue 
comprises rounded cells arranged in perpendicular columns 
and in addition to type II collagen and aggrecan, expresses 
cartilage intermediate layer protein (CILP) (Lorenzo et al.,
1998). The deep zone and calcified zone chondrocytes express 
type X collagen and alkaline phosphatase (Schmid and 
Linsenmayer, 1985), and in the deep zone the chondrocytes are 
considerably larger than in the other zones.
Clearly, the differentiation and proliferation events occurring 
during the development of articular cartilage must, therefore, 
be strictly controlled both temporally and spatially in order for 
the distinct zonal architecture of the tissue to be established. 
Various studies have shown that the surface zone of articular 
cartilage is centrally involved in the regulation of tissue 
development and growth. Not only does the surface of articular 
cartilage play a major role in the morphogenesis of the
diarthrodial joint via differential matrix synthesis (Ward et al., 
1999), but file expression of many growth factors and their 
receptors at the articular surface (Archer et al., 1994; Hayes et 
al., 2001) suggest that this region represents an important 
signalling centre. In addition, it has been shown in vivo that 
the surface zone of articular cartilage is responsible for the 
appositional growth of articular cartilage and from these 
studies we hypothesised that the surface zone of articular 
cartilage contains a progenitor/stem cell population that allows 
for the appositional growth of the tissue (Hayes et al., 2001). 
Identification of such cells holds exciting possibilities in the 
field of cartilage tissue engineering because the tissue has 
limited inherent reparative capacity after trauma (Hunziker,
1999). Here, we describe the isolation and partial 
characterisation of a specific articular cartilage progenitor cell 
using a previously described differential adhesion assay (Jones 
and Watt, 1993).
Materials and Methods
Cell isolation, differential adhesion  a ssa y  and tissu e culture 
Petri dishes (35 mm) were coated with 10 pg ml-1 bovine fibronectin 
(FN; Sigma, UK) in 0.1 M phosphate buffered saline (PBS, pH 7.4) 
containing 1 mM MgCk and 1 mM CaCh (PBS+) overnight at 4°C. 
Dishes were blocked with 1% bovine serum albumin (BSA) in PBS+
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before chondrocytes were added. Control dishes were treated with 
PBS+ containing 1% BSA overnight at 4°C.
Previous studies have utilised differential adhesion to fibronectin in 
vitro to identify epidermal stem cells (Jones and Watt, 1993). 
Fibronectin is expressed in developing mammalian articular cartilage 
in addition to the classic fibronectin receptor integrin subunits a5 and 
Pi (Hynes, 1992). We therefore utilised fibronectin in an in vitro 
adhesion assay to identify and partially characterise articular cartilage 
progenitor cells. Chondrocytes were isolated from the surface, middle 
and deep zones of articular cartilage of 7-day-old calves by sequential 
pronase/collagenase digestion as previously described (Archer et al., 
1990). After isolation, chondrocytes (4000 ml-1) were seeded onto 35 
mm plastic Petri dishes at 37°C for 20 minutes in 1:1 DMEM/F12 
containing 0.1% Gentamycin (DMEM/F12-). After 20 minutes, 
media (and non-adherent cells) was removed and placed in a second 
dish for 40 minutes at 37°C before this media (and non-adherent cells) 
was removed and placed in a third dish. After removal of media at 20 
and 40 minutes, fresh 1:1 DMEM/F12 containing 0.1% Gentamycin, 
0.5 |ig ml-1 ascorbate, 1 |ig ml-1 glucose and 10% foetal calf serum 
(FCS; DMEM/F12+) was added to the remaining adherent cells which 
were maintained in culture for up to 10 days. In all experiments, six 
fibronectin-coated dishes and six untreated dishes were used for each 
time point and for each zone of cartilage. Controls comprised cells 
subjected to differential adhesion on dishes coated with 1% BSA in 
PBS+.
For Notch 1 selection, magnetic tosyl-activated Dynal Beads 
(Dynal, UK) were coated with polyclonal anti-Notch 1 antibody (5 jig 
ml-1; Santa Cruz, CA) following the manufacturer’s instructions. 
Freshly isolated chondrocytes from the surface, middle and deep zone 
were incubated with antibody-coated beads for 30 minutes at 4°C and 
separated from Notch-negative cells using a powerful magnet. Non­
magnetic cells were aspirated and Notch-positive cells washed three 
times in PBS before isolated cells were resuspended in DMEM/F12 
and the purified cells counted using a haemocytometer. Notch 1- 
positive cells were then subjected to differential adhesion on 
fibronectin for 20 minutes (4000 cells ml-1 in 35 mm dishes as 
described above), and initial adhesion and colony forming efficiency 
assayed up to 10 days as described below.
Within 3 hours of plating, initial chondrocyte adhesion was assayed 
by counting the total number of cells adhering to the bottom of the 
dish using an inverted microscope equipped with phase contrast optics 
and expressed as a percentage of the initial seeding density. Colonies 
(defined as consisting of more than 32 chondrocytes) were counted 
using the same microscope at 3, 6 and 10 days. Thirty-two cells were 
chosen as this represents a population of cells derived from more than 
5 population doublings of a single cell, thereby discounting a transit 
amplifying cell (Jones and Watt 1993). Colony forming efficiency 
(CFE) was calculated by dividing the number of colonies by the initial 
number of adherent cells. In some experiments (n=3), the number of 
cells per colony was counted to determine the average number of cells 
per colony. Results were analysed using the Student’s t-test. However, 
for comparative purposes, we also analysed the data in terms of 
colonies comprising more than 4 cells.
For y-secretase inhibition studies, cells were isolated and subjected 
to differential adhesion to fibronectin as described above. Cells 
were maintained in media containing 50 nM N-[N-(3,5- 
diflurophenylacetate)-L-alanyl]-(S)-phenylglycine t-butyl ester 
(DAPT) (Dovey et al., 2001) in 0.1% DMSO for 7 days with media 
changes every 48 hours. Initial adhesion and CFE were assayed as 
described.
For explant cultures, full-depth cartilage chips were removed and 
bisected. One half of each explant was cultured in the presence of 50 
nM DAPT in DMEM/F12+ and 0.1% DMSO for 7 days, whereas the 
other half of the explant was cultured in DMEM/F12+ and 0.1% 
DMSO. Media was changed every 48 hours and samples fixed in 10% 
NBFS, wax embedded and stained with toluidine blue. Sections were 
examined using brightfield optics and digital images obtained. A
calibrated grid was then used to count the number of cells 0-100 p.m 
and 101-200 jim from the articular surface. Results were analysed 
using the Student’s t-test.
In separate experiments, explants were excised and cut in half. Half 
of each explant was maintained in 50 nM DAPT and the other half 
was maintained in control media as described above for 7 days. On 
days 4, 5 and 6, the thymidine analogue bromodeoxyuridine (BrdU; 
final concentration 50 mM) was added to control and experimental 
media in order to identify s-phase chondrocytes. Explants were 
removed after 24, 48 and 72 hours’ incubation in BrdU, fixed in 10% 
formalin and wax embedded. Dewaxed sections were then 
immunolabelled with monoclonal anti-BrdU (5 pg ml-1 in PBS) and 
localised using goat anti-mouse fluorescein-conjugated secondary 
antibody.
Im munocytochemistry
Chondrocytes were labelled with antibodies raised against ot5 and |5l 
integrin subunits after sequential pronase/collagenase digestion and at 
various time points after differential adhesion. Briefly, chondrocytes 
(2x10s cells ml-1) were fixed in 95% ice-cold ethanol for 10 minutes 
and washed in PBS. The cells were incubated with primary antibodies 
diluted in PBS (2 jig ml-1) for 1 hour at room temperature, washed three 
times in PBS and incubated with appropriate FITC-conjugated 
secondary antibodies (2 pg mH) diluted in 20% heat inactivated foetal 
calf serum in PBS. Cells were washed in PBS and mounted in 
Vectashield containing 1.0 mg mP1 propidium iodide. Cells were then 
observed and photographed using a fluorescent microscope. To 
determine integrin, FN-extra domain A (EDA) and Notch 1 expression 
in vivo, full-depth articular cartilage was excised from 7-day-old bovine 
metacarpal-phalangeal joints and chilled by precipitate immersion in n- 
hexane at -80°C. Cryostat sections (10 pm) were cut on a Bright’s 
cryostat and collected on APES (3-aminopropyltriethoxysilane)-coated 
slides and stored at -20°C. Sections were defrosted, post-fixed in ice- 
cold acetone for 5 minutes, washed in PBS and incubated with primary 
antibody diluted in PBS/0.01% Tween 20 (PBST) for 1 hour at room 
temperature. After washing in PBST, sections were incubated with 
relevant FTI’C-conjugated antibodies diluted in 20% heat-inactivated 
FCS in PBST for 1 hour before washing three times with PBST and 
mounting in Vectashield. Labelled sections were examined and 
photographed using either a Zeiss or an Olympus photomicroscope 
fitted with epifluorescent optics.
Flow cytometry
To assess integrin expression before differential adhesion, freshly 
isolated chondrocytes were incubated in fresh DMEM/F12- at 37°C 
on a roller prior to labelling for FACS analysis. After differential 
adhesion, chondrocytes were removed from dishes non-enzymatically 
(Sigma) and labelled for FACS analysis. All samples were counted 
and 2x10s cells were incubated for 3 hours with antibodies to cx5 and 
pi integrin subunits and Notch 1 in sextuplicate at room temperature. 
Cells were centrifuged at 500 g, supernatants removed and cells 
washed three times in PBS with centrifugation between each wash. 
Cells were then incubated with relevant FITC-conjugated secondary 
antibodies for 1 hour at room temperature and washed three times in 
PBS as described above. Finally, labelled cells were re-suspended in 
200 nl PBS and subjected to single channel FACS analysis.
Notch intracellular domain (NICD) transfection
Activated Notch constructs (Notch ICv) were obtained from Raphael 
Kopan (University of Washington) (Schroeter et al., 1998). Surface 
zone chondrocytes were subjected to differential adhesion to 
fibronectin and grown in the presence of 50 nM DAPT for 3 days. 
Excess (1 |xg) plasmid DNA was transiently transfected into surface 
zone chondrocytes 3 days after differential adhesion using Effectene
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plasmid DNA (1 pg VSV-G and 1 pg lacZ) was 
resuspended in 148 pi condensation buffer and vortexed, 
16 pi of enhancer reagent was added, mixed and 
incubated at room temperature for 5 minutes. Following 
incubation, 50 pi of Effectene reagent was added to the 
solution, mixed and after 10 minutes’ incubation at room 
temperature, 1 ml of DMEM/F12+ was added. The 
solution was mixed and the suspension added drop-wise 
to 293GP cells. Transfected cells were cultured for 3 days 
in DMEM/F12+ and viral supernatants collected after 3 
days and frozen at -80°C.
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Fig. 1. Frozen sections (A.B) and isolated chondrocytes (C-F) from 7-day bovine 
articular cartilage immunolabelled for a5 (A,C,E) and p i (B.D,F) integrin 
subunits. a5 and pi integrin subunits are localised throughout the depth of the 
articular cartilage (A,B) although not every chondrocyte is labelled. Isolated 
chondrocytes from surface zone immediately after sequential pronase/collagenase 
isolation labelled with antibody to alpha a5  (C) and pi (D) subunits. Labelling for 
a5 (E) and pi (F) is also present 72 hours after differential adhesion to fibronectin. 
Fibronectin-EDA was localised in frozen tissue sections to the surface 2-3 cell 
layers (G). Integrin oc5 and pi subunit expression was assessed by flow cytometry 
after sequential pronase/collagenase digestion (4 hours) and 72 hours after 
differential adhesion assay to fibronectin (H). At 4 hours and 72 hours, there was 
no difference in integrin subunit expression between surface zone chondrocytes 
(P>0.05), although during this time period the overall expression of a5 and pi 
subunits was significantly decreased (P<0.01). At 4 hours, middle zone 
chondrocytes had a higher expression of P5 subunits relative to P 1 subunits 
(P<0.01), although there was no difference in expression after 72 hours (P>0.05).
reagent (Qiagen), and colonies consisting of more than 32 cells were 
counted 10 days after differential adhesion and colony forming 
efficiency calculated.
Chondroprogenitor cell isolation and infection
Surface and deep zone chondrocytes were isolated from 
7-day-old bovine articular cartilage using sequential 
pronase/collagenase digestion and 5xl06 cells subjected 
to differential adhesion to FN (10 jig ml-1 in PBS+) in 60 
mm dishes for 20 minutes. Non-adherent cells were 
aspirated and chondrocytes were cultured for up to 5 days 
prior to infection. Chondrocytes were infected with 
pseudotyped retrovirus-conditioned media (5-6x106 CFU 
ml-1) containing 10 pg ml-1 polybrene for 24 hours prior 
to injection. Media was removed and cells washed in 
DMEM containing no additives, trypsinised, centrifuged 
and resuspended at 1x10s cells 10 pH .
In ovo injections and tissue processing
After harvesting, 10 pi aliquots of cell suspension 
containing lxlO5 cells (both surface and deep zone 
derived) were immediately injected into the proximal or 
distal wing bud of 3-day-old (Stage 12-14) (Hamburger 
and Hamilton, 1951) chick embryos which had been 
previously windowed. Eggs were resealed with adhesive 
tape and re-incubated for various times up to day 10 
(Stage 36-37). Embryos were killed by cervical 
dislocation, a note of their developmental stage taken and 
embryos washed in 0.1 M PBS (pH 7.4). After washing, 
embryos were fixed in 2.5% paraformaldehyde in 0.1 M 
PBS (pH 7.4) for 1 hour at room temperature followed by 
3x20 minute washes in 0.1 M PBS containing 2 mM 
MgCL, 0.01% deoxycholic acid and 0.02% igepal 
[(Octylphenoxy)polyethoxyethanol, pH 7.4]. Embryos 
were then reacted at 37°C overnight for lacZ in 0.1 M 
PBS containing 2 mM MgCh, 0.01% deoxycholic acid, 
0.02% igepal, 5 mM potassium ferricyanide, 5 mM 
potassium ferrocyanide, 1 mM spermidine 
trihydrochloride and 1 mg ml-1 X-gal previously 
solubilised in DMSO. Embryos were washed extensively 
in 0.1 M PBS, post-fixed in 10% NBFS overnight and 
wax embedded. Serial wax sections (8-10 pm) were taken 
onto 3-aminopropyl triethoxy silane-coated slides air 
dried overnight, dewaxed, stained with 1% eosin for 15 
seconds and examined under bright field microscopy after 
coverslipping. In separate experiments, immuno­
cytochemistry using antibody to bacterial gene product was performed 
as a control against endogenous P-galactosidase activity and also to 
co-localise bovine-specific type I collagen within engrafted tissues.
Culture and transient transfection of 293GP packaging cells
293GP cells expressing the gag and pol proteins (Burns et al., 1993) 
were cultured to 70-80% confluency in DMEM/F12 containing 0.5 
mg ml-1 Gentamycin and 10% FCS. Cells were then transfected with 
1 pg plasmid DNA encoding VSV-G and lacZ using the Quiagen 
Effectene kit following the manufacturer’s instructions. Briefly,
Results
Initially, we examined integrin and fibronectin expression in 7- 
day-old bovine articular cartilage using immunocytochemistry 
and flow cytometry (Fig. 1). Both a5  and p i integrin subunits 
were expressed in the majority o f chondrocytes at the surface
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Table 1. Initial adhesion of chondrocytes to fibronectin
T r e a tm e n t
A d h e s io n  t im e S F N S P B S M F N  M P B S D F N D P B S
2 0  m in u te s  
4 0  m in u te s
9 . 0 5 % ± 0 . 4 4 * 4
4 .8 9 % ± 0 .4 3
3 .8 3 % ± 0 .2 7  
4 . 1 2 % ± 0 .3 4
M ^ S h t O - S b ^ - l  3 .9 4 % ± 0 .1 9  
1 0 .8 5 % ± 0 .5 1 n  4 .2 % ± 0 . 1 9
3 .5 9 % ± 0 .2 2
3 .9 5 % ± 0 . 3 0
3 .6 8 % ± 0 .2 3
4 .2 1 % ± 0 . 3 6
I n i t i a l  a d h e s io n  to  f ib ro n e c t in  a n d  P B S -c o a te d  d is h e s . C h o n d ro c y te s  w e re  p la te d  as d e s c r ib e d  in  th e  M a te r ia ls  a n d  M e th o d s  a n d  a s s a y e d  fo r  c e l l  a d h e s io n  a t 2 0  
a n d  4 0  m in u te s . D ,  d e e p ; F N ,  f ib ro n e c t in -c o a te d  d ish es ; M ,  m id d le ;  P B S , P B S -c o a te d  d is h e s ; S , s u rfa c e . * P < 0 .0 0 1  c o m p a re d  w i th  4 0  m in u te s ;  +P < 0 .0 1  
c o m p a re d  w i th  4 0  m in u te s ; * P < 0 .0 0 1  c o m p a re d  w ith  P B S  c o n tro l;  §P < 0 .0 1  c o m p a re d  w i th  s u rfa c e  F N  2 0 ;  ^ P c O .O O l c o m p a re d  w i th  d e e p  F N  2 0 .
of the tissue with decreasing label intensity and decreasing 
numbers of chondrocytes labelled in the deeper zones of the 
cartilage (Fig. 1A,B). Using chondrocytes immediately after 
isolation and at various times after differential adhesion, 
surface, middle and deep zone chondrocytes were shown to 
express a5  and |3l subunits at all time points analysed 
regardless of substrate although differences in labelling 
intensity and the number of labelled cells were noted (Fig. 1C- 
F and data not shown). FN-EDA was localised pericellularly 
within the surface 2-3 cell layers of the articular cartilage (Fig. 
1G). Using flow cytometry immediately after isolation and 4 
hours after differential adhesion (Fig. 1H), (31 subunits were 
shown to be preferentially expressed by surface zone 
chondrocytes (88%±4.8) compared with middle (67%±2.1) 
and deep (62%±3.7) zone chondrocytes. Substantially more 
cells in the surface zone expressed a5 subunits (79%±4.8) 
compared with middle (5%±2.1) and deep (2.5%±1.7) zone 
chondrocytes.
Next, we assessed the degree of chondrocyte adhesion to 
fibronectin (Table 1). Surface and middle zone chondrocytes 
were more adherent to fibronectin than the other cohorts 
examined at 20 minutes. Initial adhesion ranged between 3.5% 
and 14.5% of the original cell number. Significant differences 
in adhesion were evident between surface zone chondrocytes 
plated on fibronectin for 20 minutes and those plated on 
fibronectin for 40 minutes (PcO.OOl) and cells cultured on 
BSA-coated dishes for 20 minutes (P<0.001). Middle zone 
chondrocytes were significantly more adhesive at 20 minutes 
than at 40 minutes when plated on fibronectin-coated dishes 
(P<0.001). In addition, middle zone chondrocytes were more 
adhesive to fibronectin at both time points compared with 
BSA-coated dishes (PcO.OOl). No differences in adhesion 
were observed between deep zone chondrocytes regardless of 
substrate or time point (P>0.05 in all cases).
If these cells with a high affinity for fibronectin are a 
population of chondroprogenitor cells then they should have 
the ability to form large numbers of colonies from an initially 
low seeding density, as is the case in other tissues with a clearly 
defined stem cell population (Jones and Watt 1993). To 
determine the clonality of the adhesive chondrocytes, we 
counted the number and size of colonies of chondrocytes 
subjected to differential adhesion to fibronectin (Fig. 2A). 
Differences in the initial adhesion of surface zone cells were 
reflected in CFE at 6 and 10 days that was not matched by the 
CFE of middle zone cells (Fig. 2B). The CFE of surface zone 
chondrocytes initially cultured on fibronectin for 20 minutes 
was greater than that of all other samples (P<0.01 at 6 days 
and P<0.001 at 10 days) when we applied the definition of a 
colony as being more than 32 cells. Indeed, using the criteria 
of 32 cells as indicative of a colony, no colonies were present
in any other cohort besides surface zone cells initially plated 
on fibronectin. Using 4 cells as being indicative of a colony for 
comparative purposes, the same trend is apparent with surface 
zone cells subjected to differential adhesion to fibronectin for 
20 minutes having a significantly enhanced CFE at both 6 and 
10 days relative to all other cohorts (Fig. 2C,D). In addition, 
the average number of cells per colony was greater in surface 
zone cells initially grown on fibronectin for 20 minutes at both 
6 (Fig. 2E) (P<0.05) and 10 (Fig. 2F) (P<0.01) days compared 
with all other samples.
These results suggest that a subpopulation o f cells within the 
surface zone have the properties of a progenitor cell. Other 
studies in our laboratory using BALBc mice had identified 
Notch family members within the surface zone of developing 
articular cartilage and that Delta was widely distributed 
through the remainder o f the tissue (Hayes et al., 2003). These 
studies suggested that Notch 1 was a suitable marker for the 
chondroprogenitor population and immunolabelling of bovine 
cartilage with a panel of antibodies to Notch family members 
revealed the presence of Notch 1 in the surface 2-3 cell layers 
of 7-day bovine articular cartilage (Fig. 3A), although not all 
cells within this layer were labelled. Another cohort of Notch 
1-positive cells was also observed in the mid and deep zone of 
the tissue. Using flow cytometry, we showed that 86% of the 
surface zone cells isolated by pronase/collagenase digestion 
were Notch 1-positive compared with 10% and 34% from the 
middle and deep zone, respectively (Fig. 3B). Using Dynal 
Bead capture of Notch 1-positive surface zone chondrocytes, 
we showed that a Notch 1-enriched population o f chondrocytes 
had both an increased adhesion to fibronectin (P<0.01) 
(Fig. 3C) and an increased CFE (P<0.05) (Fig. 3D) relative 
to unselected cells. These data suggest that the Delta/ 
Notch signalling pathway may have a major influence in 
controlling both chondrocyte colony forming efficiency and 
differentiation.
To determine the role of Notch signalling in the colony 
forming ability of surface zone chondrocytes we cultured 
surface zone cells in the presence of a y-secretase inhibitor, 
DAPT (Dovey et al., 2001), which is known to bind to the 
active site of presenillin in the y-secretase complex and not 
interfere with (3-catenin-mediated signalling (Kornilova et al., 
2003). The y-secretases are responsible for the cleavage of the 
amyloid precursor protein during the progression of 
Alzheimer’s disease and are also responsible for the 
intramembranous cleavage of Notch receptors (Berezovska et 
al., 2000). Because of their role in Alzheimer’s disease 
progression, much interest has focused on the development of 
Y-secretase inhibitors (Dovey et al., 2001), which not only 
prevent the accumulation of amyloid plaques but also prevent 
Notch family signalling (Berezovska et al., 2001). Treatment
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F i g .  2 .  Chondrocytes were subjected to differential adhesion to 
fibronectin as described in the Materials and Methods, and 
colonies consisting of more than 32 cells were counted at 6 and 
10 days and the results expressed as colony forming efficiency as 
described in the Materials and Methods. (A,B) Colonies initially 
appeared at 6 days in samples derived from the surface zone 
subjected to differential adhesion to fibronectin for 20 minutes 
and the CFE of this cohort had increased by 10 days. Using 4 
cells as being indicative of a colony the same trend was apparent, 
with surface zone cells subjected to differential adhesion to 
fibronectin for 20 minutes showing enhanced CFE at both 6 and 
10 days (C,D). Colony size of surface (S), middle (M) and deep 
(D) zone chondrocytes was also assessed at 6 (E) and 10 (F) 
days. Cells were plated and the number of cells per colony was 
counted at 6 and 10 days. Surface zone chondrocytes formed 
bigger colonies when plated onto fibronectin for 20 minutes 
(SFN 20) at both 6 (E) and 10 (F) days than any other sample. 
There was no difference in colony size within any other cohort at 
either time point. In addition, the colony size of surface zone 
cells plated on fibronectin for 20 minutes was increased at 10 
days compared with 6 days and there was no increase within any 
of the other cohorts. *P<0.01 compared with 6 days;
**F<0.01 compared with all 
other cohorts at the same time 
point; ***P<0.001 compared 
with all other cohorts at the 
same time point. Abbreviations 
as in Table 1.
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with DAPT did not affect the initial adhesion o f chondrocytes 
to fibronectin (Fig. 4A), but abolished clonality at both 6 and 
10 days compared with controls when the 32 cell definition was 
applied (Fig. 4B) such that CFE was equal to that o f  deep zone 
chondrocytes. NICD was able to rescue colony abolition when 
added to DAPT-treated cultures after 3 days (P<0.05) (Fig. 4C) 
but NICD transfection did not increase colony forming 
efficiency compared with controls (P>0.05) (Fig. 4C). Culture 
of cartilage explants in the presence o f 50 nM DAPT for 7 days 
produced a region o f  hypocellular, weakly stained matrix 
immediately beneath the surface zone (Fig. 4D,E). The region 
101-200 pm from the articular surface contained fewer cells in 
DAPT-treated samples compared with controls (P<0.05) (Fig. 
4D-F), whereas there was no difference in cell number 0-100
pm from the articular surface (P>0.05) (Fig. 4D-F). In 
addition, it was shown that incubation of explants in 50 nM 
DAPT prevented cell proliferation as there was no evidence of 
BrdU incorporation in any of the treated samples examined 
(n=24) (Fig. 4G,H).
In order to assess the differentiation potential o f the 
progenitor population, we infected a lineage label into the cells 
and injected them into the proximal limb o f stage 22 chick 
embryos and tracked them for 1 week in ovo. Twenty-four 
hours after injection, (3-galactosidase-positive cells were 
present in positions corresponding to the original injection site 
(Fig. 5A,B). Examination o f embryos injected with labelled 
deep zone cells gave variable results. Labelled cells were either 
absent suggesting that the cells could not survive in the chick
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articular cartilage labelled 
with antibody to Notch 1 (A) 
and counterstained with 
propidium iodide.
Chondrocytes within the 
uppermost 2-3 cell layers of 
the surface zone (arrows) 
label strongly for Notch 1.
Chondrocytes were labelled 
with anti-notch 1 antibody 
and subjected to single­
channel FACS analysis 
immediately after isolation 
(B). 86% of surface zone cells 
label positively for N 1 
compared with 10% and 34% 
from middle and deep zone, 
respectively. (*P<0.001 
compared with middle and 
deep.) Chondrocytes were 
selected immunomagnetically 
and subjected to differential 
adhesion and initial adhesion 
and CFE assessed. Notch 1 -
selected surface zone cells (SFN N l) were more adherent than Nl-selected middle (MFN N l) and deep zone (DFN N l) cells and unselected 
cells (SFN 20, MFN 20, DFN 20) (C). In addition, the CFE of surface zone cells selected for N 1 was greater than notch-positive middle and 
deep zone cells and unselected cells (D). *P<0.001 compared with middle and deep, **P<0.001 compared with Nl selected and unselected 
middle and deep cells, ***P<0.01 compared with unselected surface zone cells, ****P<0.01 compared with selected and unselected middle 
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embryos, or if cells were present they were seen as masses of 
labelled cells in loose connective tissue not integrated into 
surrounding host tissue (Fig. 5K).
Examination of embryos incubated to 10 days (Stage 36) 
revealed (3-galactosidase-positive cells in numerous tissue 
types, including cartilage, bone, tendon and muscle connective 
tissues (Fig. 5C-F). The sites of these positive cells 
corresponded with the sites of injection such that proximal 
injections gave (3-galactosidase-positive cells in proximal 
tissues and distal injections revealed (3-galactosidase-positive 
cells in distal structures. Furthermore, if cells were injected 
into the central proximal region of the limb bud, cells engrafted 
into the humerus. More lateral injections engrafted into 
tendons and perimysim. In order to test for functional 
engraftment, we used an antibody specific for bovine type I 
collagen. We found that in tendon, parallel arrays of fibrillar 
collagen ran along the tendon length (Fig. 5H) contrasting with 
dense immunofluorescence in the subperiosteal bone (Fig. 5J). 
In addition, both the perichondrium and articular fibrocartilage 
(Fig. 5G) and the perimysium (Fig. 5H) labelled with anti- 
bovine type I collagen antibody.
Discussion
Using differential adhesion to serum fibronectin, we have 
described the isolation and partial characterisation of a 
subpopulation of articular cartilage chondrocytes with 
properties akin to those of a progenitor cell and that are able to 
engraft into a variety of tissue types, albeit of the connective 
tissue lineage. These cells reside within the surface zone of 
articular cartilage, where the EDA isoform of fibronectin is
differentially expressed and the cells have an extended cell cycle 
time (Hayes et al., 2001). This sub-population of surface zone 
cells has a high affinity for serum fibronectin but not other 
ligands, e.g. collagen types I, II and IV. laminin and tenascin 
(J.C.B., G.P.D. and C.W.A., unpublished results), and were 
capable of forming large numbers of colonies from an initially 
low seeding density, unlike cells isolated from the middle zone 
which also have high fibronectin affinity. The initial adhesion 
of surface zone chondrocytes to fibronectin can be explained by 
their high expression of a5(3l integrin subunits, the ‘classical’ 
fibronectin receptor (Hynes, 1992). This high level of a5|3l 
expression and affinity for fibronectin does not, however, 
provide a marker of the cells’ colony forming ability. Middle 
zone chondrocytes exhibit higher affinity for fibronectin than 
surface zone cells (~15% middle compared with ~10% surface) 
(Table 1), but lack the ability to form colonies (Fig. 2) and may 
represent a transit amplifying population. In addition, the 
percentage of cells that possess a high colony forming 
efficiency within the surface zone (approximately 1-2% of the 
initial number adhered) is only a fraction of the number of 
cells expressing a5(3l subunits (approximately 75%), for this 
reason we could not use a5(3l integrin expression as a 
chondroprogenitor marker.
Previous studies have documented the expression of Notch 
family members during articular cartilage and growth plate 
development (Hayes et al., 2003; Crowe et al., 1999). Of 
particular interest was the specific expression of Notch 1 at the 
developing articular surface of mouse knee joints (Hayes et al., 
2003). This specific expression in the surface zone of articular 
cartilage suggested that Notch 1 may provide a marker for 
colony forming cells in the bovine model used in the present
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study. Indeed, Notch 1 expression in immature bovine articular 
cartilage matches that in developing mouse articular cartilage, 
such that in both species, Notch 1 is present in the chondrocytes 
of the surface zone articular cartilage to a depth o f 2-3 cells (see 
Fig. 3) (Hayes et al., 2003). Flow cytometry o f freshly isolated
chondrocytes revealed that Notch 1 expression was significantly 
increased in surface zone chondrocytes and these high levels o f  
Notch 1 expression were maintained in surface zone cells after 
differential adhesion, relative to middle and deep zone 
chondrocytes. Using magnetic immunoselection, Notch 1-
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positive cells were isolated from bovine articular cartilage and 
subjected to differential adhesion. Surface zone cells thus 
isolated had a higher affinity for fibronectin than Nl-selected  
middle and deep zone cells and unselected cells (Fig. 3). These
Fig. 5. lacZ-infected chondrocytes were injected into the w ing bud of 
stage 22 chick embryos and incubated for stage 36 (10 days). 
(3-galactosidase-positive cells were present 24 hours after injection in 
the humerus (A,B. arrow), i.e. in the proximal region corresponding 
to the site of injection. After 10 days’ incubation, |3-galactosidase 
activity was present in several tissues, including perimysium (C), 
tendon (D), bone (E, arrow) and articular fibrocartilage (F. arrow). 
Using anti-/ucZ and bovine-specific collagen type 1 antibody, bovine 
cells and collagen were co-localised in articular fibrocartilage 
(G, arrow), tendon (H. arrow), perimysium (I, arrow) and bone 
(J. arrow). Samples from animals injected with deep zone cells 
contained few /ucZ-positive cells and when present were not 
identifiable in any organised tissue (K. arrow).
Nl-selected surface zone cells also had an increased colony 
forming efficiency compared with unselected cells. These 
results suggest that Notch 1 plays a significant role in the 
signalling mechanisms controlling the clonality of surface zone 
chondrocytes, although given that approximately 75% of 
surface zone cells express Notch 1 and only 1-2% of these 
selected cells form colonies. Notch 1 expression per se is not a 
specific marker of progenitor chondrocytes. The precise role of 
Notch in the promotion of clonality or maintenance of 
progenitor status remains unclear, although our own studies 
have shown the expression of several Notch ligands (Jagged and 
Delta) in articular cartilage, although their expression is not 
specific to the articular surface (Hayes et al.. 2003). Notch 1 
signalling may play one of two roles in the surface zone of 
articular cartilage; it may function to maintain cells in a 
proliferative state, i.e. maintain clonality, or it may promote 
chondrocyte differentiation and hence cartilage growth. In skin, 
activ ation of Notch by Delta promotes terminal differentiation, 
i.e. prevents proliferation (Lowell et al., 2000). however the 
high CFE of Notch 1-selected chondrocytes and the reduction 
in CFE by Notch signal inhibition would suggest that Notch 1 
signalling within articular cartilage maintains clonality and 
proliferation. These inhibitory effects are negated by activated 
Notch but activated Notch does not increase colony forming 
ability, suggesting that clonality is dependent upon rate limiting 
factors downstream of Notch signalling.
Cartilage explants cultured with DAPT contain a 
hypocellular zone beneath the articular surface and BrdU 
immunolabelling highlights the lack of proliferation in DAPT- 
treated samples. These results would indicate that Notch 
inhibition via DAPT inactivation of presenillin prevents 
chondroprogenitor proliferation, thus depleting the number of 
daughter cells capable of differentiating and contributing to 
articular cartilage growth.
At present, we cannot sate which member of the Notch 
family controls chondrocyte proliferation/differentiation, but 
the results o f the immunolabelling for Notch 1 in both bovine 
and mouse (Hayes et al., 2003) and the enhanced clonality of 
Notch 1-selected chondrocytes suggests that this family 
member is central to cartilage growth and differentiation.
The engraftment of bovine surface zone-derived cells and 
their tissue-specific matrix synthesis in ovo highlights the 
plasticity of this cell population. This plasticity further 
supports our argument that these cells represent a progenitor 
population as plasticity is a key marker of a stem cell 
population (Morrison et al., 1997).
We conclude that immature articular cartilage contains a
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population of progenitor cells (which as yet has no definitive 
marker) that is responsible for the appositional growth of the 
tissue and that this population of cells exhibits a significant 
degree of plasticity in its differentiation pathway. The existence 
of a progenitor population within the surface zone of articular 
cartilage opens up the possibility of using this population 
to engineer cartilage in vitro. Because these cells are 
undifferentiated, they should have the capability to reproduce 
the structural and hence biomechanical properties of normal 
articular cartilage and thus integrate more fully into articular 
cartilage lesions.
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